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ABSTRACT 
Biosynthetic Studies on Tropic Acid and Piliformic Acid 
This thesis is divided into two parts and covers biosynthetic studies on two secondary 
metabolites, tropic acid in Part I and piliformic acid, in Part II. 
(S)-Tropic acid is the acid moiety of the alkaloids hyoscyamine and 
scopolamine, which are produced by a number of plants of the Solanacae family. An 
intriguing rearrangement of the L-phenylalanine side chain gives rise to the 
isopropanoid (S)-tropic acid skeleton. The detailed nature of the rearrangement has 
however remained elusive despite continued interest over the years. In chapter two the 
identification of intermediates between L-phenylalanine and (S)-tropic acid is 
discussed, which has placed (R)-D-phenyllactic acid as an immediate precursor. The 
stereochemical features of the rearrangement are described in chapter 3 and finally in 
chapter 4 a mechanism for the rearrangement is proposed. This is based on information 
obtained from the incorporation of various isotopically labelled precursors to tropic acid 
into two of the minor alkaloids, 3a -2'-hydroxyacetoxytropane and 3a-
phenylacetoxytropane. This work was carried out in collaboration with Dr Richard 
Robins at the AFRC Institute of Food Research in Norwich. 
Piliformic acid is elaborated by the slow growing fungus Poronia piliformis. 
The incorporation of a number of isotopically labelled substrates into piliformic acid 
has revealed a mixed biosynthetic origin, comprising Cg and C3 fragments. These have 
been shown to be of acetogenic and citric acid cycle origins respectively. The Cg 
fragment has been further demonstrated to be a degradation product of a longer chain 
fatty acid. The mode of coupling of the two fragments has been investigated and 
suggests the intermediacy of a novel a-carboxyoctanoate. A pathway for the assembly 
of piliformic acid, involving a 1 ,3-hydrogen shift, is proposed, consistent with the 
above findings. These results are the subject of chapter 6. 
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.. . And scientists, who ought to know, 
Tell us that it must be so. 
Oh, let us never, never doubt, 
What nobody is sure about. 
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FORWARD 
RadioD and Stable Isotope Labellin~: as a Tool for Biosynthetic Studies 
Classically radioisotope labelled molecules have been used to follow the fate of 
substrates administered to biological systems, primarily 14C, 3H and 32p_ The attraction 
of this technique lies primarily in its sensitivity. The tracer is detected by scintillation 
counting and a very low level of activity can be recorded. In addition the half-life of 
l4C is 5600 years and that for 3H is 12.26 years, therefore losses due to decay can be 
essentially neglected. However, a significant disadvantage of radiolabelling is that 
scintillation detection is not site-specific. To follow the fate of an individual carbon 
atom from the precursor into the molecule of interest, each carbon must be identified 
uniquely by chemical degradation and the degradation products rigorously purified. In 
essence, each carbon of interest must be individually carved out. There are also 
problems associated with handling radioactive material, such as contamination of 
personnel and cross contamination between high and low level sources. 
With the advent of high field NMR analysis the use of stable isotopes became 
widely used in biosynthetic studiesl,2 with 13C NMR being most commonly used as an 
analytical tool. It has a low natural abundance ( = 1.1%) which means that even low 
levels of incorporation can be readily detected. Comparison between a labelled and 
unlabelled 13C-NMR spectrum quickly shows which sites have become enriched by 
comparing peak heights. The level of incorporation can also be determined from the 
peak integrals. The interpretation of spectra is facilitated by proton decoupling and the 
wide chemical shift range of carbon. 
Deuterium labelling, combined with 2H NMR analysis offers an even more 
sensitive probe, since the natural abundance of 2H is only 0.016%. The short relaxation 
time of deuterium avoids saturation problems and the relative levels of deuterium 
incorporation can therefore be accurately assessed by integration. The 2H chemical 
shifts correspond very closely to the I H chemical shifts and therefore a fully assigned 
I H NMR spectrum enables the 2H resonances to be assigned, although the range of 
resonances (in Hz) is only about 15% of that for I H. Deuterium is a quadrupole nucleus 
(spin = l) and consequently the principal disadvantages of 2H NMR analysis are the low 
sensitivity to detection (low magnetogyric ratio) and broadening of the signals. 
Tritium can also be assayed directly by 3H NMR and since tritium has the 
highest magnetogyric ratio of any known element, and a nuclear spin of I12, the lines in 
the spectra are sharp and relatively small quantities can be detected. Again, the 
chemical shifts correspond to proton resonances. The very low natural abundance of 
tritium ( l Q-15%) also facilitates detection of tritium enrichment, although this method is 
not as sensitive as scintillation counting. The assessment of tritium by 3H NMR is site 
specific. However the principal disadvantage of 3H NMR is that the level of tritium 
required risks contamination between high and low level sources. 
The integrity of chemical bonds in the administered precursors and final 
metabolite can be probed with double labelling techniques. Since the abundance of Be 
is low the probability of two Bes lying adjacent to one another in the same molecule is 
very small ( 1.1 o/o x 1.1 o/o) and coupling between two Bes is not normally observed. If 
however a precursor, with adjacent I3es such as 1,2-[l3e2]-acetate, is introduced any 
residual coupling in the recovered metabolite indicates that the (acetate) e-C bond has 
remained intact during the biosynthetic process. 
The fate of deuterium can also be followed with 13e NMR. Deuterium has a 
spin of l and will couple to the Be that it is attached to. Thus when a 2H is tagged to a 
l3e atom it can be readily observed in the Be NMR spectrum. Furthermore a carbon 
attached to a deuterium will be shifted upfield by 0.25-0.3ppm per deuterium. This is 
known as the a-effect (l3e-D). The number of deuteriums may then be directly 
observed by the magnitude of the shift related to that at natural abundance. Where the 
spectrum is complicated by the coupling of a carbon atom with one two or three 
2 
deuterium atoms attached in different molecules, the signal can be collapsed to show a 
series of singlets by simultaneously decoupling deuterium and hydrogen (i.e. 13CH3, 
13CH2D, 13CHD2, 13CD3) by use of a NMR machine with a triple resonance probe. 
Carbon-13 adjacent to a C-D group is also shifted to lower frequency. This is 
the ~-effect (13C-C-D). It is a smaller effect resulting in a shift of only 0.05-0.0Sppm 
per deuterium atom but it is still observable and a useful tool. When an enriched carbon 
is placed next to a site with several deuterium atoms attached, the shift is additive, and 
hence the presence and number of deuterium atoms can be deduced directly without 
loss of signal to noise, as there is no 2J13c-2H coupling. The fate of 18Q can similarly be 
followed by 13C NMR, through the induced chemical shift in the 13C spectrum. 3 
Another technique, increasingly used for isotope detection, is mass spectral 
analysis, often combined with GC or HPLC purification. The principal attractions of 
this technique are that much smaller samples can be analysed compared to NMR 
techniques. The number of isotopes in a particular molecule can also be assessed. The 
disadvantage however, as with radioisotope labelling, is that the detection of 
incorporation is not site specific and chemical degradation may prove necessary to 
locate the isotope. 
Techniques using isotopes other than carbon-13 are particularly useful as they 
give information beyond the assembly of the carbon skeleton of the molecule, revealing 
details of the origin of the peripheral hydrogens or heteroatoms. For example, the 
incorporation of 18Q from 1802 into isoflavonone (chapter 4) indicated a radical rather 
than an ionic process for the rearrangement of flavanone to isoflavonone.4 Deployment 
of these techniques with suitably designed substrates allows the site specific enrichment 
of carbon atoms and the integrity of C-C and C-D bonds to be evaluated directly in a 
biosynthetic study, without recourse to the more tedious, traditional radiolabelling 
approach. 
3 
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PART I 
THE 
BIOSYNTHESIS 
OF 
TROPIC ACID 
CHAPTER! 
Introduction and Background 
1.1 Introduction 
(S)-Tropic acid (1) is the acid moiety of the tropane alkaloids, hyoscyamine (2) and 
scopolamine (3) (fig. 1), secondary metabolites which are produced by plants of the 
Solanacae family. The hallucinogenic and hypnotic properties of these alkaloids, 
together with their high toxicity has led to many of the tropane alkaloid producing 
plants becoming infamous through their associated folklore.l.2 These plants include 
mandrake (Mandragora officinarum), henbane (Hyoscyamus niger), deadly nightshade 
(Atropa belladona) andjimson weed (Datura stramonium). 
0¥0H 
())H 
(S)-tropic acid (1) 
Me}R 
-. 0 . 
Y'O 
hyoscyamine (2) 
MejRN 
0 . _,.oH 
... 
. 0 . 
Y'O 
scopolamine (3) 
The use of extracts of these plants as poisons, in magico-religious activities and as 
medicines has been recorded since biblical times. Mandrake has been long associated 
with fertility and the priestesses of the Delphic Oracle would inhale the smoke from 
burning henbane. As mandrake plants became prized for their medicinal and devinatory 
6 
uses a wealth of legends grew regarding the collection of the plants. The mandrake, 
when uprooted was believed to utter a shriek so terrible that any who heard it would 
die. Consequently a number of collection rituals arose, commonly using dogs to pull up 
the plants. The use of tropane alkaloid producing plants in witchcraft did not become 
widespread until the Middle Ages when a means of avoiding the risks associated with 
oral administration of the plant extracts was discovered. Extracts of various 
combinations of mandrake, henbane and deadly nightshade were combined with fats to 
make 'witches salves' or 'flying ointments' which were spread onto the skin, thus the 
transdermal absorption of the readily fat soluble alkaloids was facilitated. The 
hallucinogenic effects of hyoscyamine intoxication undoubtedly accounts for the 
experiences of flying and lycanthropy reported by witches and werewolves. Deadly 
nightshade later found a cosmetic use. Renaissance ladies would use the juice of the 
berries in their eyes, to dilate the pupils, which was considered to be attractive. The 
name belladona derives from the Italian, meaning beautiful woman. Atropine (racemic 
hyoscyamine), the principal alkaloid found in Atropa belladona, was used for the same 
purpose in ophthalmology until recently when it was replaced by safer synthetic 
analogues. 
Both hyoscyamine and scopolamine are acetylcholine antagonists, selectively 
blocking the muscarinic class of acetylcholine receptors. The physiological effects of 
hyoscyamine or scopolamine intoxication are an increased heart rate, vasodilatation, 
(which causes the skin to become flushed), smooth muscle relaxation, pupil dilation, 
and drying up of the glandular secretions of the nose, throat and bronchial passages. In 
overdose death is ultimately a result of respiratory failure. Hyoscyamine and 
scopolamine, in controlled doses, have also found much use in modem medicine. The 
hypnotic effect of scopolamine is used in premedication prior to surgery and in sleeping 
pills, while the antispasmodic, antiemetic properties of hyoscyamine have made it 
useful in the treatment of gastroenteritis, motion sickness and ulcers. Hyoscyamine is 
also an antidote to nerve gas. 3 Nerve gas contains fluorophosphoric acids which inhibit 
choline esterase, the enzyme responsible for the breakdown of acetylcholine in 
7 
synapses. Extracts from tropane alkaloid producing plants are still used in some parts of 
the world to treat asthma, and synthetic analogues, which relax the bronchial tubes 
without the associated effects on the heart, are used in modern anti-asthma drugs. 
1.2 The Use of Trans&enic Root Cultures in Biosynthetic Studies 
The biosynthesis of hyoscyamine (2) has been shown to occur exclusively in the roots 
of the plants, although the oxidative elaboration of the tropane skeleton to generate 
scopolamine occurs predominantly after translocation to other parts of the plant. 4 It has 
further been observed that root cultures of plants have the ability to synthesise alkaloids 
characteristic of the plants from which they are derived. In one experiment where 
reciprocal grafts between tobacco plants and tomato were performed it was found that 
nicotine only accumulated in the plants with the tobacco roots.5 
Transgenic root cultures, or 'hairy roots' offer advantages over the use of whole 
plants for biosynthetic studies, since they grow rapidly and can be harvested after only 
two weeks growth, whereas whole plants take several months. Transformed root 
cultures are also amenable to manipulation in the same way as callus or suspension 
cultures without the associated problems of genetic stability or maintenance of 
secondary metabolism. They are cultured in sterile conditions and will grow and 
produce secondary metabolites in the absence of phytohormones.4,6 There is potential 
for the use of transformed root cultures in the generation of commercially important 
n~tural products as well as for biosynthetic studies. Transgenic root cultures are 
produced by a natural genetic engineering process that occurs when a plant is infected 
by the plant pathogenic bacterium Agrobacterium rhizogenes, responsible for hairy root 
disease in plants. To effect the transformation an aseptic tissue culture is stabbed with a 
hypodermic needle containing the bacteria. A plasmid from the bacteria enters the plant 
cell and encodes the proliferation of fast growing 'hairy roots' at the site of inoculation. 
After antibiotic treatment to kill the remaining bacteria, the hairy roots can be grown 
and subcultured indefinitely. 7 
8 
1.3 The Biosynthesis of the Tropane Skeleton 
The carbon atoms of the tropane skeleton are derived from ornithine (4) and acetate (5) 
as shown in fig. 2. 
M:~2 
6,_, 4~ 3 
OH 
/ 
• 
from 
from 
0 
~OH 
5 
The incorporation of ornithine into the pyrrolidine portion of the tropane skeleton was 
first established by Leete in 19548 and was later shown to be unsymmetrical, [2-14C]-
labelling only the C-1 bridgehead carbon9,10 (fig.3). 
Datura 
• ~··••OR 
Fig. 3 
• = t4c 
This pyrrolidine ring is however common to a number of alkaloids including hygrine 
(6), cuscohygrine (7), nicotine (8) and the tropane alkaloid cocaine (9) (fig. 4). Many of 
these alkaloids are produced by a number of different species and while ornithine is 
incorporated unsymmetrically into some, as is the case with hyoscyamine produced by 
D. stramonium, in others symmetrical incorporation is observed and label from [2-14C]-
ornithine is distributed equally between the C-1 and C-5 carbons.ll-13 The most 
obvious interpretation of the unsymmetric incorporation of ornithine into the 
pyrrolidine moiety of hyoscyamine is the absence of a symmetrical intermediate in the 
biosynthetic pathway. o-N-Methylornithine (10)14-16 was proposed as a biosynthetic 
intermediate, thus retaining the identity of the two C-2 and C-5 ~arbons of ornithine 
through N-methylputrescine (11), an established intermediate. I? 
9 
cu N 
Me 
hygrine (6) cuscohygrine (7) 
MeN C02Me ~OC{O)Ph 
nicotine (8) cocaine (9) 
N-Methylputrescine was then assumed to undergo transammination to 4-N-
methylaminobutanal (12) and cyclise to form an N-methylpyrrolinium salt (13) which 
is then further elaborated to tropinone (14) (fig. 5). 
--~ Me~J)-H --~ D 
x- Me 
12 13 
Fi~. 5 
. --MeN J\_ NH, 
H 
11 
--~ 
0 14 
The conversion of labelled ornithine (4) to 4-N-methylaminobutanal (12) has been 
demonstrated in vivo.18 It was originally proposed that the double bond of the N-
methylpyrrolinium salt might isomerise and so explain the symmetrical labelling 
patterns observed in some species. Leete has however failed to observe this 
phenomenon both in vitro and in vivo, in Nicotiana tabacum to generate nicotine 
labelled only on the C-2' carbon of the pyrrolidine ring19 (fig. 6). 
10 
0 
+ N -Me X 
0 
+ N -
Me X 
Putrescine (15) itself has also been successfully incorporated into the tropane 
alkaloids20,21 although this was initially interpreted as an aberrant pathway since it is a 
symmetrical molecule.I3 However, since the symmetrical incorporation of ornithine by 
some species cannot be explained through the isomerisation of the N-
methylpyrrolinium salt and the incorporation of putrescine has been demonstrated, it 
was necessary to invoke putrescine as an intermediate. The separate identity of the C-2 
and C-5 carbons of ornithine could be explained by suggesting that free putrescine was 
not an intermediate, rather an enzyme bound form resulting from the decarboxylation of 
ornithine which is then methylated to N-methylputrescine.l3 This has been verified as 
the pathway to the N-methylpyrrolinium salt in vivo (fig. 7) and the enzymes involved, 
ornithine decarboxylase (ODC), putrescine methyltransferase (PMT) and N-
methylputrecine oxidase (MPO) are well described .22 
ODC 
~
MPO J1_ ~Me~ O H ~ 
12 
0 
+N 
x- Me 
13 
Fig. 7 
PMT 
~
~ 
MeNJ\_NH2 H 
11 
~ 14 0 
It is now known that in some species the predominant precursor to putrescine is actually 
arginine (16), rather than ornithine. The metabolic relationship between these amino 
acids is shown in fig. 8. The incorporation of agmantine (17), an intermediate between 
11 
arginine and putrescine, has been demonstrated and through the selective inhibition of 
either ornithine or arginine decarboxylase activity, the major pathway has been 
revealed. 23 
t arginase 
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The remaining carbons of the tropane skeleton have been shown to derive from 
acetate. Acetoacetate (18) is also efficiently incorporated and had gained general 
acceptance as a bonafide intermediate.24 This would involve condensation between the 
N-methylpyrrolinium salt and acetoacetate, possibly activated as its coenzyme-A ester 
to generate a.-carboxyhygrine (19). Decarboxylation to generate hygrine (6), an 
established intermediate in hyoscyamine biosynthesis24,25 would be followed by 
oxidation of the pyrrolidine ring, and finally the cyclisation of hygrine would generate 
tropinone (fig. 9). 
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[I-14C]-Acetate has been shown to label C-9 of cocaine, consistent with this hypothesis 
(fig. 10). However, the mode of incorporation of acetate into tropinone has remained a 
contentious issue and this generally accepted pathway, utilising acetoacetate, has been 
called into question, and has recently been re-evaluated. 
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Fig. 10 
The reaction between the N-methylpyrrolinium salt and acetoacetate is a facile process 
and occurs spontaneously in vitro26 and there has been speculation that the 
incorporation of acetoacetate in vivo simply represents an alternative, non-enzymatic 
pathway)3,22 It became clear that an alternative biosynthetic pathway to the tropane 
skeleton was operating when Leete and Kim27 observed the incorporation of [1-13C, 
14C, 15N]-(methylamino)butanal diethylacetal (20) into cocaine and were surprised to 
observe that C-5, rather than C-1 became enriched (fig. 11). If acetoacetate is a true 
intermediate this would require the C-4 of acetoacetate (or its coenzyme-A ester) to 
react with the N-methylpyrrolinium salt, a pathway which is less reasonable than 
condensation with C-2. 
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This led to a new proposal where the acetate derived carbons were incorporated via 
malonyl-CoA (21), as shown in (fig. 12).24 Hydrolysis and decarboxylation of 22 
would then be a necessary prerequisite for hyoscyamine biosynthesis . 
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The intermediacy of acetoacetate was finally discredited by Hemscheidt and Spenser28 
who demonstrated that [ 1 ,2,3,4-13C4]-acetoacetate was not incorporated intact into 
hyoscyamine, but instead gave the same labelling pattern as [ 1 ,2-l3C2]-acetate in 
hyoscyamine from D. stramonium (fig. 13), indicating that the acetoacetate had been 
degraded to acetate prior to incorporation. 
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It was also observed28 that the two bridgehead carbons were equally labelled in these 
experiments, and that N-methyl-[2-2H]-pyrrolinium chloride (13a) placed deuterium 
equally at the two bridgehead positions (fig. 14). This suggested that perhaps either 
achiral N-methylpyrrolidine or racemic hygrine may be involved in tropinone 
biosynthesis. 
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A similar result was obtained through feeding [2'3'-l3C2]-hygrine (6a) and ethyl 
[2',3'13C2]-N-methyl-2-pyrrolidinyl-3-oxobutyrate (22a) to D. innoxia (fig. 15).29 
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The ketone functionality of tropinone is finally reduced to generate tropine prior 
to esterification. Two tropinone reductases have been identified, and purified from 
several sources.22 They are specific for either the reduction of tropinone to tropine (23) 
or its 3-~-epimer, pseudotropine (24) (fig. 16). 
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The conversion of the tropine moiety to the 6,7-epoxide moiety of scopolamine (3) 
occurs after hyoscyamine formation (fig. 17). 30 The first stage of this conversion is C-6 
hydroxylation to give 6-~-hydroxyhyoscyamine (25), an isolable intermediate. 
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Fig. 17 
The enzyme responsible for the conversion of hyoscyamine to scopolamine has been 
shown to require iron (II), oxygen, and oxoglutarate.31 It has so far proved impossible 
to separate the hydroxylation and epoxidation activities and it cannot be discounted that 
a single protein may be responsible for both activities. 32,33 
1.4 The Biosynthesis of Tropic Acid: An Historical Perspective 
The biosynthesis of tropic acid (1) has attracted interest over many years34,35 and was 
first investigated by Leete in the 1960s.36 It was initially proposed that tropic acid may 
be derived from prephenic acid (26),37 which is an established intermediate in the 
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biosynthesis of many aromatic compounds. Two plausible routes were suggested, 
differing only in the timing of the introduction of the hydroxymethyl group (fig. 18). It 
was envisaged that either formaldehyde or a biosynthetic equivalent would attack 
prephenic acid itself, or that prephenic acid would first be degraded to phenylacetic acid 
(27) via phenylpyruvic acid (28). 
Leete administered DL-[3-13C]-phenylalanine to D. stramonium plants to investigate 
the intermediacy of phenylpyruvic acid. The incorporation of phenylalanine would 
clearly implicate phenylpyruvate as an intermediate, since the two can interconvert via 
transammination (fig. 19). 
29 28 
Fig. 19 
In the event DL-[3-13C]-phenylalanine was efficiently incorporated, labelling the 
benzylic carbon (fig. 20), a result later confirmed by Underhill and Youngken.38 
However, attempts to probe the postulated C-1 origin of the hydroxymethyl group, by 
feeding [14C]-formate, were unsuccessful, although this negative result was 
inconclusive as formate is a poor C-1 source in plants. 
D. stramonium • = t4c 
Fig. 20 
In a second experiment Leete and Louden39 administered DL-[2-14C]-phenylalanine, 
expecting to see incorporation into the carboxyl carbon of the tropate moiety, however, 
it was the hydroxymethyl group which was uniquely enriched. This then led to the 
17 
suggestion that C-1 of phenylpyruvic acid might be lost (fig. 21) during the 
biosynthesis. 
·--~ 
Fig. 21 
L-[ 1-14C]-Phenylalanine was later shown to specifically and efficiently label the 
carboxyl group of tropic acid (fig. 22), which demonstrated that all the carbons of tropic 
acid were derived from L-phenylalanine.40, 41 
0 0¥0H 
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Fig. 22 
The discovery of the coenzyme B 12 mediated rearrangement of succinyl-CoA (30) to 
methylmalonyl-CoA (31) (fig. 23)42 at the time prompted Leete to speculate41 that the 
rearrangement of the linear propanoid L-phenylalanine side chain to the isopropanoid 
tropate side chain might have a related mechanism. 
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Leete et af43 later carried out a definitive experiment administering DL-[1,3-13C2]-
phenylalanine to D. innoxia plants and observed that the l3C enriched sites were 
18 
coupled in the 13C NMR spectrum of the isolated hyoscyamine. This study, made 
possible by the advent of high field NMR, demonstrated unequivocally that tropic acid 
was formed as the result of an intramolecular rearrangement of L-phenylalanine (fig. 
24). 
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1.5 Identification of Intermediates Between L-Phenylalanine and Hyoscyamine 
Since the realisation that all the carbons of L-phenylalanine are retained in the 
tropate skeleton, interest in the pathway has been maintained although intermediates 
between L-phenylalanine and hyoscyamine have only recently emerged. The 
identification of (R)-0-phenyllactic acid (32b) as a direct precursor is the subject of 
Chapter 2.44,45 Further, Robins et al46 have recently shown that littorine is the most 
immediate precursor to hyoscyamine to date. The rearrangement thus occurs at the 
tropine ester level (fig. 25). 
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1.6 The Stereochemistry of Tropic Acid Biosynthesis 
The fate of the hydrogens at C-3 of phenylalanine was first investigated 
independently by Haslam et a[41 and Leete48,49 who came to contradictory conclusions. 
Leete's interpretation was that a vicinal interchange process was operating, i.e. that a 
hydrogen from C-3 of L-phenylalanine migrated in the reverse direction to the carboxyl 
moiety. He further concluded it was the 3-pro-S hydrogen of L-phenylalanine which 
underwent the backmigration, resulting in retention of configuration at C-2 of tropic 
acid (fig. 26). This view has gained general acceptance. 
D. innoxia 
Fig. 26 
The stereochemical course at the other migration terminus had not previously been 
investigated. It was not known whether the C-2 hydrogen of (R)-D-phenyllactic acid 
occupied the 3'-pro-R of 3'-pro-S site of hyoscyamine after the rearrangement. Through 
the use of chiral methyl methodology we have demonstrated that this hydrogen 
occupies the 3'-pro-S site, and that the new hydrogen is introduced to the 3'-pro-R site, 
and therefore the configuration at this centre is inverted (fig. 27) during the 
biosynthesis. 50 
0 
D. stramonium 
OH 
Fig. 27 
This result indicated the operation of a retention - inversion process, which was difficult 
to reconcile with the accepted view of a vicinal interchange process, as the hydrogen 
would have to be removed from and delivered to opposite faces of the molecule. This 
20 
prompted us to re-evaluate the stereochemical course of the rearrangement at C-2' of 
hyoscyamine.SI From our results we could find no evidence for a vicinal interchange 
process, but observed the complete loss of the 3'-pro-R hydrogen of (R)-D-phenyllactic 
acid and the retention of the 3'-pro-S hydrogen at C-2' of hyoscyamine (fig. 28). These 
conclusions, which contradict Leete's results, are discussed in Chapter 3. 
Fig. 28 
Finally, the incorporation of a number of phenyllactic acids into two of the 
minor tropane alkaloids, 2'-hydroxyacetoxytropane (34) and phenylacetoxytropane (35) 
(fig. 29) was investigated in collaboration with Dr Richard Robins, then at the AFRC 
Institute of Food Research in Norwich. We present evidence, in Chapter 4, that these 
two alkaloids are shunt metabolites of the rearrangement of littorine to hyoscyamine 
and propose a putative mechanism for the rearrangement, involving an iron-oxo 
initiated radical process. 52 
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phenylacetoxytropane (35) 
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CHAPTER2 
Intermediates Between L-Phenylalanine and Hyoscyamine 
2.1 The Intermediacy of Phenyllactic Acid 
It has been established since 1962 that all the carbon atoms of the phenylalanine side 
chain are utilised in tropic acid biosynthesis.! Further, an intramolecular carbon skeletal 
rearrangement is involved2 between L-phenylalanine and hyoscyamine. However, the 
true intermediates have only recently emerged from an array of candidate precursors. 
Cinnarnic acid (36) is a key intermediate in the biosynthesis of a wide variety of 
non-nitrogenous aromatic plant secondary metabolites. These include cinnamoyl esters, 
alcohols, flavanones, xanthones and benzoic ester derivatives) Cinnamic acid is 
derived directly from L-phenylalanine by the action of phenylalanine ammonia lyase 
(fig. 30). 
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Its widespread occurrence in the biosynthesis of plant phenylpropanoids (C6-C3 
compounds) made it an attractive intermediate in tropic acid biosynthesis.4 However, 
Woolley5 and Leete6,7 have independently failed to observe the incorporation of 
radiolabelled cinnamic acids into the tropane alkaloids. Experiments have also been 
carried out with (R)- and (S)-3-hydroxy-3-phenylpropionic acids (37)6 and 
epoxycinnamic acid (38)7, both plausible oxygenated derivatives of cinnamic acid. 
Some support for this hypothesis was provided by the evidence that the epoxide of 
cinnamic acid, as its phenyl thiolester (39) could be induced to rearrange in vitro with 
25 
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the addition of boron trifluoride etherate,S through carboxyl migration,9 to furnish the 
tropate skeleton as a-formylphenylthiolacetate (40). The tropate oxidation level could 
then be achieved by a selective reduction with sodium cyanoborohydride9 (fig. 31 ). 
However, no in vivo incorporations of these acids have been observed. 
Fig. 31 
NaBH3CN 
.. 
There is one isolated report of the incorporation of cinnarnic acid into tropate esters.lO 
However, this has subsequently been disregarded as the probable result of 
radiochemical contamination of the alkaloids with a cinnamic acid derivative.6 More 
recently the intermediacy of 2-phenyl-3-aminopropionic acid (41) has been 
investigated, 11 the putative product of a rearranging enzyme acting directly on 
phenylalanine. However, in the event this compound was not incorporated into 
hyoscyamine in D. innoxia plants. These results are summarised in fig. 32. 
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Fig. 32 
26 
Attention then turned to two other phenylpropanoid carboxylic acids, 
phenylpyruvic acid (28) and phenyllactic acid (32). These were clearly potential 
precursors since the two can interconvert with L-phenylalanine (29), through 
transammination and reduction, processes which are facile and well documented. 12-15 
(fig. 33). 
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All of these acids are incorporated into the tropane alkaloids at high and approximately 
equallevels.5,7,16-l8 Consequently feeding experiments with these precursors, carrying 
isotopic labels on the carbon skeleton, had not delineated the closer precursor. 
Phenyllactic acid is an attractive precursor as the functional group interconversion of 
the -NH2 to -OH is then set up to furnish the hydroxymethyl moiety of tropic acid. 
A mounting body of circumstantial evidence has appeared in the literature over 
the past 25 years in support of this view. In 1969 Evans and V. A. Woolley19 observed 
the incorporations of 14C labelled phenylalanines into littorine (33), the ester of 
Me~ = R 
Fig. 34 
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phenyllactic acid (32) and tropine (23), hyoscyamine (2) and scopolamine (3). Their 
observation that the level of incorporation of radioactivity decreased in the order 
littorine > hyoscyamine > scopolamine was consistent with phenylalanine being a more 
direct precursor to phenyllactate than tropate (fig. 34). 
More recently Kitamura et aL.20 have directly observed the interconversion of 
phenylalanine (29) and phenyllactic acid (32) in tropane alkaloid producing root 
cultures of Duboisia lecharditti. This was shown by using an isotope trapping 
technique. The technique involved the simultaneous feeding of [t-14C]-phenylalanine 
and unlabelled phenyllactic acid. After incubation, the phenyllactic acid isolated from 
the root cultures was rigorously purified and found to be radioactive, i.e. the radioactive 
phenylalanine had been "trapped" as phenyllactate. Incorporations of radioactivity into 
the alkaloids were reduced in comparison to previous experiments feeding only the [ 1-
14C]-phenylalanine without phenyllactic acid. Trapping techniques have precedence in 
the determination of biosynthetic intermediates, however, the possibility that the 
trapped phenyllactate was not used for the production of tropane alkaloids, but for some 
other metabolite, could not be excluded. Attempts were also made to trap both 
phenylpyruvic acid (28) and tropic acid (1) without success. Phenylpyruvic acid (28) is 
a necessary intermediate between phenylalanine (29) and phenyllactic acid (32) and the 
failure to trap this acid has been attributed to the inability of the cultures to directly 
utilise exogenously added phenylpyruvic acid in alkaloid biosynthesis. 
Competitive feeding experiments with [t-14C]-phenyllactic acid and [2-14C]-
phenylpyruvic acid together, with unlabelled precursors, placed phenyllactic acid closer 
than phenylpyruvic acid to the tropate moiety.16 Subsequently Ansarin and Woolley21 
. inferred the obligate intermediacy of phenyllactic acid from the observation that tritium 
from (RS)-[t-14C, 2-3H]-phenyllactic acid is incorporated into the tropoyl moiety of 
hyoscyamine (fig. 35). Over a series of experiments the 3H: 14C ratio of the recovered 
tropic acid remained similar to the administered phenyllactic acid. This result, although 
surprising, given that racemic phenyllactic acids were administered and despite the very 
28 
low incorporation (0.0 1% ), provided the strongest evidence to that date that 
phenyllactic acid was an obligatory intermediate in the biosynthesis of tropic acid. 
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In light of the mounting evidence for the intermediacy of phenyllactic acid, a 
definitive experiment was conducted to lay the issue to rest. 
2.2 Experimental Work to Determine the Role of Phenyllactic Acid 
As discussed previously, phenylalanine (29), phenylpyruvic acid (28) and phenyllactic 
acid (32) readily interconvert and all are incorporated efficiently into the tropoyl moiety 
of hyoscyamine (2) and scopolamine (3). Labelling solely on the carbon skeleton of 
these molecules is therefore insufficient to fully assess their position in the tropic acid 
biosynthetic pathway. Here a dual l3C..2H isotopic labelling strategy was employed. If 
deuterium retention from the chiral centre of phenyllactic acid (32) could be 
demonstrated then this would place it as a more direct precursor to tropate than 
phenylpyruvic acid (28) or phenylalanine (29), since oxidation of the phenyllactate to 
phenylpyruvate would result in irretrievable loss of deuterium (fig. 36). The deuterium 
was tagged to a l3C reporter atom to render its presence identifiable in the l3C NMR 
spectrum. This technique can also be used to assess the extent of deuterium washout. 
To this end [2-l3C,2H]-phenyllactic _acid (32a) was synthesised and administered to 
transformed root cultures of Datura stramonium. 22 
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2.3 The Synthesis of [2al3~ 2HJ-Phenyllactate (32al 
D retained 
D lost 
[2-l3C,2H]-Phenyllactic acid was synthesised according to the route outlined in scheme 
1, starting from the commercially available [1-13C]-phenylacetic acid (27a). The 
carboxylic acid was converted to its methyl ester (42a) and then the deuterium was 
introduced by reduction with lithium aluminium deuteride. Oxidation to 
phenylacetaldehyde (44a) with PCC followed by formation of the cyanohydrin (45a), 
and then hydrolysis, generated the required phenyllactic acid. This route proved 
versatile in the syntheses of a number of other labelled phenyllactic acids and has the 
potential to be further modified to place a l3C label at either C-1 or C-3 of phenyllactic 
acid by the use of sodium [l3C]-cyanide or [2-13C]-phenylacetic acid respectively. 
0"!0 CJ!o ii OAOH ... ... 
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(i) CH2N2, (ii) LiAlD4 (iii) PCC, 3A sieves, (iv) Na2S20s, 
(v) NaCN (vi) 50% HCl (vii) 0.1M NaOH 
Scheme 1 
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2.4 f1.13k_ 2H21-2-Phenylethanol (43a) 
[I-13C]-Phenylacetic acid (27a) was converted to its methyl ester (42a) in quantitative 
yield by treatment with an excess of diazomethane in ether. This modification proved 
necessary in order to effect a smooth reduction in the next step. Reduction with lithium 
aluminium deuteride then generated [1-l3C, 2H2]-2-phenylethanol (43a) in 86% yield. 
2.5 f1.13k_ 2HJ-Phenylacetaldehyde (44a) 
The oxidation of 2-phenylethanol to phenylacetaldehyde was a key step in the synthesis 
of phenyllactic acid. This route was selected over an alternative strategy which involved 
introducing the deuterium by the direct reduction of either methyl phenylacetate or 
benzyl cyanide to phenylacetaldehyde, with an appropriately labelled reducing agent. 
Also a route to [1-l3C]-benzyl cyanide has already been established by Cox.23 A 
preparation of Li(OEt)3H from lithium aluminium hydride and ethanol has been 
published by Brown and Shoaf24 which would be amenable to the preparation of the 
deuterated analogue. This reagent proved versatile for the reduction of a variety of 
aliphatic and aromatic nitriles to generate aldehydes in good yield, however in the case 
of benzyl cyanide the enhanced acidity of the methylene protons simply led to the 
evolution of hydrogen rather than reduction. It was anticipated that this would be a 
general problem with this methodology and thus the route was abandoned. 
Attention then focused on the optimisation of the oxidation reaction. The Swern 
oxidation (DMSO and (COClh) is a classic and general route to aldehydes and ketones 
from alcohols. In an early paper discussing this reaction, Omura and Swern report only 
a 23% yield for the oxidation of 2-phenylethanol to phenylacetaldehyde by this 
method,25 the remaining material being principally unreacted starting material. Both 
benzyl alcohol and 3-phenylpropanol were oxidised efficiently under these conditions 
and no explanation for this anomalous result was offered. 
31 
Another potential approach involved the use of ruthenium dioxide and 
potassium periodate.26 This reaction is carried out in a biphasic solution of water : 
acetonitrile : tetrachloromethane (3: 1: 1 ). Initially water soluble ruthenium dioxide is 
oxidised by the periodate to organic soluble ruthenium tetroxide. The ruthenium 
tetroxide is then reduced back to ruthenium dioxide with the concomitant oxidation of 
the alcohol. However, after 24 hours the oxidation of 2-phenylethanol to 
phenylacetaldehyde was largely incomplete (33% ). 
Another classic reagent for the oxidation of alcohols to aldehydes is pyridinium 
chlorochromate (PCC). 27 While this is a versatile and mild oxidising agent reactions 
involving PCC characteristically produce sticky brown tars which hinder product 
isolation. In the event, such reactions were incomplete and low yielding. A modification 
of the PCC oxidation involves supporting the reagent on either molecular sieves28 or 
alumina. 29 This has been shown to accelerate the reaction and also to facilitate the work 
up. Accordingly, 2-phenylethanol was oxidised efficiently using PCC supported on 3A 
molecular sieves, and the crude product could be isolated simply by filtering the 
reaction mixture away from a brown powder through a silica pad. The product after 
evaporation, was slightly green, presumably due to contamination with a chromium (ill) 
species, and was purified by distillation. Yields for this reaction were between 70 and 
90%. Phenylacetaldehyde is susceptible to polymerisation, which is apparent in the 
product as a slight cloudiness or as a fine white precipitate. For this reason 
characterisation of labelled compounds was limited to 1 H NMR to avoid loss of 
material after redistillation immediately prior to use. 
2.6 (RSl-f2-13_c.2HJ-Phenyllactic Acid (32a) 
The cyanohydrin (45a) derived from [1-l3C, 2H]-phenylacetaldehyde (44a) was 
prepared according to an established procedure. 30 Initially the bisulfite adduct was 
formed and this was reacted with sodium cyanide. The cyanohydrin was hydrolysed 
directly without prior purification, using 50% hydrochloric acid, to generate (RS)-[2-
Bc, 2H]-phenyllactic acid (32a) in typically around 40% yield over the two steps. The 
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acid was then purified by recrystallisation from chloroform. The first time that (RS)-[2-
Be,2H]-phenyllactic acid (32a) was prepared it became apparent that the material was 
contaminated with approximately 3.6% [t-13e]-phenylacetic acid (43a). This was 
detected from the unusually prominent carbonyl peak in the Be NMR spectrum, which 
had not been visible in unlabelled runs. A small doublet at 3.41ppm was apparent in the 
1 H NMR and re-examination of the 1 H NMR spectra from some of the unlabelled runs 
revealed a minor singlet at 3.41ppm, consistent with this interpretation. This material 
was however used directly since phenylacetic acid is not esterified with tropine in D. 
stramonium to any measurable extent, if at all. Some evidence for an enzyme capable of 
esterifying phenylacetic acid and tropine to generate phenylacetyl tropine has been 
detected at very low levels on some Solanaceous species31 but this is not the primary 
route to phenylacetyl tropine. This assessment was validated by the result of the 
experiment, which is further discussed in chapter 4. The contamination in the prepared 
material was presumed to arise as a result of incomplete cyanohydrin formation. Such 
contamination was avoided in subsequent runs by the repeated recrystallisation of 
phenyllactic acid. 
2.7 Incorporation Studies with CRSl-PhenyUactic Acid 
Sodium DL-[2-13e,2H]-phenyllactate was administered to 5 day old transformed root 
cultures of D. stramonium and after 17 days growth the alkaloids were extracted. 
Initially the crude alkaloid extract was analysed by GC-MS and the mass enhancements 
of the alkaloids hyoscyamine (2), littorine (33), and apoatropine ( 46) (the dehydrated 
derivative of hyoscyamine, (fig. 37)) were assessed. These are given in Table 1. The 
figures are adjusted to take into account the natural abundance of heavy isotopes, and 
therefore represent actual incorporations. These results clearly indicate the 
incorporation of both Be and 2H labels into hyoscyamine, apoatropine and littorine to 
give clear M+2 mass enhancements, with smaller M+ 1 mass enhancements. 
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Littorine Hyoscyamine 
76.92% 77.36% 
5.05% 5.69% 
18.03% 16.95% 
Table 1 
Apoatr opine 
81.22 % 
5.83 % 
12.95 % 
Preparative TLe gave hyoscyamine containing a small amount (4.6%) of 
littorine. Hyoscyamine and littorine have similar chromatographic properties, however, 
the 13e NMR resonances for the e~1', C~2' and e~3' carbons are distinct, so the small 
amount of littorine did not interfere with the NMR analysis of the hyoscyamine. The 
fate of the deuterium label was determined by Be { 1 H} and 13e { 1 H, 2H} NMR (fig. 38 
and fig. 39) analysis. The incorporation of Be from [2-13e, 2H]-phenyllactate into e-3' 
of the tropate ester was clearly visible in the 13e { 1 H} NMR spectrum from the 
enhancement of the peak at 63.9ppm. The adjacent coupled peak 0.35ppm upfield (a-
shift) shows the intact incorporation of the 13e-2H bond from [2-Be, 2H]-phenyllactic 
acid. This triplet collapsed to a singlet in the Be { 1H,2H}NMR spectrum as expected. 
A similar pattern is observed for the peaks at 71.5ppm (singlet) and 71.1ppm (triplet) 
which are attributed to both single and double labelled components with e-2' of 
littorine. 
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2.8 Discussion 
It is clear from these results that the (C-2)-H bond of phenyllactic acid (32) can remain 
intact during the rearrangement process to become the (C-3')-H bond of hyoscyamine. 
This experiment demonstrates unambiguously that phenyllactic acid (32) is a more 
direct precursor to the tropate ester of hyoscyamine than phenylpyruvic acid (28) or L-
phenylalanine (29), confirming the evidence previously obtained by inferencel6,20,21 
(fig. 40). It is also apparent from the incorporations into littorine that phenyllactic acid 
is esterified directly with tropine to form this alkaloid. 
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It is also interesting to note that while the predominantly intact incorporation of the 
13C-2H bond (16.95%, hyoscyamine and 18.0% littorine, by GC-MS) was observed 
there was significant deuterium washout (5.69%, hyoscyamine and 5.05% littorine by 
GC-MS). This is also clearly evidenced from the l3C enriched singlets at 63.9ppm and 
71.5ppm in the 13C{ 1 H} NMR spectrum corresponding to C-3' of hyoscyamine and C-
2' of littorine respectively. The M+ 1 enhancements in the CG-MS analysis of 
hyoscyamine (2), littorine (33) and apoatropine (46), are approximately one third of the 
M+2 enhancements. The most reasonable explanation for this is an interconversion 
between phenyllactic acid (32) and phenylpyruvic acid (28) (fig. 41) as expected, 
especially as only one of the enantiomers present can be a substrate for direct 
rearrangement. Alternatively a phenyllactate racemase may be operating, 
interconverting the enantiomeric forms of phenyllactic acid prior to esterification with 
tropine (23). 
C02R ~co~~co~~co~~ 
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Fig. 41 
With this result, the previous contrasting report that negligible loss of 3H relative to 14C 
occurred21 is surprising. However, the operation of a kinetic isotope effect and the 
different biological system used (plants v.s. root cultures) may invalidate too critical a 
comparison between the two experiments. 
2.9 The Role of Free Tropic Acid 
It was considered for some time that the esterification of tropic acid (1) or its co-
enzyme-A ester33 with tropine (23) may be a key step in the pathway from L-
phenylalanine (29) to hyoscyamine (2). Evidence has however been accumulating 
which indicates that free tropic acid itself is not an intermediate in hyoscyamine 
biosynthesis. The first piece of evidence came from the observation of Robins et al. 34, 
35 that exogenously added tropic acid decreased rather than increased the tropane 
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alkaloid production in Datura root cultures. This result was mirrored with mandelic 
acid ( 47) (fig. 42), a tropic acid analogue, which was not esterified. 
0 
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However, no such decrease in alkaloid production was observed when phenyllactic acid 
(32), a known precursor, was administered. Hyoscyamine (2), when fed to the cultures, 
was found to accumulate to levels 30-fold in excess of natural concentrations and 
Robins et al. therefore concluded that it was neither the ability to accumulate 
hyoscyamine, nor the availability of the esterifying acid which limited hyoscyamine 
production, but rather that the tropic acid could not be directly utilised. More evidence 
to support this view can be drawn from the observation of Simola et al. that the addition 
of tropine (23) and tropic acid (1) to suspension cultures of Atropa belladonna failed to 
stimulate alkaloid production. 36 
In contrast there have been some reports that tropic acid increased the tropane 
alkaloid production,37-39 although this has only been observed in low yielding 
cultures. IS Further, one early report describes the esterification of exogenously added 
[14C]-tropic acid and tropine to form hyoscyamine in Nicotiana tabacum, however, 
these plants do not normally produce tropane alkaloids and this is the only report of this 
esterification taking place in a non-tropane alkaloid producing species.40 These 
conflicting reports prompted two groups to carry out some definitive studies to establish 
or otherwise the intermediacy of free tropic acid. 
In 1992 Kitamura et al. 41 compared the efficiency of incorporation of 
radiolabelled L-phenylalanine (29) and tropic acid (1) into the hyoscyamine (2) from 
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Duboisia leicharditii. While L-phenylalanine was incorporated into the acid moiety of 
the alkaloid at the high level expected from Leete's observations42 the tropic acid was 
incorporated at a very low level (less than l% ). Their subsequent failure to trap tropic 
acid in a similar manner to the trapping of phenyllactic acid20 combined to provide the 
strongest evidence to date that tropic acid is not an intermediate. The authors could not 
however preclude the possibility that tropic acid was metabolised to non-alkaloidal 
products before reaching the site of alkaloid biosynthesis. The conversion of tropic acid 
to glucose esters has been observed in Datura innoxia and to its glycoside in Eucalyptus 
periniana, 43 equally, such processes could explain the failed incorporation. 
It has been extensively demonstrated that free phenyllactic acid (32) is 
incorporated into hyoscyamine (2)16,17 and that it is a direct precursor to the tropate 
moiety.21,22 The relationship between phenyllactic acid (32) and tropic acid (1) has 
recently been evaluated by Robins et a[)8,44 [1,3-13C2]-Phenyllactic acid was 
administered to transformed root cultures of D. stramonium or Brugmansia candida x 
aurea and the expected high level of incorporation was observed. However, when the 
labelled phenyllactate was fed in competition with unlabelled tropic acid no reduction 
in the phenyllactate incorporations into hyoscyamine (2) or apoatropine (46) were 
observed, as would be expected if the exogenously added tropic acid was competing 
with tropic acid derived from phenyllactic acid for esterification with tropine. 
Incorporations of the labelled phenyllactic acid into littorine (33) were enhanced, which 
suggests the excess tropic acid had stimulated the metabolism of phenyllactate to 
littorine. From these results it is clear that tropic acid (1) cannot be placed as a more 
immediate precursor to hyoscyamine (2) than phenyllactic acid (32). 
These experiments combine to demonstrate that free tropic acid in not an 
intermediate in the biosynthesis of hyoscyamine. None of these results however negate 
the possibility that an activated from of tropic acid, such as its co-enzyme A ester, is 
involved. This is discussed in the following section. 
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2.10 Littorine: The Substrate for the Rearran&Une Enzyme 
The direct rearrangement of littorine (33) was first investigated by Leete,7 in whole 
plants of D. innoxia, who observed that the 3H : l4C ratio in hyoscyamine after feeding 
[3~-3H, 1 •_l4C]-littorine was substantially different to the 3H : l4C ratio in the 
administered substrate (fig. 43). This result was consistent with the hydrolysis of the 
[3~-3H, 1'-14C]-littorine to [3~-3H]-tropine and [t-l4C]-phenyllactic acid and separate 
use of the acid and base in the formation of hyoscyamine after dilution from the non-
radioactive pools, i.e. the phenyllactyl moiety of littorine did not undergo 
rearrangement to tropate while esterified to tropine. It is known that tropine esters will 
hydrolyse in vivo45, 46 and Leete did not ignore the possibility that the facile hydrolysis 
of littorine was also reversible. Hydrolysis followed by dilution of the label and re-
esterification would also effect a change in the 3H : 14C ratio, masking any small 
amount of littorine rearranging directly. This was however dismissed as improbable 
since the 3H ; l4C ratio in the recovered littorine was essentially the same as in the 
administered littorine. If such hydrolysis and re-esterification was occurring then the 
littorine 3H: l4C ratio would also be expected to change. 
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Subsequent studies in root cultures of D. stramonium have however placed 
littorine as the substrate for the rearranging enzyme. The intermediacy of littorine was 
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first implied by Sauerwein et al. 47 They observed that the level of incorporation of [I-
nc, 2-2H3]-acetate into the acetate derived carbons of the tropane skeleton decreased in 
the order tropinone > tropine > littorine > hyoscyamine > 6-hydroxyhyoscyamine and 
scopolamine. This was seen as an indication as to their position in the biosynthetic 
pathway, the earlier intermediates being the more highly enriched. The intermediacy of 
littorine was directly and recently re-examined by Robins et al. 48 Quintupally labelled 
littorine, prepared from [methyl-2H3]-tropine and [1,3-13C2]-phenyllactic acid (fig. 44). 
and was administered to transformed root cultures of D. stramonium. 
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The alkaloids were examined by GC-MS analysis and the results from feeding the 
quintupally labelled littorine, without dilution, are summarised in Table 2. 
Littorine Hyoscyamine Tropine Methyl 
Phenyllactate 
M+S 8.7% 4.4% 
-- --
M+3 3.9% 4.7% 12.2% 
--
M+2 10.1% 3.1% 18.0% 
--
Table 2 
The M+5 mass enhancement in hyoscyamine of 4.4% was considered to be too high to 
arise from hydrolysis of the littorine and separate use of the labelled tropine and 
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phenyllactic acid after dilution from the unlabelled pools. From examination of the M+3 
and M+2 incorporations into hyoscyamine it can be seen that statistical recombination 
of labelled tropine and tropic acid from independently rearranged phenyllactic acid 
could only account for an M+5 enrichment 3.1% x 4.7% = 0.2%. Further, the intact 
incorporation was increased rather than diminished by the exogenous addition of 
unlabelled phenyllactic acid or tropine. These results are therefore best explained by the 
direct rearrangement of littorine, i.e. littorine is indeed the substrate for the rearranging 
enzyme. 
It was also apparent from this experiment that the expected hydrolysis of 
littorine was still occurring. M+2 and M+3 mass enhancements in hyoscyamine of 3.1% 
and 4.4% respectively were observed arising form either the separate use of the [1,3-
l3C2]-phenyllactate or the [methyl-2H3]-tropine. The tropine and methyl phenyllactate 
pools were enriched to 12.2% and 18.0% respectively. Similarly the littorine recovered 
had an M+5 mass enhancement of 8.7% together with M+2 and M+3 mass 
enhancements of 10.1% and 3.9% respectively. Clearly littorine is hydrolysed and 
reformed from labelled phenyllactate and tropine. The greater M+2 mass enhancement 
indicates a greater re-use of the labelled phenyllactic acid than the tropine. 
The hydrolysis of the esters and recombination of the two labels would 
adequately explain the change in 3H: 14C ratio that Leete observed in hyoscyamine in 
the corresponding radioactive experiment.? It does not however fully explain the 
consistent 3H : 14C ratio observed in the recovered Iittorine, although it is interesting to 
note that the M+5 mass enhancement in Iittorine in Robins' experiment is approximately 
twice the magnitude of the M+5 enhancement in the hyoscyamine. Another interesting 
feature which cannot be fully explained is that the M+2 mass enhancement in the 
Iittorine is approximately three times greater than the M+2 mass enhancement in the 
hyoscyamine. From the argument that hyoscyamine arises solely from the 
rearrangement of littorine it follows that M+2 and M+3 hyoscyamine should only arise 
from M+2 and M+3 Iittorine. If this is the case it would be expected that the levels of 
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M+2 and M+3 enrichment in littorine and hyoscyamine would be similar. A statistical 
level of M+5 enrichment into hyoscyamine resulting from the separate use of the 
phenyllactic acid and tropine has been discussed. However, the possibility that the pools 
of phenyllactic acid I tropic acid and tropine, in a form primed for esterification, may 
become saturated with labelled material, must be considered. This would make the 
probability of label recombination events more likely than the statistical 0.2%. While 
the proportion of M+5 littorine and hyoscyamine is higher in the presence of added 
phenyllactate or tropine the figures are still small, even bearing in mind that only the 
natural R-(-)-littorine would be processed. 
In light of these still unexplained features it would be of interest to confirm this 
result. Two further experiments would be helpful. Firstly, it may be useful to re-
evaluate this recombination by another analytical method, NMR. If littorine were 
synthesised from [t-13C]-phenyllactic acid and [180]-tropine (fig. 44) intact 
incorporation could be seen directly by NMR as the 18Q will induce an a.-shift in the 
enriched l3C signal. The use of a NMR analysis should still arrive at essentially the 
same conclusion. Here again however, higher than simply statistical levels of re-
combination would not be detected. 
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The extent of recombination of labels after hydrolysis could be assessed from a 
crossover experiment. If the quintupally labelled littorine that Robins et al. 48 fed was 
introduced as an admixture with littorine synthesised from [2-13C]-phenyllactic acid 
then M+5 mass enhancements into hyoscyainine would indicate intact incorporation 
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and M+2 and M+3 mass enhancements, would necessarily arise after hydrolysis as 
described above. M+ 1 mass enhancements could indicate either direct incorporation or 
incorporation after hydrolysis and re-esterification. M+4 incorporation would however 
indicate the use of phenyllactic acid from the M+ 1 littorine after hydrolysis together 
with tropine from the M+5 littorine and so the extent of re-combination of labelled 
material in vivo could be assessed. As studies move away from whole cells to cell free 
extracts it is important to be confident of the substrate for the rearranging enzyme. 
While the Robins result provides strong and convincing evidence that littorine is the 
substrate the conversion of littorine to hyoscyamine in a cell free extract will probably 
be required for definitive proof. 
2.11 (R)-D- or (S)-L-Phenyllactic Acid? 
It became relevant to establish whether (R)-D or (S)-L-phenyllactic acid (32a or 32b) 
was the true intermediate in the biosynthesis of hyoscyamine. Littorine (33) (fig. 46), 
the ester of (R)-phenyllactic acid (32b) and tropine (23), has emerged as the most likely 
substrate for the rearranging enzyme. 
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Littorine (33) was first isolated as the major alkaloid from a Western Australian plant 
Anthocercis littorea49 and has subsequently been shown to be widespread in Datura 
together with hyoscyamine. 50 This provided circumstantial evidence that the (R)-
enantiomer of phenyllactic acid is further processed to (S)-tropic acid. The 
incorporations of both L-(S)- and D-(R)-[1,3-13C2]-phenyllactic acids into hyoscyamine 
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have been observed at approximately equallevels.Sl This can only be explained by their 
rapid interconversion in vitro via phenylpyruvate (fig. 47). However, more recent 
studies have indicated that (R)-D-phenyllactic acid is incorporated at slightly higher 
levels than (S)-L-phenyllactic acid.55 In order to identify which enantiomer of 
phenyllactic acid is the true substrate for rearrangement, the separate enantiomers were 
fed to D. stramonium root cultures. The dual labelled methodology, employing a 13C-
2H combination at C-2 was deployed once again (section 2.2). 
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2.12 Incorporation Studies with <R>·D· and <S>-L-Phenyllactic Acid 
Since the two potential substrates, (R)-D- and (S)-L-phenyllactic acids can interconvert 
in vivo, 13C labelling alone has proved insufficient to determine the closer intermediate 
to tropic acid. However, if the retention of deuterium from the chiral centre of either 
(R)-D- or (S)-L-phenyllactic acid could be demonstrated, then this would confirm the 
role of a particular enantiomer. Following the argument _presented in section 2.2, if one 
enantiomer was incorporated directly this would result in the intact incorporation of the 
13C-2H bond. Conversely, if prior epimerisation was a requirement the deuterium will 
be lost during the oxidation to phenylpyruvic acid (28) and only 13C incorporation 
would be observed (fig. 48) in the resultant hyoscyamine (2). To this end DL-[2-
13C,2H]-phenyllactic acid (32a) was synthesised, using the route previously described 
in section 2.3 and the material was then resolved into its component enantiomers (32d 
(R) and 32e (S)) as dicussed in the next section. The (R)-D- and (S)-L-phenyllactic 
acids were then fed in separate experiments to transformed root cultures of D. 
stramonium53 and the isotope incorporation into hyoscyamine determined, both by 
NMR and GC-MS analysis. 
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2.13 The Resolution of Phenyllactic Acid 
Initially two enzymatic methods for the resolution of phenyllactic acid were considered, 
both using Candida cylindracea (rugosa) lipase (CCL). In the first case the selective 
formation of the butyl ester of phenyllactate (48) has been described, with an 
enantiomeric excess of 74% (fig. 49).54 The enantiomeric excess is rather low for our 
purposes, but recrystallisation of the free acid may have improved it sufficiently. 
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The second method described the resolution of methyl 0-acetylmandelate (49) by the 
selective hydrolysis of the acetyl ester. 55 It was envisaged that this method could have 
been extended to methyl 0-acetyl phenyllactate (50) (fig. 50). 
A disadvantage common to both these methods is that the phenyllactic acid 
would need to be derivatised and later recovered, modifications that would clearly 
compromise the yield. 
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Alternative methodology used the recrystallisation of the diastereomeric salts of 
(RS)-phenyllactic acid and a suitable chiral base. Methods using morphine56 and 
strychnine57 are already described but it was judged prudent to avoid the use of either 
controlled or very toxic substances. The method developed by Saigo et al. was 
eventually used,58 which involved the recrystallisation of diastereomeric salts of 
phenyllactic acid (32) and (R)- or (S)-2-phenylglycinol (53). After recrystallisation to 
constant optical rotation the free phenyllactic acid was liberated simply by decomposing 
the salt in dilute mineral acid. Both enantiomers of 2-phenylglycinol are commercially 
available and so each enantiomer of phenyllactic acid was readily accessed. This 
methodology was initially tested on unlabelled material and the enantiomeric purity of 
the resolved material was judged to be very high by both optical rotation and melting 
point. However, since the quantity of the material was small and the rotations were low 
the enantiomeric excess was also assessed by 1 H NMR studies on the methyl 0-
acetylphenyllactate derivative (50). This demonstrated that the resultant material had an 
enantiomeric excess greater that 95% ee. When the [2-13C,2H]-phenyllactic acid sample 
was resolved the optical resolutions recorded were slightly lower than that from the 
unlabelled material from both the (R)- and (S)-phenyllactates ([a.]o20 = + 17" and -16° 
versus [a.]o20 = +19° and -19° respectively) (see experimental). We attribute this 
anomaly to the presence of 2H at the chiral centre. 
47 
2.14 NMR Determination of the Optical Purity of the Resolved Phenyllactic Acids 
The enantiomeric excesses of the resolved phenyllactic acids were determined by lH 
NMR analysis of the methyl 0-acetylphenyllactate derivatives with the chiral shift 
reagent tris-[2-heptafluoropropylhydroxymethylene ]-( + )-camphoratol europium III 
derivative (Eu(hfc)3). Methyl 0-acetylphenyllactates from racemic material, an 
authentic sample of (S)-phenyllactic acid and the resolved phenyllactic acids (32b (R) 
and 32c (S)) were prepared using the route shown below (scheme 2). 
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Initially the phenyllactic acid was converted to its methyl ester (52) with diazomethane. 
This was then coupled with acetic acid using dicyclohexylcarbodiimide (DCC) and a 
catalytic quantity of 4-N,N-dimethylaminopyridine (DMAP) to give methyl 0-
acetylphenyllactate (50) in 84% yield over the two steps. 
In the I H NMR analysis the authentic (S)- methyl 0-acetylphenyllactate no 
splitting of the methyl signals of the ester or acetate could be seen. Racemic methyl 0-
acetylphenyllactate was then added in small portions until a concentration of 10% 
racemate (i.e. 5% of the other enantiomer) had been reached. At this concentration 
small additional peaks were visible to higher frequency of the methyl peak and to lower 
frequency of the acetate methyl peak. The derivatives of the resolved phenyllactic acids 
were analysed in the same manner and again, no additional signals appeared until 10% 
racemic material had been added. These spectra are shown in fig. 51 and fig. 52. From 
this analysis the enantiomeric excess of the resolved material was demonstrated to be at 
least 95%. 
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2.15 (R)-D-Phenyllactic Acid and (S)-L-Phenyllactic Acid Incorporations and 
Conclusions 
The resolved (R)-D- and (S)-L-[2-l3C, 2H]-phenyllactic acids (32d and 32e) were 
administered to 4 day old transformed root cultures of D. stramonium. The (R)-D-
phenyllactate supplemented cultures showed signs of bacterial contamination after 6 
days growth, which was controlled by the addition of the antibiotic ampicillin. 
Although growth was slightly affected the alkaloids were still produced at a normal 
level. The hyoscyamine and littorine alkaloid components were isolated and analysed 
by 13C{ 'H} and 13C{ IH,2H} NMR, and relevant sections of the spectra are shown in 
fig. 53 and fig. 54. M+2 and M+l mass enhancements were determined by GM-MS 
(Table 4). 
M+ 
M++l 
M++2 
Littorine Hyoscyamine Apoatropine 
R s R s R 
69.7% 86.5% 77.6% 92.5% 79.2% 
1.5% 10.3% 0.8% 5.1% 1.4% 
28.9% 3.3% 21.7% 2.4% 19.5% 
Incorporations of (R)-D- and (S)-L-phenyllactic acids 
into littorine, hyoscyamine and apoatropine 
Table 4 
s 
92.9% 
7.1% 
0.1% 
13C NMR analysis of the hyoscyamine isolated for the (R)-D-phenyllactic acid (32d) 
experiment shows a highly enriched singlet at 64.05ppm, corresponding to C-3' of 
hyoscyamine, with an associated triplet shifted to lower frequency. This triplet collapses 
to a singlet when deuterium decoupling is applied, as can be seen in the l3C {' H, 2H} 
' . 
NMR spectrum. The ratio of the two C-3' signals corresponding to l3C and l3C-2H 
enrichment in the deuterium decoupled spectrum is about 1:3. This clearly shows that 
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l3C{ lH,2H}NMR 
.-r-rr-rr· .. ,..,..,,_,...,,-r-r-rT•·r·,-~•-·7""·•~~---......,....,--r•·rT•·:--r-·····,-,~..,, ''''I' •·; ~--~-,.,,,., ... , .. ,..,., ·r,••• 
82 80 18 76 74 72 10 68 66 62 60 S8 
-rT"f"'""'.....,...._,..,..,.,.....,...."'""'T'""'....,..........,......~~T"TT'""'"~~rjTT'"'1T""T'~"'r'~• ,,..,.-,·r-rrr~l r-r·ri'""T"l-TT..,.,...,'T"":"'I,....,T'T"'TT.,.,..~ 
82 80 71 16 74 12 10 c;a 66 64 tJ2 60 sa 
Hyoscyamine isolated after feeding (R)-D-[2-l3C, 2H]-phenyllactic acid .. 
Fig. 53 
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13C{ IH,2H}NMR 
70 60 50 
13C(lH} NMR 
l l .J.-Lu 
1 "'f 
70 60 50 
Hyoscyamine isolated after feeding (S)-L-[2-l3C, 2H]-phenyllactic acid. 
Fig. 54 
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the 13C-2H bond has been incorporated largely intact. Conversely, for the (S)-L-
phenyllactic acid (32e) there is no a.-shifted component associated with the signal at 
64.05ppm and this indicates very clearly that all of the deuterium from C-2 of (S)-L-[2-
13C, 2H]-phenyllactic acid has been washed out. 
An interesting feature of these spectra is the signal at 71 ppm corresponding to 
C-2' of littorine. The (R)-D-phenyllactic acid fed material shows a similar pattern to the 
C-3' signal of hyoscyamine in the 13C( lH} NMR spectrum: an enriched singlet with an 
associated a.-shifted triplet which collapses to a singlet in the l3C { 1H,2H} NMR 
spectrum. This again demonstrates the predominantly intact incorporation of (R)-D-
pheny llactic acid with a little deuterium washout. More significant however is the 
resonance from C-2' of littorine after feeding (S)-L-phenyllactic acid. Here there is only 
an enriched singlet at 71ppm in the 13C(lH} NMR spectrum with no a.-shifted 
component. This demonstrates that the (S)-phenyllactic acid is not able to esterify with 
tropine to form the unnatural epimer of littorine. 
These experiments demonstrate unambiguously that (R)-D-phenyllactic acid 
(32b) is processed more directly than (S)-L-phenyllactic acid (32c) in the biosynthesis 
of hyoscyamine (2) and littorine (33) (fig. 55). This is consistent with only (R)-D-
littorine being formed and that (R)-D-littorine is the direct precursor to hyoscyamine in 
D. stramonium. The result also implicates the operation of a (R)-D-phenyllactate 
dehydrogenase enzyme at a pivotal point between L-phenylalanine metabolism and 
alkaloid biosynthesis. 
While vertebrates and higher plants contain only L-lactate dehydrogenases, 
invertebrates, lower fungi and prokaryotic organisms may contain either L- or D-lactate 
dehydrogenases or sometimes both.59-61 The racemisation of lactate in some bacteria 
has been shown to occur as a consequence of the activities of both L- and D-lactate 
dehydrogenases operating in the same organism,62 and in other examples the operation 
54 
of a lactate racemase has been shown. 63 The ability of D. stramonium to process L-
phenyllactic acid as well as the required D-phenyllactic acid suggests that either both D-
and L-phenyllactate dehydrogenases are present in this plant, or perhaps that a 
phenyllactate racemase is present which interconverts the two enantiomers . 
.. 
R-Phenyllactic acid is directly incorporated into littorine and rearranged. 
~co,H ...:::;;:::~ 
.. 
S-Phenyllactic acid is epimerised before incorporation. 
Fig. 55 
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CHAPTER3 
Stereochemical Features of the Tropic Acid Biosynthesis 
3.1 The Fate of the HydroKeDS at Ca3 of La Phenylalanine 
The fate of the hydrogens at C-3 of L-phenylalanine was investigated by Leete in 
1984,1 in a study which has gained general acceptance. A mixture of all four possible 
stereoisomers of [t-14C, 3-3H]-phenylalanine was administered to D. stramonium and 
D. innoxia plants. The location of the tritium at C-3' of the tropate esters, hyoscyamine 
and scopolamine, was determined after hydrolysis, by dehydration to atropic acid (53) 
and degradation of the tropic acid to benzoyl formic acid (54) (analysed as an oxime) 
and formaldehyde (55) (analysed as dimedone) (fig. 56). 
C02H C02H ~: T T ~ T~ + o=='.. H 
53 54 55 
Fi~:. 56 
The presence of tritium in the formaldehyde derivative was consistent with its location 
at C-3 of tropic acid. From this result Leete concluded that a hydrogen from C-3 of 
phenylalanine was migrating in the reverse direction to the carboxyl group during the 
rearrangement, i.e. a mutase enzyme was mediating a vicinal interchange process. 
Leete highlighted the potential analogy with the (2R)-methylmalonyl-CoA mutase 
mediated interconversion of (2R)-methylmalonyl-CoA and succinyl-CoA (fig. 57). 
0 
HO_ ~ Jl n """ ""SCoA 
0 
30 
methylmalonyl-CoA 
mutase 
co-enzyme B 12 
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_ )-seoA 
~OH 
0 
31 
In a subsequent study2 Leete administered stereospecifically labelled (2S,3R)-
[t-l4C, 3-3H]-phenylalanine and (2S, 3S)-[t-l4C, 3-3H]-phenylalanine to the plants. 
From analysis of the radioactive tropic acid obtained, after barium hydroxide hydrolysis 
of the alkaloids, he concluded that it was the 3-pro-S hydrogen of L-phenylalanine 
which had migrated to appear at C-3' of (S)-tropic acid (fig 58), i.e. the configuration at 
C-2' of the tropate ester was retained during the rearrangement. 
D. innoxia 
Leete's conclusionsl,2 
Fi~. 58 
These experiments are discussed in the context of more recent results later in this 
chapter. 
3.2 The Cryptic Stereochemistry at C-3' of Tropate 
At this point there was one remaining stereochemical aspect of tropic acid biosynthesis 
that had not been previously addressed. The hydrogen delivered to C-3' of the tropate, 
moiety after rearrangement must occupy either the 3'-pro-R or 3'-pro-S site at C-3 of 
tropate (fig. 59). Also the new bond must be formed with either retention or inversion 
of configuration. 
pro-R or 
~02R .-llf/k .. pro-S ? 
C02H D. innoxia ~...: • • retenti.on or V OH mverston ? 
Fi~. 59 
Enzyme reactions which involve the transfer of hydrogen to generate a pro-chiral centre 
do not result in the creation of a new chiral centre but are none the less stereospecific. 
The stereochemical course of such reactions cannot be determined simply by 
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examination of the substrate or product and as such the stereochemistry of such 
processes is said to be cryptic.3 The stereochemical course of the delivery of hydrogen 
to C-3' of hyoscyamine was probed using chiral methyl methodology. Such a strategy 
involves the generation of a methyl group made chiral by virtue of isotopic substitution 
with all three isotopes of hydrogen. Thus, delivery of tritium to the C-3' prochiral centre 
of hyoscyamine in a biosynthetic experiment followed by chemical modification 
introducing deuterium allowed generation of a chiral methyl moiety. This chiral methyl 
group was then carved out as chiral acetic acid for analysis (fig. 60).4 
T _ ..... 
Fig. 60 
3.3 The History of the Chiral Methyl Group 
The chiral methyl group was first synthesised, as chiral acetate, in 1969 independently 
by Cornforth et al. 5,6 and Arigoni et al. 7 Two different approaches were used. In the 
Cornforth et al. synthesis a chiral methyl group was synthesised racemically, but 
diastereoselectively, bearing a chiral auxiliary, R *. The two enantiomers were then 
separated by recrystallisation of the diastereomeric salts with respect to R * with the 
chiral base brucine. Subsequent derivatisation -led to the chiral acetate (scheme 3). 
i H H ii 0 0 
Ph D __... 
Ph>=<D 
__... HMH + Ph'AD 
Ph D 
'iii H 
H 
separated by recrysallisation HO H HO H H~ ~D+ Phlj ~D with brucine 
Ph T H T 
HO H iv, v OHD OHD H~ (-D VI ... ... 
Ph T PhO T PhO T 
(i) Diimide, (ii) PhC(0)02H, (iii)LiBT4, (iv) H2Cr207, (v) CF3C(0)02H, (vi) NaOH 
Scheme 3 
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Alternatively, Arigoni et al. relied on the stereospecific introduction of the three 
isotopes of hydrogen to the carbon centre. The key step in this route is the formation of 
either (S)- or (R)-glycolic acid by reduction of glyoxylate with either L-lactate 
dehydrogenase or glyoxylate reductase from spinach leaves respectively (scheme 4). 
0 
HO 0 Hr< 
T OH 
v, vi 
... 
ii, iii 
.. 
(i) L-LDH, (ii) MeOH, (iii) BrosCl, (iv) LiAlH4, (vi) 02, Pt 
Scheme4 
Perhaps the most elegant synthesis was that devised by Townsend, Scholl and Arigoni,8 
where the three isotopes of hydrogen were introduced stereospecifically in a series of 
electrocyclic reactions (scheme 5). 
OMe 
orJ-o 
D --~ ~ H 
T 
(i) .!\, (ii) H2Cr207, H2S04 
Scheme 5 
0 
ii Jl -
... HO' 't'HD 
T 
Since its development chiral methyl methodology has been used to probe many cryptic 
stereochemical problems in chemistry and biochemistry. A number of other syntheses 
have appeared and the subject has been extensively reviewed.9-12 
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3.4 Analysis of the Chiral Methyl Group 
Tritiated compounds cannot be used in an isotopically pure form due to the practical 
difficulties associated with handling radioactive compounds. Chiral methyl preparations 
therefore invariably contain a predominant -CH2D component and consequently 
chiroptical methods of analysis cannot be used. Both the Comforth5,6 and Arigoni7 
groups developed and enzymatic method of analysis, based on radioactive assay, which 
hinged on the operation of a kinetic isotope effect resulting in the preferential fission of 
the C-H over the C-D over the C-T bonds (scheme 6) in the condensation of acetyl-
CoA (56) and glyoxylic acid (57). First the acetic acid is activated to its coenzyme-A 
thioester and is then condensed with glyoxylic acid (57), to form malate (58) mediated 
by malate synthase (kH/ko =3.813). Subsequent dehydration, mediated by fumarase, 
results in the stereospecific loss of water. The tritium remaining in the fumarate (59) is 
then determined by scintillation counting and the percentage of tritium remaining in the 
fumarate is known as the F value. As the initial kinetically controlled malate synthase 
reaction with glyoxylic acid (57) results in the preferential, but not exclusive breaking 
of the C-H bond the results are interpreted thus: 79% retention of radioactivity indicates 
the exclusive presence of the (R)- enantiomer and 21% the exclusive presence of the 
(S)- ~nantiomer. 
0 
~00Na ., 
H acetyl-CoA 
synthase 
0 
~0seoA 
H 
56 
0 
HO~H 
0 57 
malate 
synthase 
.. 
Scheme 6 
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HO- -~- Jl 
')( 1 ""oH 
0 OH 
58 
fumarase ~ -TOH 
T 0 
HOyYOH 
0 H 
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Tritium NMR has also been used to determine the optical purity of chiral acetate.9 The 
malate produced, by condensation of acetyl-CoA and glyoxylic acid, possess a chiral 
methylene group with the tritium occupying one site, geminal to deuterium, or the 
other, geminal to hydrogen. Whether a tritium is next to a deuterium or hydrogen is 
readily assessed from the lH-3H coupling or a 2H induced 3H shift. Thus from the 
assignment of the pro-R and pro-S resonances the optical purity can be determined. 
Direct NMR analysis of diastereomers containing the chiral methyl group is usually 
confounded due to the free rotation of the methyl group. However, Anet and 
Kopelevichl4 have demonstrated that it is possible to determine the enantiomeric purity 
of a chiral methyl group directly, by creating a diastereomer in which there is a strong 
preference for one conformational isomer (rotamer) (fig. 61). 
Fig. 61 
3.5 Generating a Chiral Methyl Group at C-3 of Tropic Acid 
The tritium at C-3 of tropic acid was introduced by incubating transformed root cultures 
of D. stramonium with [2-3H]-phenyllactic acid (321) (918J.1Cimmol-l). The retention of 
0 
~OH v~ 
28 
0 
NaO~T 
D 
63 
... 
vi 
0 
~OH v r'oH 
32f 
ii 
v 
(i) NaBT 4, (ii) D. stramonium, (iii) saturated Ba(OH)2(aq) (iv) CH2N2 
(v) MesCI, DMAP, Py, (vi) LiAlD4, (vii) KI04, KMn04 
Scheme 7 
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the C-2 hydrogen of phenyllactic acid in the hydroxymethylene group of tropic acid had 
previously been established from the stable isotope studies using (RS)-[2-l3C, 2H]-
phenyllactic acid (32a) (section 2.7). The isolated hyoscyamine, containing tritium, was 
then hydrolysed and derivatised in a stereocontrolled manner as outlined in scheme 7, 
to stereospecifically generate chiral acetic acid for analysis. 
3.6 [2.3HJ-Phenyllactic Acid (320 
(i) NaBT 4, (ii) CH2N2, (iii)TMSBr 
Scheme 8 
[2-3H]-Phenyllactic acid (32t) (specific acitivity 918J.1Cimmol-l) was generated by the 
reduction of phenylpyruvic acid (28) with sodium boro-[3H]-hydride in methanol. The 
crude phenyllactic acid was converted directly to its methyl ester (52b) with 
diazomethane, to enable purification by flash chromatography. The ester was then 
hydrolysed with TMS bromide using an established procedure15 to regenerate the free 
acid. This proved effective as it is a mild process and the excess reagent is volatile. 
Purification of the product was achieved simply by converting the acid to its sodium 
salt with dilute sodium hydroxide solution- and-then washing with chloroform. This 
generated sodium [2-3H]-phenyllactate (32t) in 95% yield and a 1% radiochemical 
yield (scheme 8). 
3. 7 Feeding Experiment and the Isolation of [3.3HJ. Tropic Acid 
[2-3H]-Phenyllactic acid (32t) was administered (0.2J.LCimi-1) to 4 day old transformed 
root cultures of D. stramonium. The hyoscyamine (204J.LCimmol-l) isolated was diluted 
10-fold with cold carrier. The material was hydrolysed by refluxing in saturated barium 
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hydroxide solution for 30 minutes and was then acidified to generate tropic acid. The 
free acid was then converted to its methyl ester (60a), using diazomethane, in 67% 
yield over the two steps. 
3.8 Methyl [J.3HJ-3-Methanesulphonyltropate (6la) 
A key step in the derivatisation of tropic acid was the conversion of the hydroxymethyl 
group into a functionality amenable to dispacement with lithium aluminium deuteride. 
An obvious first choice was the p-toluenesulphonyl derivative (64) since it is an 
excellent leaving group and generates a crystalline product. A crystalline product at 
some stage in a radioactive synthesis is attractive as recrystallisation ensures a highly 
pure product for the determination of specific activity. A high conversion was also an 
important criterion since the quantities of material were small. Unfortunately, this 
derivative could not be prepared in good yield due to a subsequent elimination reaction 
(fig. 62); the presence of 65 was evidenced in the lH NMR spectrum: 5.89ppm (lH, d, J 
1.25Hz) and 6.36ppm (lH, d, J 1,25Hz). The use of pyridine as a mild base left the 
reaction largely incomplete (23% yield) and the use of the stronger base, triethylamine, 
resulted in further elimination ( 19% yield). 
cfMe 
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Fig. 62 
The methanesulphonate derivative (61) was then prepared. The more reactive 
methanesulphonylchloride reacted efficiently, at lower temperature in the presence of 
pyridine and DMAP and achieved a good conversion (74% yield) without any sign of 
competing elimination. The pr~duct was also crystalline, which was an added 
advantage. 
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Deuterium was introduced, to fully furnish the chiral methyl group by reduction with 
lithium aluminium deuteride. This generated [1-2H2, 3-2H,3H]-2-phenylpropanol (62b) 
in 96% yield. It is important to note that the displacement of the methanesulponyl group 
by deuteride is in this case an SN2 reaction which proceeds with inversion of 
configuration. This clearly has to be taken into account in the final analysis. 
3.10 A Mechanistic Investigation 
The deuterium isotope was introduced into the chiral methyl group by the displacement 
of the methanesulphonyl group with lithium aluminium deuteride. This reaction was 
anticipated to occur stereospecifically, through an SN2 mechanism, resulting in an 
inversion of stereochemistry at this centre (fig. 63). 
~: u ~· 
62b 
Fi~. 63 
It was however important to establish that the elimination of the methanesulphonate 
was not occurring prior to reduction, since this would result in racemisation (fig. 64), 
particularly as it had already been demonstrated that the p-toluenesulphonate derivative 
(64) was prone to elimination under basic conditions. 
C02 Me C02 Me CD20H 
~ T .. D 
~) 
D 
Fi~. 64 
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To investigate this potential problem, methyl tropate (60b) was generated enriched with 
deuterium at the chiral centre. To achieve this the relatively labile hydrogen at C-2 of 
methyl tropate was exchanged by stirring methyl tropate in a solution of sodium 
methoxide in MeOD. The methanesulphonate (61b) was thus prepared and then 
reduced to the alcohol (62c) using the conditions described in sections 3.8 and 3.9, 
which had been optimised previously with unlabelled material (scheme 9). 
D 111 .. 
Scheme 9 
It was evident from the lH NMR spectrum of the isolated 2-phenylpropanol (62c), that 
the deuterium had been fully retained through the reduction step. The methyl and 
methylene protons appeared as broad singlets at 1.18ppm and 3.60ppm respectively and 
there was no resonance at 2.79ppm for the methine proton. It was therefore concluded 
that the reaction proceeded by the expected SN2 process, and without any evidence for 
an elimination I reduction process. This placed the methodology on a firm footing for 
the preparation of the chiral methyl group in a stereospecific manner. 
3.11 Chiral Acetic Acid (63) 
The Kuhn Roth oxidationl5,16 was developed in the 1930s as an analytical technique 
for the quantitative determination of methyl groups in a molecule. The substrate is 
heated with a mixture of chromic and sulphuric acids and then the acetic acid is 
collected by steam distillation. The methyl group of acetic acid is derived from the 
pendant methyl groups of the original molecule. The reaction has also been used 
extensively in the synthesis of chiral acetic acid.8-l0, 18-20 This methodology however 
proved unsuccessful for 2-phenylpropanol (62) in our hands. No acetate was detected 
after steam-distillation. It is possible that the oxidation did not proceed beyond the 
formation of 2-phenylpropionic acid. 
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Another method commonly used for the oxidative degradation of compounds to 
generate acetic acid, utilises potassium periodate and a catalytic amount of potassium 
permanganate.21.22 This methodology is typically used for unsaturated molecules and 
attracted our attention as it was known to be effective in the oxidative generation of 
chiral acetic acid from cumene (66).23 It is noteworthy that cumene (66) would be 
obtained by the dehydration of 2-phenylpropanol (62) in our system (fig. 65). 
OH ---~ 
Fig. 65 
The periodate/permanganate oxidation of cumene was thus re-evaluated and in our 
hands was found to be efficient. However, in the event, the dehydration of 2-
phenylpropanol to cumene was unnecessary since the periodate/permanganate oxidation 
of 2-phenylpropanol itself was found to generate acetic acid in adequate yield. Acetate 
generated from unlabelled reactions was characterised as the p-phenylphenacyl acetate 
(67) derivative. The only contaminant in the acetate samples was some formate (acetate 
: formate 2: 1), as expected, however, formate does not effect the analysis of chiral 
acetic acid when co-administered to the coupled enzyme assay. The relative amounts of 
sodium acetate to sodium formate in the chiral acetate sample was determined by 1 H 
NMR analysis of the mixture. 'Fhis analysis also distinguished two populations of 
acetate i.e. those carrying a single deuterium and unlabelled acetate as evidenced from 
the singlet at 1.90ppm and the 2H-shifted triplet at 1.89ppm in the lH NMR spectrum 
(fig. 66). In retrospect, the unlabelled acetate was deduced to arise from a source other 
than 2-phenylpropanol. Re-analysis of the lH NMR spectrum of the 2-phenylpropanol 
recorded prior to oxidation revealed a small quantity of diethyl ether, the solvent used 
in the lithium aluminium deuteride reduction. The presence of unlabelled acetate is 
attributed to the oxidation of this residual diethyl ether to (unlabelled) acetate. 
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3.12 Analvsis of the Chiral Acetate and Discussion 
The optical purity of the acetate sample was determined using the coupled malate 
synthase I fumarase assay described in section 3.4. This was kindly carried out by H. G. 
Floss and A. Kastelle in Washington, Seattle. The analysis indicated that the acetate had 
the (R)- configuration with an enantiomeric excess of 96% (F value 77.9). From this the 
stereochemical location of tritium in the tropate moiety can be deduced as outlined in 
scheme 10, taking into account one stereochemical inversion during the SN2 
displacement of the methanesulphonyl group. 
0 
HO~:¢ 
D 
Scheme 10 
The tritium therefore occupied the 3'-pro-S site of hyoscyamine, and thus the hydrogen 
that is delivered to this carbon, following rearrangement, appears at the 3'-pro-R site. It 
has already been demonstrated in this thesis that it is (R)-0- and not (S)-L-phenyllactic 
acid which is utilised, therefore it is further deduced that the C-3'-H bond of 
hyoscyamine replaces the C-1 '-C-2' bond of littorine with inversion of configuration 
(fig. 67). 
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3.13 Is There a Vicinal Interchange? 
Leete I had concluded that a vicinal interchange process was operating during tropic 
acid biosynthesis. That is, a hydrogen from C-3 of L-phenylalanine (and therefore 
littorine) migrates in the reverse direction to the carboxyl group, to appear at C-3' of 
hyoscyamine. He also concluded that it was the 3-pro-S hydrogen of L-phenylalanine 
that underwent the 1 ,2-migration which forced the conclusion that a retention of 
configuration took place at this migration terminus2 (fig. 68). 
Fig. 68 
The rearrangement of littorine to hyoscyamine has obvious, but perhaps 
superficial similarities to the co-enzyme B 12 mediated rearrangements24,25 of 
methylmalonyl-CoA mutase,26 isobutyryl-CoA mutase,27,28 glutamate mutase29 and a-
methyleneglutamate mutase (fig. 69). All of these reactions are vicinal interchange 
processes involving the 1 ,2-migration of a carboxyl moiety with the concurrent 1,2-
backmigration of a hydrogen atom. This similarity to the rearrangement of the L-
phenylalanine (D-phenyllactate) skeleton to tropic acid has been highlighted for some 
time.30 
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In the cases of methylmalonyl-CoA mutase and isobutyryl-CoA mutase the migrating 
hydrogen replaces the COSCoA group with retention of configuration. We have 
demonstrated that the hydrogen delivered to C-3 of tropic acid after rearrangement is 
delivered with inversion of configuration and so the steric course in tropic acid 
biosynthesis, in this respect, is opposite. However, in the case of glutamate mutase the 
COSCoA group is replaced with inversion of configuration. The occurrence of vitamin 
B 12 in plants is however not well documented. Leete has failed to detect any of this 
vitamin in Datura plants,2 and there is only a single report that vitamin B12 occurs in 
comfrey (Symphytum officinale ). 31 The involvement of the co-factor in the biosynthesis 
of hyoscyamine must be considered unlikely. Also the extension of the analogy such 
that the rearrangement occurs at the co-enzyme-A ester level has been countered by 
Robins et az32 who placed littorine, and not phenyllactyl-CoA as the substrate for the 
rearranging enzyme. 
A surprising feature to emerge from the combined stereochemical studies of the 
rearrangement is that to effect an inversion at C-3 of tropic acid and invoke a vicinal 
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interchange process, then the 3-pro-S hydrogen of littorine must be abstracted from one 
side of the molecule and subsequently returned to the opposite side (fig. 70). 
Hx!XH' 
H I OH 
Ph 
Fig. 70 
Intuitively, this would seem to be an unlikely scenario as it would require a substantial 
change in the conformation of the substrate or active site of the rearranging enzyme to 
allow the abstracted hydrogen to be delivered to the opposite face. This prompted us to 
re-evaluate the stereochemical course at the other migration terminus. 33 
3.14 InvestiKation of the Fate of the C-3 HydroKens of Phenyllactic Acid 
A series of experiments was carried out to determine the fate of the C-3 hydrogens of 
phenyllactic acid. A number of phenyllactic acids labelled with 2H at C-3 were 
administered to D. stramonium transformed root cultures. In each experiment a 13C 
reporter atom was placed at C-2 of phenyllactic acid and deuterium at C-3 such that any 
migration of the deuterium to C-3 of tropic acid could be detected directly by 13C 
NMR. Initially (2R,3S)-[2-13C, 3-2H, ring-D5]-phenyllactic acid (J2g) and (2R, 3R)-[2-
13C,2H, 3-2H]-phenyllactic acid (32h) were administered to 4 day old transformed root 
cultures of D. stramonium. These two phenyllactic acids were kindly supplied by 
Professor H. G. Floss, and Kevin Walker, at the University of Washington, Seattle. The 
synthetic route to (2R, 3R)-[2-13C,2H, 3-2H]-phenyllactic acid (32h) is outlined in 
scheme 11 and (2R,3S)-[2-13C, 3-2H, ring-D5]-phenyllactic acid (32g) was synthesised 
by an analogous procedure, starting from [2H6]-benzaldehyde and reducing with 
hydrogen at step (iii) rather than using deuterium gas. 
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(i) Ac20 80"C, (ii) 1 equiv NaOH, (iii) {h, Rh(S,S)CHIRAPHOS, 
(iv) 6N HCl, reflux, (v) NaN02(aq) 
Scheme 11 
Compound 69 was synthesised from glycine and benzoyl chloride using an established 
procedure.34 The synthesis developed by Weightman et a[35 was then used to prepare 
the stereospecifically labelled D-phenylalanines. In the original procedure the 
hydrogenation (step iii) was carried out simply using palladised charcoal as a catalyst. 
The reaction occurred, as expected, with syn stereospecificity to generate the racemic 
(2RS, 3SR)-[3-2H]-phenylalanine. This was then converted to the corresponding N-
chloroacetylphenylalanine which was enantioselectively hydrolysed using hog renal 
acylase to generate (2S, 3R)-[3-2H]-phenylalanine and (2R, 3S)-[3-2H]-N-
chloroacetylphenylalanine. The latter product could be hydrolysed non-enzymatically. 
This methodology generates the phenylalanines with approximately 93% correct 
stereochemistry at C-3. Kevin Walker however used a modification of this procedure 
developed by Fryzuk and Bosnich36 whereby the hydrogenation (or deuteration) is 
carried out stereospecifically in the presence of Rh(SS)CHIRAPHOS. 
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D-phenylalanine obtained from this reaction was then deprotected and diazotised with 
retention of configuration37 to generate the required phenyllactic acid. The 
stereochemical integrity of the synthetic route is already demonstrated and as expected 
the (2R, 3S)-[2-l3C, 3-2H, ring-2Hs]-phenyllactic acid (32g) and (2R, 3R)-[2-l3C, 3-
2H]-phenyllactic acid (32h) were judged to be >98% ee by GC analysis of the Mosher's 
ester derivative of the methyl ester of the phenyllactates. 
(RS)-[2-l3C, 3-2H2]-Phenyllactic acid (32i) was synthesised using a modified 
version of the procedure used to prepare (RS)-[2-l3C,2H]-phenyllactic acid (32a), as 
described in section 2.3. Deuterium was exchanged into methyl [ 1-l3C]-phenylacetate 
(42a), by deprotonation with LDA and quenching the resulting anion with MeOD. 
Reduction with lithium aluminium hydride to generate [1-13C, 2-2H2]-phenylethanol 
(43b) which was converted to [2-l3C, 3-2H2]-phenyllactic acid (32i), as previously 
described (scheme 12). 
~0 ~~o~~~~co,H VoMe v~Me v- v~H 
42a 42b 43b 32i 
(i) LDA, -7s·c, MeOD, (ii) LiAll4 
Scheme 12 
Two more isotopically labelled phenyllactic acids were synthesised. The aim of this last 
experiment was to investigate the possibility of any crossover of deuterium between 
substrate and product molecules (fig. 71). [ 1-13C]-Phenyllactic (32j) acid was 
synthesised from [1-13C]-methyl phenylacetate (42a), again, using the methodology 
described in section 2.3. [3-2H2]-Phenyllactic acid (32k) was prepared by initially 
exchanging deuterium into phenylpyruvic acid (28) followed by reduction with sodium 
borohydride. These compounds were then admixed at a 1: 1 ratio for the feeding 
experiment. 
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3.15 Methyl f1.13C, 2-2H2J-Phenylacetate (44b) 
~0 V OMe 
42a 
Scheme 13 
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Methyl [1-13C]-phenylacetate was deprotonated with LDA (-78°C) and the deep blue 
dianion was then quenched with MeOD to generate methyl [1-13C,2-2H2]-
phenylacetate in 78% yield (scheme 13) containing approximately 20% [1-13C,3-2H]-
pheny lace tate. 
3.16 [3-2H2J-Phenyllactic Acid (32k) 
o-rco,H_ ... .,~ c(rco,H 
28 28a 
(i) K2C03, D20, (ii) NaBI4, (iii) CH2N2, (iv) 1M KOH 
Scheme 14 
[3-2H2]-Phenyllactic acid (32k) could have been prepared in an analogous manner to 
the [2-13C, 3-2H2]-phenyllactic acid (32i) by exchanging deuterium into methyl 
phenylacetate. However, since no 13C label was required the alternative method of 
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exchanging deuterium into phenylpyruvic acid followed by reduction with sodium 
borohydride was selected as a higher deuterium incorporation could be achieved 
(scheme 14). Phenylpyruvic acid (28) was dissolved in a solution of potassium 
carbonate in D20 (pHil) and left at 4°C for 12 hours. After extraction into ether the 
phenylpyruvic acid was reduced and directly methylated according to the procedure 
described in section 3.5.1 to generate methyl [3-2H2]-phenyllactate (52c). Hydrolysis 
then gave the required [3-2H2]-phenyllactic acid, (32k) in 31% yield over the three 
steps. No monodeuterated material was apparent by analysis of the 1 H NMR spectrum. 
3.17 Results From FeedinK (2R.3Sl-£2-13C, J.2H, rine-2H.sJ-Phenyllactic Acid (32Kl 
The incorporation of the l3C label into the C-3' of hyoscyamine was evident by the 
highly enriched singlet at 64.33ppm in the l3C NMR spectrum. There was no evidence 
of deuterium coupling. The major component of the enriched peak was clearly ~-
shifted, as indicated from the natural abundance peak at 64.30ppm. A similar pattern 
was also visible at 71.69ppm, the signal corresponding to C-2' of littorine. In this case 
the highly enriched singlet also had a ~-shift induced component, caused by the 
presence of deuterium at C-3' (fig. 72). In contradiction to Leete's resultsl,2 the 3-pro-S 
deuterium of the administered phenyllactic acid had not migrated to C-3' of the tropate 
moiety of hyoscyamine. The ~-shift associated with the C-3' enriched peak is however 
consistent with the retention of deuterium at C-2' of the tropate ester (fig. 73). 
D. stramonium 
Fig. 73 
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3.18 Results From Feedin& (2R. 3Rl £2.13_c,2H, J-2HJ-Phenyllactic Acid (32hl 
The carbon-13 in this phenyllactic acid was already directly bonded to a deuterium 
atom, which we know from feeding (R)-[2-13C,2H]-phenyllactic acid is retained at C-3 
of tropic acid. The backmigration of the 3-pro-R deuterium would therefore have been 
obvious by the presence of two deuterium atoms attached to C-3 of tropic acid. This 
would produce a charactaristic quintet with a large associated a-shift in the l3C NMR 
spectrum, at 64ppm. 
The l3C NMR spectrum of hyoscyamine (fig. 74) showed a large enriched 
singlet at 63.90ppm with an associated a-shifted triplet at 63.55ppm. This indicates the 
intact incorporation of the C-2-2H bond of the administered phenyllactic acid with 
partial deuterium washout. This complements the (R)-[2-l3C, 2H]-phenyllactic acid 
(32d) experiment (section 2.15). There was no doubly deuterated component, and the 
peaks were not ~-shifted. This is consistent with the complete loss of the 3-pro-R 
deuterium of (2R, 3R)-[2-13C,2H, 3-2H]-phenyllactic acid (fig. 75). 
D 
2 C02H D.stramonium 
Fig.75 
By comparison the C-2' signal of littorine (71ppm) signal showed both (a+~)- and ~-
shifted components which indicated the predominantly intact incorporation of the (C-
2)-2H bond of the phenyllactic acid, with some deuterium washout and the retention of 
the 2-pro-R deuterium. This result is consistent with the direct esterification of (2R, 
3R)-[2-l3C,2H, 3-2H]-phenyllactic acid to form littorine, as previously demonstrated 
through by feeding (R)- and (S)-[2-13C, 2-2H]-phenyllactic acids (section 2.15). 
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3.19 Results Form Feedina= (RS>-f2-13C,3-2H2J-Phenyllactic Acid 
(RS)-[2-l3C, 3-2H2]-phenyllactic acid (32i) was fed to reinforce the above results, and 
in particular to establish unambiguously that there is no backmigration. It was also 
necessary to demonstrate that the shift of the C-3' enriched peak observed in the 13C 
NMR spectrum of the (2R, 3S)-[2-13C, 3_2H, ring-2Hs]-phenyllactic acid (32g) 
experiment hyoscyamine was indeed a ~-shift and not, the less likely scenario, that it is 
a shift induced by the perdeuterated phenyl ring. Here again in the resultant l3C NMR 
(fig. 76) spectrum of hyoscyamine, the major component of the enriched peak at 
64.0ppm is ~-shifted with a minor peak occurring at 64.06ppm. The peak is not 
coupled, therefore no deuterium is directly bonded to the C-3' atom. This is again 
consistent with the retention of one deuterium at the chiral centre, C-2', of the tropate 
ester, the other being abstracted and not returned to C-3' (fig. 77). Some loss of 2H is 
apparent from C-3 of the [2-l3C, 3-2H2]-phenyllactic acid, since the non-~-shifted peak 
is larger than that observed in the (2R, 3S)-[2-l3C, 3-2H, ring..2Hs]-phenyllactic acid 
experiment. This was expected to occur to some extent since the [2-13C, 3-2H2]-
phenyllactic acid contained approximately 20% [2-l3C, 3_2H]-phenyllactic acid, 
however, the loss of deuterium may also be a consequence of the exchange of 
deuterium during epimerisation of the (S)-[2-13C, 3-2H2]-phenyllactic acid present in 
the racemic substrate. 
D. stramonium 
Fig. 77 
The littorine enriched C-2 signal showed the expected pattern. The major component is 
the doubly ~-shifted signal at 71.44pm with a singly ~shifted component at 71.49ppm 
and a non-~-shifted, natural abundance peak, at 71.54ppm. This is the singly deuterated 
component again arising due to the [2-l3C, 3-2H]-phenyllactic acid in the administered 
substrate. 
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3.20 Results From Feedin2 (RSl-f2-13CJ-Phenyllactic Acid (32j) and (RS)-[3a21b.k 
Phenyllactic Acid (32k) as an Admixture 
The 13C NMR spectrum of the isolated hyoscyamine showed only an enriched singlet 
at 64.10ppm (fig. 78). There was no evidence of any crossover of deuterium between 
the labelled substrates (fig. 79). The 13C NMR spectrum of littorine showed only a 
highly enriched singlet at 71.53ppm as expected. 
Fig. 79 
3.21 Conclusions 
D. stramonium 1' £02R 
'\L__ ~D 7~ v 3'oH 
The results from these experiments are summarised in fig. 80. 
Fig. 80 
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These results are unambiguous and demonstrate the loss of the 3-pro-R hydrogen of 
phenyllactic acid (and therefore littorine) during the rearrangement. From these 
experiments there is no evidence that this hydrogen is returned and accordingly a 
vicinal interchange discounted. The 3'-pro-S hydrogen is retained at C-2', the chiral 
centre, of the tropate moiety. The implications of these results are firstly that the 
rearrangement does not involve a vicinal interchange, as was generally accepted, and 
secondly that there is inversion of configuration at both migration termini (fig. 81). 
Fig. 81 
3.22 Discussion 
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Clearly these results are inconsistent with Leete's conclusions of a mutase enzyme 
mediating a vicinal interchange process. Earlier work by Haslam et al. 38 however 
reports findings entirely consistent with our own. Both (2S, 3R)- and (2S, 3S)-[t-14C, 
3-3H]-phenylalanines were synthesised using Wrightman's procedure35 which gives the 
desired phenylalanines with 90% enantiomeric excess of the desired stereochemistry at 
C-3 (this also being the synthesis that Leete used). The phenylalanines were 
administered to whole D. stramonium plants and the isolated hyoscyamine and 
scopolamine were hydrolysed to tropic acid and dehydrated to atropic acid to locate the 
tritium. The results from these experiments were considered to be consistent with the 
loss of the 3-pro-R hydrogen of phenylalanine, which was not returned, and with the 
retention of the 3-pro-S hydrogen at the chiral centre (fig. 82). 
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Leete's criticism of the work hinged on the argument that both hyoscyamine and tropic 
acid are readily racemised under basic conditions. If this were the case then the loss of 
the 3-pro-R tritium could be explained by wash out at the chiral centre of tropic acid 
during the hydrolysis in 10% NaOH, and not by abstraction during the rearrangement 
process. He considered the retention of the 3-pro-S tritium a consequence of its 
migration to C-3 of tropic acid, rather than its persistence from C-2 of tropic acid (fig. 
83). 
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Fig. 83 
The key issue here is the readiness of the tropic acid to racemise under basic conditions, 
a matter we felt warranted investigation. 
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3.23 A Study on the Rate of Deuterium Exchanae From the Chiral Centre of 
Tropic Acid 
Methyl [2-2H]-tropate was synthesised as described in section 3.6. This served as a 
model system to study the rate of racemisation of hyoscyamine/tropic acid during the 
hydrolysis of the alkaloid in either Ba(OH)z or Na(OH)z (fig. 84). 
Fi~:. 84 
Methyl [2-2H]-tropate (60b) was initially subjected to hydrolysis in saturated barium 
hydroxide solution for 30 minutes, the conditions used by Leete to hydrolyse 
hyoscyamine and scopolamine. It was apparent from the I H NMR spectrum of the 
resulting tropic acid that the deuterium had remained largely intact at the chiral centre 
of tropic acid, with only a small level of washout. This is evidenced from the coupling 
of the hydroxymethyl protons and the integral of one of the hydroxymethyl and methine 
resonances, which are coincident. 
[2-2H]-Tropic acid (lc) was then refluxed in 10% sodium hydroxide removing 
aliquots of the reaction mixture at different times to assess the rate of exchange. The 
aliquots were immediately acidified to prevent further exchange and the isolated tropic 
acid was analysed by I H NMR. From these spectra it can be seen that a substantial 
quantity of deuterium is still present after 5 minutes and 10 minutes, washout is 
however substantial after 20 minutes (fig. 85) and essentially complete after 30 
minutes. These results indicate that the exchange may not be as fast as suggested by 
Leete. 2 The kinetic isotope effect operating in the exchange of tritium from the chiral 
centre of tropic acid would be expected to be significantly larger than that for deuterium 
(kHikD = l-7 kHikT = 1-1639). It is quite conceivable that there was residual tritium 
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present at the chiral centre of tropic acid after Ba(OHh hydrolysis and probably after 
10% NaOH hydrolysis carried out by Haslam et al. and the interpretation of their result 
is in our view correct. 
The inconsistency between our results and Leete'sl,2 are however not so easily 
explained. From his degradation studies, in particular the conversion of C-3 of tropic 
acid into formaldehyde dimedone, there can be no question that Leete did indeed 
observe tritium at C-3 of tropic acid, albeit at a low level ("" 0.1% ). However, there are 
some important differences between the two studies which probably account for the 
different results. Firstly, in the earlier experiments L-phenylalanine was administered 
rather than the more immediate precursor phenyllactic acid. It is now known that the 
incorporation of L-phenylalanine must proceed via phenylpyruvic acid. The 
stereospecific loss of tritium from phenylpyruvic acid into the water in the cells cannot 
be discounted (fig. 86). 
T T 
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The incorporation of tritium into NAD(P)H could allow for its re-introduction into C-3 
of phenyllactic acid via a (2R)-phenyllactate dehydrogenase (fig. 87). Additional 
delivery of tritium to C-3' of hyoscyamine may also occur after rearrangement in a 
manner which is discussed in section 4.5. 
NAD(P)T 
(2R)-pheny llactate 
dehydrogenase 
Fig. 87 
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It is interesting to compare here the results from feeding (2R, 3S)-[2-l3C, 3-2H, ring-
2Hs]-phenyllactic acid (32g) and (RS)-[2-l3C, 3-2H2]-phenyllactic acid (32i). The non-
P-shifted component is much larger in the latter case, indicating some loss of deuterium 
relative to nc. This is unlikely to be an artefact due to chemical manipulation as 
identical alkaloid isolation procedures were used. The loss of 2H in the latter case could 
be explained as loss from the (S)-enantiomer, which must epimerise either via oxidation 
to phenylpyruvic acid and reduction with a (2R)-phenyllactate dehydrogenase or a 
racemase as discussed in section 2.15. The second significant factor is the use of whole 
plants rather than submerged transformed root cultures. If tritium were lost into the 
water in the cell, its incorporation into NAD(P)H and re-introduction via a 
dehydrogenase would be more likely in the whole plant situation since the volume of 
water is limited to the small volume of the cell and its immediate environs. Conversely, 
with the submerged root cultures exchange of tritiated water with water from the 
medium would be expected and so dilute the labelled water available in the cells. 
Another relevant feature of whole plant experiments is the much lower levels of L-
phenylalanine incorporation observed. This is in the region of 0.02%, compared to the 
15-40% incorporation of phenyllactic acid in the transformed root culture studies. 
A further feature is the stereospecifically labelled L-phenylalanines used in 
these experiments were only approximately 90% enantiomerically pure at C-3, 
compared to the (2R)-phenyllactic acids which were 98% enantiomerically pure at C-3. 
It is possible that the results were perturbed significantly by contaminating isotope from 
the small amount of the other enantiomer present, particularly in the light of the low 
level of incorporations observed. 
Whatever the origin of the misinterpretation of Leete's study, this re-evaluation 
using stable isotopes offers an unambiguous assessment of the stereochemical course in 
hyoscyamine biosynthesis. 
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CHAPTER4 
Mechanistic Insia:hts 
4.1 Introduction 
The intermediates between L-phenylalanine (29) and hyoscyamine (2) are now 
identified and all the stereochemical features of the rearrangement of the linear 
propanoid side chain, to generate the branched tropate moiety, are now evaluated. L-
Phenylalanine is initially transamminated and then reduced to form (R)-D-phenyllactic 
acidl (32b). Esterification with tropine (23), to generate littorine (33) has been shown 
to precede the rearrangement.2 Littorine is then converted to hyoscyamine, with the loss 
of the 3'-pro-R hydrogen, and with inversion of configuration at both migration 
termini) These results are summarised in fig. 88. 
~co,H::::;;::~ 
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O"rco,H::::;;::~ 
28 
pi" per· 
0~0 
H2 :: H3 
H4 
... 
H 
33 2 
Fig. 88 
4.2 3a-2' -Hydroxyacetoxytropane and 3a-Phenylacetoxytropane 
3a-2'-Hydroxyacetoxytropane (34) and 3a-phenylacetoxytropane (35) (fig. 89) occur as 
minor alkaloids in Datura species4 and these two alkaloids would appear to be shunt 
metabolites from the rearrangement of littorine (33) to hyoscyamine (2). 
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3a-2'-Hydroxyacetoxytropane (34) and 3a-phenylacetoxytropane (35) are 
produced only in small quantities compared to hyoscyamine, approximately 0.01% and 
0.02% of the total alkaloid content of the roots of Brugmansia candida x aurea, 
compared to hyoscyamine which accounts for approximately 30%.5 These minor 
alkaloids are therefore not amenable to NMR analysis. In collaboration with Dr Richard 
Robins (then) at the AFRC Insitute of Food Research in Norwich, the incorporations of 
a number of isotopically labelled substrates into 2'-hydroxyacetoxytropane (34) and 
phenylacetoxytropane (35) was assessed by GC-MS analysis. Alkaloid extracts from 
roots, which had been supplemented with [1,3-l3C2]-phenyllactic acid and [1',3'-13C2 
N-methyl-2H3]-Iittorine, and my own alkaloid extracts from feeding (RS)-, (R)- and (S)-
[2-13C,2H]-phenyllactic acid, were exarnined.6 
(RS)-[1,3-l3C2]-Phenyllactic acid was administered to transformed root cultures 
of D. stramonium and B. candida x aurea hybrid. Efficient incorporation into 
phenylacetoxytropane, 2'-hydroxyacetoxytropane and hyoscyamine was observed, at 
approximately equal levels ( =::40% ). This supports the view that these different 
compounds became enriched by closely related processes. These results are summarised 
in Table 5. Additionally, no reduction in the level of these incorporations was observed 
when exogenous unlabelled phenyllactic or tropic acids were added, consistent with 
previous results. 6 
95 
H:ydrox:yacetox:y-- Phen:ylacetox:y- H:yosc:yamine 
trogane -tronane 
Datura M++t 43.3% 16.4% 6.1% 
stamonium 
M++2 I 37.2% 37.7% 
Brugmansia M++t 41.7% 9.5% 7.5% 
candida x 
aurea M++2 I 40.9% 41.3% 
Incorporations of [1,3-13Cz]-phenyllactic acid into 2'-hydroxyacetoxytropane, 
phenylactetoxytropane and hyoscyamine (determined R. J. Robins). 
Table 5 
The M+ 1 mass enhancements in 2'-hydroxyacetoxytropane (34) when fed with (RS)-
DL-[1,3-13C2]-phenyllactic acid is consistent with the loss of the ((C-3) +phenyl) of 
the phenyllactic acid. Correspondingly, the M+2 incorporations into 
phenylacetoxytropane (35) clearly indicate that both the l3C labels have been retained 
and therefore C-2 of phenyllactic acid had been lost (fig. 90) and not C-1, as might be 
anticipated as a result of an oxidative degradation of phenyllactic acid in vivo. M+ 1 
incorporations into both hyoscyamine (2) and phenylacetoxytropane (35) are much 
lower than the M+2 incorporations, although they are still significantly above natural 
abundance. These enrichments can however be attributed to the presence of 
approximately 9% of (RS)-DL-[t-l3C]-phenyllactic acid and (RS)-DL-[3-13C]-
phenyllactic acid in the (RS)-DL-[1,3-13Cz]-phenyllactic acid administered.& 
0 
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Isotope from (RS)-DL-[2-I3c, 2H]-phenyllactic acid did not enrich 
phenylacetoxytropane (35), a result which is again consistent with the loss of C-2 of 
phenyllactate (fig. 91 ). 
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OH 
loss of (C-2) 
-------~ 
Fig. 91 
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This result was confirmed by examining the simultaneous incorporations into 
phenylacetoxytropane (35) and 2'-hydroxyacetoxytropane (34) from (R)-D- and (S)-L-
[2-13C, 2H]-phenyllactic acids.l These results are presented in Table 6. 
Hydroxyacetox! Phenylacetox! H!OSCJamine 
-trogane -trogane 
(R) M++t 1.4% -1.5% 0.8% 
M++2 18.4% -0.4% 21.7% 
(S) M++t 9.8% -0.6% 5.1% 
M++2 1.0% -0.4% 2.4% 
Incorporations of (R)- and (S)-[2-13C, 2H]-phenyllactic acids into 2'-
hydroxyacetoxytropane, phenylacetoxytropane and hyoscyamine. Negative 
numbers represent an error of approximately 2% in determination. 
Table 6 
Again no incorporations into phenylacetoxytropane (35) were observed from either 
enantiomer of [2-13C, 2H]-phenyllactic acid, consistent with the loss of C-2. The 
possibility that this alkaloid was formed via oxidation of the phenyllactic acid (32) to 
phenylpyruvic acid (28), with subsequent decarboxylation to generate free phenylacetic 
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acid (27), and can be discounted from the results as in this event a strong M+ 1 mass 
enhancement would result but is not observed (fig. 92). 
Fig. 92 
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The 18.4% M+2 mass enhancement evaluated for 2'-hydroxyacetoxytropane (34) after 
feeding (R)-D-[2-l3C, 2H]-phenyllactic acid, demonstrates that one of the C-H bonds of 
the hydroxymethyl group is retained intact from the C-H bond of C-2 at (R)-D-
phenyllactic acid. However, the corresponding 9.8% M+ 1 mass enhancement, apparent 
after feeding (S)-L-[2-l3C, 2H]-phenyllactic acid demonstrates that incorporation from 
this enantiomer occurs only after epimerisation to (R)-D-phenyllactic acid, as observed 
for both littorine and hyoscyamine. 
In order to reinforce the hypothesis that phenylacetoxytropane (35) and 2'-
hydroxyacetoxytropane (34) are products closely related to the rearrangement process, 
the incorporations of quintupally labelled (RS)-[1 ',3'-13C2 methyl-2H3]-littorine (33) 
were examined by Richard Robins (Table 7). The M+5 incorporation of this quintupally 
labelled littorine into hyoscyamine was deemed too high to be the result of the separate 
use of the tropine and phenyllactic acids after hydrolysis of the administered ester. 
Similarly, phenylacetoxytropane was found to have a significant M+5 mass 
enhancement (""' 3.5% ). Although lower than the M+5 mass enhancement evaluated for 
hyoscyamine this was still too high to be the result of the hydrolysis of the quintupally 
labelled littorine and recombination of the [l,J-13C2]-phenyllactic acid and [methyl-
2H3]-tropine. Further, the M+2 and M+3 mass enhancements were smaller then the 
M+5 mass enhancement which again indicates that the hydrolysis of the littorine was 
not the predominant route to incorporation. [1 ',3'-13C2, methyl-2H3]-Littorine was 
efficiently incorporated into 2'-hydroxyacetoxytropane to give predominantly a M+4 
mass enhancement, as expected from the loss of ((C-3')+phenyl) (fig. 93). 
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H)::drox)::acetox)::- Phen)::lacetox)::tronane H)::OSC)::amine 
tronane 
Additional M++3 M++4 M++2 M++3 M++S M++2 M++3 M++5 
compound 
fed 
None 5.1% 13.0% nd nd nd 3.3% 4.8% 4.5% 
Tropine 4.9% 18.8% 2.2% 1.9% 4.0% 4.3% 3.8% 6.5% 
(0.25mM) 
(RS)- 4.1% 16.0% 1.8% 1.6% 3.3% 3.5% 3.5% 6.1% 
IPheny llactate 
(0.25M) 
Incorporations of [1 ',3'-13C2, methyl-2H3]-littorine into 2'-hydroxyacetoxytropane, 
phenylacetoxytropane and hyoscyamine, nd =insufficient area under GC-MS peak to 
determine incorporation (determined by R. J. Robins). 
Table 7 
pJD' 
0 
0 
Fig. 93 
Following the argument outlined in section 2.10 it is concluded that 
phenylacetoxytropane (35) and 2'-hydroxyacetoxytropane (34) are necessarily shunt 
metabolites of hyoscyamine biosynthesis. 
A comparison of the littorine (33) to hyoscyamine (2) rearrangement with the 
rearrangements mediated by the coenzyme-B12 mutases (of which the rearrangement of 
methylmalony-CoA mutase is an illustrative example (fig. 94)), has been discussed 
(section 3.13). 
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The rearrangement is most probably initiated by abstraction of the 3'-pro-R hydrogen of 
littorine. Such a process could be either radical or ionic in nature. However, a radical 
process is attractive since radical processes have precedent in biochemistry whereas 
anionic and cationic processes are rare (fig. 95).9 
O~OR 
? m~ OR -----~ 
O~OR 
? 
OR -----~ ()1+ 
OH 
Fig. 95 
A benzylic radical should find stability via a transient cyclopropyl intermediate (74) 
which can open across the (C-1')-(C-2') bond to furnish the tropate skeleton. This would 
be the normal, predominant process resulting in the interconversion of hyoscyamine 
and littorine (fig. 96). However, hydroxylation of radical (73) could initiate a pathway 
to 2'-hydroxyacetoxytropane (34) and hydroxylation of radical (75) could initiate a 
pathway to phenylacetoxytropane (35). This is discussed in section 4.5. 
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4.3 Iron-oxo Enzymes 
The evidence that vitamin B 12 is not found in plants, 10 and the recent conclusion that 
there is no vicinal interchange process operating, limits the extention of the analogy to 
methylmalonyl-CoA mutase or a related coenzyme B12 process. However, a more 
reasonable suggestion is radical initiation by an iron-oxo enzyme, a process which has 
some precedent in the rearrangement of flavanone to isoflavone in plants.11-13 
Iron-oxo enzymes14 mediate oxidative reactions. These are predominantly 
hydroxylation, however, some alcohol to aldehyde oxidations, desaturations and C-C 
bond cleavage reactions are also found. Enzymes of this type include the cytochrome P-
450 enzymes which contain a protoporphyrin ring as a prosthetic group and a cystein 
residue which forms as an axial ligand to the haem iron (fig. 97); others are non-haem 
and contain iron ligated to histidine residues. 
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These enzymes require both NADPH and 02 and mediate the stepwise cleavage of 
molecular oxygen. Initially a superoxide is formed which abstracts hydrogen to form a 
hydroperoxide. The remaining 0-0 bond is then cleaved heterolytically to generate a 
FeiVO. radical, which is responsible for the abstraction of hydrogen from the C-H bond 
of the substrate. The carbon radical generated is then quenched by a hydroxyl radical 
from the iron species. This association process is known as oxygen rebound 14 (fig. 98). 
I 
+ -C-OH 
I 
4.4 The Flavonoids 
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The flavonoids15 are a group of L-phenylalanine derived secondary metabolites which 
occur almost universally in higher plants. They are normally present as glycosides and 
have a variety of functions including flower pigments and antimicrobial activity. The 
flavonoids are biosynthesised, like many phenylpropanoids, from cinnamate, which is 
in turn derived from ;L-phenylalanine (29) by the action of phenylalanine ammonia 
. "/'' '~ i 
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lyase. Cinnamic acid (36) is then hydroxylated to form coumaric acid, which is 
activated to its coenzyme-A ester (76). Coumaryl-CoA then condenses with three units 
of malonyl-CoA (21), in a manner analogous to polyketide biosynthesis. The 
condensation of malonate units and subsequent cyclisation are mediated by chalone 
synthase, to generate chalcone (77), an isolable intermediate. Rapid cyclisation then 
furnishes the flavanone skeleton (78), which is then further modified to the flavonoids 
characteristic of the individual plant (fig. 99). 
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Fig. 99 
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The isoflavonoids (79)15 are a relatively small group of secondary metabolites 
found predominantly in the Leguminosae. They are elaborated from the flavonoids by a 
1,2-aryl migration from C-2 to C-3 of the pyrorie ringl7,18 (fig. 100). This has been 
shown to be a two step process, involving an oxidative aryl migration and subsequent 
dehydration (fig. 101). The operation of a P-450 enzyme in the first reaction was 
implicated by the observation that the process required both NADPH and 02, was 
inhibited by CO and P-450 inhibitors and was partially reversed by light.l2,13 
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The C-2 hydroxyl was shown to be derived from molecular oxygen, not water, which is 
consistent with a radical mechanism. The operation of a P-450 enzyme was eventually 
demonstrated unequivocally by Hakamatsuka et al. 11 and a possible mechanism was 
suggested and is reproduced in fig. 102. 
~OH HOWO ··\'v oxidative 
I .. ~ aryl migration 
OH 0 
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Fig. 101 
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The precise mechanism of the flavanone - isoflavanone rearrangement is still the 
subject of some debate and some modifications regarding the detail of the mechanism 
have subsequently been suggested. 19 Hakamatsuka et al. 11 have further speculated the 
involvement of iron-oxo enzymes in a number of other natural product biosyntheses 
which can all be rationalised by invoking a mechanism of hydroxylation associated 
with radical rearrangement. 
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4.5 A Modified View of the Mechanism of the Littorine Rearran1ement 
A mechanism for the littorine rearrangement (fig. 103) utilising an iron-oxo enzyme 
clearly requires modification of the original proposal, since the radical generated by the 
iron-oxo species is subsequently quenched by a hydroxyl radical in an oxygen rebound 
process, rather than a hydrogen radical. This could happen before or after the 
rearrangement. The radical would then rearrange via the postulated cyclopropyl 
transition state to generate a hyoscyamine radical (75). This could then be quenched by 
a hydroxyl radical and generate the aldehyde hydrate moiety (80). The action of a 
dehydrogenase on this aldehyde hydrate would then generate hyoscyamine (2). 
However, if the radical (73) was aberrantly quenched with HO· instead of rearranging, 
the dihydroxy species (82) would be susceptible to oxidative cleavage across the (C-2')-
(C-3') bond. The scission of this bond would then result in the loss of ((C-3') +phenyl) 
to generate 2'-hydroxyacetoxytropane (34). The aldehyde hydrate (80) or a-
formylphenylacetoxytropane (81) formed after quenching the product radical (75) 
would similarly be susceptible to the loss of (C-3') and generate phenylacetoxytropane 
in a manner consistent with the labelling patterns observed (section 4.2). This pathway 
is attractive for a number of reasons. Firstly, it rationalises the low level formation of 
phenylacetoxytropane (35) and 2'-hydroxyacetoxytropane (34). Also, the introduction 
of one of the hydroxymethylene hydrogens from a reductase enzyme may account for 
Leete's10,20 observation that tritium from C-3 of L-phenylalanine was re-introduced to 
this site. As discussed in section 3.22, tritium lost into the water in the cells could 
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become incorporated into NAD(P)H by a circuitous route and result in its delivery to 
this site in the final reductive step. The 'same face' carboxyl migration is attractive, as 
according to Akhtar and Wright's 14 postulate, the stereochemical course of iron-oxo 
enzymes is not a consequence of the mechanism, but of the lack of mobility of the 
substrate within the Michaelis complex. This is believed to be an evolutionary feature 
arising to prevent the highly reactive intermediate radicals participating in random 
reactions and thereby denaturing the active site. 
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A modification of this mechanism can be considered, arising for the recent view of 
Golding et af.21 concerning the mechanism of coenzyme-B 12 mediated mutase 
reactions. Here a fragmentation-recombination process is envisaged, rather than the 
previously accepted view of a cyclopropyl transition state (74). The extension of this 
hypothesis to the littorine I hyoscyamine rearrangement is outlined in fig. 104 . 
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If such a process were operating then inhibition by both phenylacetaldehyde and formyl 
tropine would be anticipated, in the same way as glycine and acrylate have been shown 
to inhibit glutamate mutase (fig. 105).21 
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0 C02H 
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The intermediacy of a-formylphenylacetoxytropane (81) has been previously 
suggested, when the utilisation of a C6-C2 fragment derived from phenylalanine was 
still under discussion.22-24 a-Formyphenylacetic acid has been synthesied by Gross et 
al. 25 but proved to be very unstable in aqueous media, making feeding studies 
impossible with this intermediate. 
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Further experimental work is now required to test the iron-oxo hypothesis. 
Initially it would be interesting to determine the 18Q incorporation from [2-
13C,180,2H]-phenyllactic acid. The deuterium would be necessary to distinguish 
between losses due to interconversion with phenylalanine and losses after 
rearrangement. It is anticipated that half of the 18Q relative to 2H would be lost from 
the aldehyde hydrate (fig. 106), determined from the heavy isotope shifts associated 
with the C-3' 13C NMR signal. 
• = 1s0 
Fi~. 106 
The operation of a iron-oxo enzyme could also be probed using a cell free system able 
to convert littorine to hyoscyamine. The dependence or otherwise of the process on 
NADPH and 0 2 could be determined, and the incorporation of 18Q from 1802 into the 
hydroxymethylene group investigated (fig. 107). 
+ 
Fi~. 107 
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PART II 
THE 
BIOSYNTHESIS 
OF 
PILIFORMIC ACID 
CHAPTERS 
Introduction and Backa:round 
5.1 Introduction 
Piliformic acid (82), a secondary metabolite of the slow growing dung fungus Poronia 
piliformis, was first isolated by Edwards in 19851 (fig. 108). 
piliformic acid (82) 
Fie. 108 
Poronia are morphologically related to the genus Xylaria, fungi which grow on dead 
and decaying wood. Four Xylaria have been identified I which produce piliformic acid 
and Poronia piliformis was selected for this study as the highest levels of the metabolite 
are produced from this organism. No previous biosynthetic work has been carried out 
on piliformic acid. However, on inspection there is no obvious contiguous chain, and 
the molecule can be viewed as being constructed from a C3 and Cg chain. A mixed 
biosynthetic origin can therefore be hypothesised comprising a fatty acid or polyketide 
fragment and a c3 fragment of different origin (fig. 109). 
c3 fragment 
H02C~ 
polyketide I fatty acid fragment 
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Piliformic acid has a structural relationship to a number of other metabolites from 
lichens and fungi. In the case of the lichens these secondary metabolites are assumed to 
be products of the mycobiont. 2 A number of examples are illustrated, l-8 all of which 
can be considered to derive from a polyacetate chain and either a C3 or C4 fragment 
(fig. 110 and fig. 111). Some of these compounds have been shown to have useful 
pharmacological properties, in particular, protolichesterinic (83) (Cetraria islandica) 
acid has antifungal, antibacterial, antitumour and growth regulating effects.9 
Chaetomellic acid-A (98) (Chaetomella acutiseta) has potential as an anticancer 
agentS, lO and has been shown to act through the inhibition of the first stage in the post 
translational processing of the ras-oncogene, farnesylation, mediated by farnesyl-
protein transferase.ll A mutated form of this gene is involved with 25% of human 
tumours.l2 Molecular modelling8 has shown that chaetomellic acid mimics farnesyl 
pyrophosphate (100) (fig. 112), which similarly comprises a hydrophilic head and 
hydrophobic tail. 
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farnesyl pyrophosphate (100) 
Fig. 112 
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( + )-protolichesterinic acid (83) 
Cetraria islandica 
lichesterinic acid (84) 
Cetraria islandica 
nephromopsic acid (85) 
Nephromopsis stracheyi 
nephrosterinic acid (86) 
Cetraria endocrocea 
nephrosteranic acid (87) 
Cetraria endocrocea 
caperatic acid (88) 
Parmelia caperata 
rangiforrnic acid (89) 
Cladonia rangiformis 
roccellic acid (90) 
Roccella trictoria 
0 
0 
Funeal Metabolites 
seiridin (91) 
Seiridium cardinale 
2-methyl-3-carboxyhexanoic acid (92) 
Hypoxylon illitium 
3-butyl-4-methylfuran-2(5H)-one (93) 
Hypoxylon serpens 
0 
3-butyl-4-methylenefuran-2(5H)-one (94) 
Hypoxylon serpens 
glauconic acid (95) 
Penicillium purpurogenum 
0 
0 
Fig. 111 
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byssochlarnic acid (96) 
Penicillium purpurogenum 
0 
avenaciolide (97) 
Aspergillus avenaceus 
chaetomellic acid A (98) 
Chaetomella acutiseta 
chaetomellic acid B (99) 
Chaetomella acutiseta 
5.2 The Structure of Piliformic Acid 
From comparison of the proton resonances with various crotonic acidsl3 Edwardsl 
assigned the double bond stereochemistry as E. The structure and double bond 
geometry were confirmed by synthesis. Consistent with this assignment, in my own 
studies, an NOE effect was seen between the C-2 methine proton and the methylene 
protons on C-6 (fig. 113). 
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Piliformic acid has an asymmetric carbon at C-2 and it is interesting to observe 
that while Poronia piliformis, Xylaria longipes, and Xylaria polymorpha all produce 
piliformic acid with a strong negative rotation: [a.]o23 = -89. (c=1, MeOH), the 
metabolite isolated from Xylaria mali and Xylaria hypoxylon is racemic and Hypoxylon 
deustum generates piliformic acid with a positive rotation, smaller in magnitude: [ a.]o23 
= +31 ·cc=1, MeOH). The absolute stereochemistry of piliformic acid has yet to be 
determined from any of the optically active sources. Edwards attempted to degrade 
piliformic acid using the reverse of the scheme he used to synthesise it. The proposed 
strategy involved converting it first to the lactone (101) and then carrying out a reverse 
aldol reaction to generate a methylsuccinic acid (102), which could be compared to 
authentic (R)- and (S)- samples (fig. 114). In the event the acid could not, however, be 
converted to the lactone. I 
~ HO)::( ~ 
H11cs o o 
82 101 102 
Fi~. 114 
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5.3 The Biosynthesis of Piliformic Acid 
As discussed above, a mixed biosynthetic origin for piliformic acid can be inferred, 
comprising C3 and Cg fragments. Isotopic labelling studies have been used to determine 
much of the detailed origin of piliformic acid in Poronia piliformis. The long chain 
fragment was suggestive of a fatty acid or polyketide origin, both involving the head to 
tail coupling of acetate units. An initial series of experiments, in which cultures of P. 
piliformis were supplemented with labelled acetates, confirmed this hypothesis. It was 
subsequently shown that the precursor to the Cg fragment of piliformic acid is in fact an 
intact octanoate chain (103) (fig. 115). 
0 
{"o~ 
Fig. 115 
There were two possible origins for the Cg fragment, either a fully saturated unbranched 
chain originating from the P-oxidation of a long chain fatty acid or from a fragment 
which is generated from acetate condensation mediated by a dedicated polyketide 
synthase. To distinguish between these two possibilities the stereochemical course of 
the enoyl reductase enzyme was determined. It has recently become apparent14-17 that 
the stereochemical courses of the fatty acid synthase enoyl reductase and the polyketide 
synthase enoyl reductase are opposite in fungi and that each type follows the same 
stereochemistry within this class of organism. The outcome of this experiment was that 
the enoyl reductase enzyme involved in the biosynthesis of piliformic acid followed the 
stereochemical course expected for a fatty acid synthase and it was therefore concluded 
that the octanoate fragment of piliformic acid is the degradation product of a long chain 
fatty acid, rather than the product of a dedicated polyketide synthase (fig. 116). 
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It was envisaged that the C3 and Cs units of piliformic acid become joined 
through the attack of an activated form of octanoate (103) onto a suitable funcionalised 
c3 or c4 fragment (fig. 117). 
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As such, the precursor to the C3 fragment has two likely origins. It would be chemically 
reasonable to suggest pyruvate (104), which could be generated from the glycolytic 
pathway or from the transamrnination of L-alanine (105). This would be quite an 
unusual precursor. A second possibility is that this fragment is not originally a C3 
fragment but a C4 fragment. Oxaloacetate (106), a dicarboxylic acid generated in the 
citric acid cycle, also provides a suitable a.-ketone functionality and could 
decarboxylate to generate the methyl group at C-11 of piliforrnic acid. Both molecules 
fulfil the electronic requirements for piliformic acid assembly. The delineation of the 
closer intermediate is however hampered by the fact that these two molecules can 
interconvert in vivo (fig. 118). 
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The formation of oxaloacetate (106) through the citric acid cycle involves the back to 
back coupling of acetate units (fig. 119). Incorporation of acetate in this manner, into 
piliformic acid, was clearly observed in our initial acetate experiments. 
citric acid 
2 ~~ cycle., 
~OH 
0 0 
HO~OH 
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Fig. 119 
Pyruvate (104) proved to be a difficult substrate to synthesise carrying appropriate 
isotopic labels. To investigate the possible C3 origin of the C3 fragment of piliformic 
acid, L-alanine (105) was administered to P. piliformis. This provides an equivalent 
result since pyruvate (104) and L-alanine (105) interconvert in vivo through 
transammination (fig. 120). 
/"co H 2 
105 
transammination 
Fig. 120 
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The low incorporations of isotopically labelled alanines indicated that alanine was not 
an efficient precursor to piliformic acid and it was therefore considered unlikely that 
pyruvate was an immediate or obligate precursor to piliformic acid. Succinate 
(converted to oxaloacetate in the citric acid cycle) was however incorporated efficiently 
into piliformic acid. This observation, and that of the acetate incorporations, provides 
convincing evidence that oxaloacetate (106) rather than pyruvate (104) condenses with 
the octanoate unit during the biosynthesis of piliformic acid. 
As discussed above, it is envisaged that an octanoate fragment and the 
oxaloacetate (106) react by the nucleophillic attack of the Cg unit onto the oxaloacetate 
a.-ketone functionality. This then requires the activation of C-2 of octanoate towards 
119 
deprotonation. Again two reasonable possibilities exist. Firstly the intermediate could 
simply be a ~-keto-octanoate (107), derived directly as an intermediate in the ~­
oxidation of fatty acids, or alternatively a-carboxylation could generate a suitably 
activated octanoate unit (108) (fig. 121). The latter option, employing a putative 
octanoate carboxylase, is consistent with the incorporation of acetate, propionate and 
butyrate into polyketides more generally, although an octanoate carboxylase has never 
previously been identified. 
0 0 0 
~OH or 
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Fig. 121 
These two possibilities were investigated by determining the retention, or otherwise, of 
deuterium from the ~-carbon of the octanoate fragment. Clearly ~-oxidation would 
result in the loss of deuterium from this site, whereas a-carboxylation would not (fig. 
122). 
D D 0 
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Fig. 122 
In the event this study demonstrated that deuterium was retained, and thus it is 
proposed that the activation of the octanoate chain occurs through an a-carboxy 
octanoate. It also became apparent during this study that a 1 ,3-hydrogen shift from C-4 
to C-2 occurs during piliformic acid biosynthesis (fig. 123), a result which has shed 
some light on possible mechanisms of piliformic acid biosynthesis. 
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Fig. 123 
These results are discussed in detail in the following chapter and a pathway for 
the biosynthsis of piliformic acid is proposed which is consistent with the labelling 
patterns observed. The biosynthesis of piliformic acid is discussed in the context of 
biosynthetic studies that have been carried out by other workers on the related 
metabolites introduced in section 5 .1. The 1 H and 13C NMR spectra of piliformic acid 
are shown in fig. 124 and fig. 125. 
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CHAPTER6 
Isotopic Labellin& Studies on Piliformic Acid 
6.1 Fatty Acid Biosynthesis I 
Fatty acids are primary metabolites built up from the head to tail condensation of 
acetate units. This gives rise to even chain lengths, although odd chain lengths may 
arise from the incorporation of non acetate starter units. The chain length, which is 
determined by the steric constraints of the fatty acid synthase (PAS), usually terminates 
at C16 or C1s-
The initial process in fatty acid biosynthesis is the activation of acetyl-CoA (56) 
to malonyl-CoA (21) by acetyl-CoA carboxylase, an enzyme which requires biotin as a 
co-factor (fig. 126). 
0 
~SCoA 
56 
acetyl-CoA carboxylase, 
biotin, 
Fi~. 126 
0 0 
HO~SCoA 
21 
This activated form of acetate is then transesterified onto the acyl carrier protein and 
undergoes a decarboxylative condensation with a molecule of acetyl-CoA (56) to 
generate ~-ketobutyryl-ACP (109). This is then fully reduced by the sequential 
operation of a ~-keto-ACP reductase, a ~-hydroxy-ACP dehydratase and finally a 
trans-enoyl-ACP reductase. These reactions are illustrated in fig. 127. The butyryl-ACP 
(112) is then transesterified and re-enters the cycle to condense with another molecule 
of malonyl-ACP and initiate chain elongation. These four enzymes and associated co-
factors, which are constituents of the fatty acid synthase, mediate the synthesis of a 
fully saturated fatty acid. Any functionality in the final product, such as unsaturation, is 
introduced by post assembly modification (with the exception of some bacteria). 
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The nature of the fatty acid synthase (FAS) depends on the organism and fatty acid 
synthases have been classified into two basic types. A Type I FAS consists of one 
multifunctional protein. These are found in higher organisms such as mammals, birds 
and insects. Type II F ASs are found in bacteria and plants and consist of up to seven 
discrete enzymes and a separate acyl carrier protein. Fungi fall somewhere in between 
these two extremes having two almost identical multifunctional proteins, a. and ~. 
which function as an <X.6~6 oligomer. In fatty acid assembly it would appear that there is 
a level of commitment for the first few condensation reactions. Chain lengths below 
C14 are rare, as are chain lengths above Ct8· 
Polyketides are secondary metabolites, constructed in a similar manner from the 
head to tail condensation of acetate units. The enzymes that mediate the synthesis of 
these molecules almost certainly evolved as a result of genetic mutations of the genes 
responsible for fatty acid synthases. The principle difference between the two systems 
126 
is that any functionality residual in polyketide chains is introduced as the chain is 
assembled. This is known as a "processive assembly" process. The fatty acid cycle is 
selectively modified so that functionality is not removed during synthesis. A carbonyl is 
introduced by not performing the reductions at all, an alcohol by reducing once only 
and an alkene is generated by missing out the final reduction. 
6.2 The Ori&in of the Lon& Chain Fraements of Related Metabolites 
The acetogenic origin of the long chain fragments of a number of metabolites, 
apparently related to piliformic acid, has been demonstrated through feeding 
isotopicallly enriched acetates. Studies by Bloomer2 on the lichen metabolite, 
protolichesterinic (83) acid serve as an illustrative example (fig. 128). 
/' from acetate 
Fig. 128 
A similar experiment was carried out on glauconic acid (95),3 a metabolite elaborated 
by Penicillium purpurogenum. This metabolite is constructed from two C9 units with 
identical carbon skeletons each constructed from an acetate derived C6 unit and a C3 
unit of different origin (fig. 129) 
Et Et 
0 0 
/ from acetate 
Fig. 129 
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A further example is provided by avenaciolide (97),4 produced by Aspergillus 
avenaceus. This metabolite was labelled in separate experiments by [ 1-13C]-acetate and 
[2-13C]-acetate revealing a C12 polyacetate fragment, and again a C3 fragment (fig. 
130). 
0 
/ from acetate 
0 
Fig. 130 
A feature of the long chain fragments, common to all these metabolites, is the 
lack of any functionality (oxygenation, unsaturation, methylation etc.). This is also a 
feature of fatty acid biosynthesis and is therefore suggestive of a fatty acid origin of 
these polyacetate chains. Further to this evidence, there is a strong implication for a 
fatty acid origin of these fragments in some lichen metabolites5 simply on structural 
grounds, i.e. the chain lengths of the polyacetate fragments correspond exactly to the 
chain lengths of common fatty acids. The polyacetate chains of protolichesterinic acid 
(83), lichesterinic acid (84), nephromopsic acid (85), caperatic acid (88) and 
rangiformic acid (89) have Ct6 chains from which a palmitic acid origin is implied. 
Similarly nephrosterinic acid (86), nephrosteranic acid (87) and roccellic acids (90) 
have C14 chains suggesting a myristic acid origin. However, there are many examples, 
including piliformic acid (82), where the chain length does not correspond to a common 
fatty acid. These metabolites include glauconic acid (95) and avenaciolide (97), which 
are discussed above, and the metabolites from various species of Xylaraceous fungi: 2-
methyl-3-carboxyhexanoic acid (92),6 3-butyl-4-methylenefuran-2(5H)-one (93) and 3-
butyl-4-methylfuran-2(5H)-one (94).7 Fatty acids with chain lengths shorter than C14 
are rare so the origin of the polyacetate fragments in these metabolites is not clear. As 
outlined in chapter 5, there are two possibilities, either these fragments are generated 
from acetate and malonate by a dedicated polyketide synthase or alternatively they arise 
by degradation (~-oxidation) of a longer chain fatty acid. 
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6.3 The Oria=in of the Cs Frament of Piliformic Acid 
The expected polyacetate origin of the long chain fragments of a number of related 
metabolites has been demonstrated and it was therefore necessary to verify the 
acetogenic origin of the Cg fragment of piliformic acid. A number of isotopically 
labelled acetates were administered to P. piliformis and high incorporations were 
observed, in the expected head to tail manner, characteristic of fatty acids and 
polyketides. The scene was then set to probe in detail the origin of the Cg fragment. In 
the first instance we were able to demonstrate the intact incorporation of octanoate by 
feeding [ 1-13C]-octanoic acid. These results are described in detail in the following 
paragraphs. 
The acetate origin of the side chain carbons of piliformic acid was demonstrated 
by feeding [1,2-l3C2]-acetate at 15mmolar to cultures of P. piliformis. This was 
incorporated into the Cg fragment at 5.7%. The residual nc-nc couplings in the nc 
NMR spectrum (fig. 131) of the isolated metabolite confirmed the expected 
connectivity (fig. 132). A lower level of incorporation (0.48%) was also seen in the C3 
fragment and this is discussed later. The high concentration of labelled acetate in the 
medium led to the occasional incorporation of two units of [1,2-l3C2]-acetate 
incorporated adjacent to each other, in the same molecule. This is evidenced from the 
minor couplings in the nc NMR of the isolated piliformic acid. The magnitudes of the 
1Jt3cl3c couplings were determined by an INADEQUATE experiment (Table 8). 
0 
HO~ 
Fig.132 
Bond 1JtJct3c 
(C-8)-(C-9) 35Hz 
(C-6)-(C-7) 35Hz 
(C-4)-(C-5) 42Hz 
(C-1 0)-(C-3) 71Hz 
(C-1)-(C-2) 54Hz 
Table 8 
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The origin of the hydrogens of the Cg chain was investigated by supplementing 
P. piliformis with [ 1-l3C, 2-2H3]-acetate ( 15mmolar). This material was incorporated at 
4.6%, a similar level to the [ 1 ,3-l3C2]-acetate (fig. 133). 
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Fig. 133 
The presence of deuterium was detected by the characteristic ~-shift associated with the 
l3C reporter atom in the l3C NMR spectrum (fig. 134 and fig. 135). The signal 
corresponding to C-8 is predominantly ~-shifted by three deuteriums attached to C-9, 
with smaller components to higher frequency corresponding to two, one and no 
deuterium atoms at this site. A fifth minor peak is also apparent, to lower frequency of 
the others. This is interpreted as a result of four ~-shifts on the l3C atom as a 
consequence of two molecules of labelled acetate being incorporated adjacent to each 
other in the same molecule (fig. 136). This phenomenon has already been demonstrated 
in the [ 1 ,3-l3C2]-acetate result. This additional signal cannot be interpreted as a 
2Jt3cl3c coupling as the magnitude of the chemical shift difference between this- peak 
and the other associated peaks is too large, the 2 J I3c I3c couplings from alkanes being 
typically around 3Hz8. 
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Fig. 136 
The incorporation of deuterium was also detected directly by 2H NMR (fig. 137). There 
is some evidence for a "starter effect," i.e. there is a particularly prominent enrichment 
in the terminal acetate methyl group of the polyacetate chain due to the more facile 
direct incorporation of labelled acetate from the acetate pool, rather than the more 
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indirect incorporation from the malonate pool. This is a common phenomenon as there 
is less exchange of deuterium with the medium from acetate than from the malonate. 
In a complementary experiment [2-13C, 2H3]-acetate was fed ( 4.8mmolar) to 
cultures of P. piliformis. Again the expected 13C enrichments into the Cg fragment were 
observed (2.4%) (fig. 138) in the 13C { IH} and 13C( lH, 2H} NMR spectra (fig. 139) of 
the isolated piliformic acid and the deuterium could be clearly seen through the a.-shifts 
associated with the enriched peaks. A low level of deuterium enrichment was also 
observed into the C-11 methyl group, the implications of this result are discussed in 
section 2.12. 
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The intermediacy of an intact octanoate chain was next investigated by 
administering sodium [l-13C]-octanoate to cultures of P. piliformis. The 13C NMR (fig. 
140) of the isolated piliformic acid (fig. 141) showed a very large enhancement (5.5%) 
at C-1 0 and smaller enhancements at the carbons expected -to be labelled by [ 1-13C ]-
acetate in the side chain (2% ). 
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This shows that the greater portion of the substrate had been incorporated intact 
although some ~-oxidation had occurred. This experiment clearly demonstrates that 
octanoate is an intermediate in piliformic acid biosynthesis. 
6.4 Fatty Acid or Polyketide? 
The experiments described above demonstrate that the side chain of piliformic acid is 
derived from the head to tail assembly of acetate units and further that octanoate is a 
biosynthetic intermediate. It then remained to delineate more specifically the origin of 
the Cg fragment. It could arise either as a degradation product of a long chain fatty acid, 
or as the product of a dedicated Cg polyketide synthase. The incorporation of 
carboxylic acids into polyketide secondary metabolites is rare, since there is a tendency 
for micro-organisms to degrade longer chain fatty acid, or polyketide substrates, to 
acetate prior to incorporation.9,10 However, the incorporation of longer chain 
carboxylic acids is not without precedent. Averufin (113),11 a precursor to aflatoxin 
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aflatoxin B 1 (114) 
averufin (113) 
(114) elaborated by a mutant strain of the fungus Aspergillus parasiticus, has been 
shown to incorporate an intact hexanoate starter unit (fig. 142). This hexanoate has been 
shown to be fatty acid in origin.l2 
A more unusual example is the bacterial polyketide fungichromin (115), and the 
related metabolite filipin (116),13 produced by Streptomyces cellulosae. Here an intact 
octanoate unit is condensed at the end of the polyketide chain (fig. 143). It has 
subsequently been demonstrated that the octanoate chain is derived from oleate.l4 
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Fig. 143 
Initially, a straight forward experiment was carried out to investigate the 
possible fatty acid origin of the octanoate fragment. 16-Fluoropalmitate (117) was 
introduced to P. piliformis cultures. It was anticipated that ~-oxidation to a Cs chain 
would lead to incorporation of a terminal fluorine atom in the polyacetate chain (fig. 
144). This would be readily detected by 19p NMR analysis. However, no such 
incorporation was observed in the resultant piliformic acid. There are several possible 
reasons for this failure. The substrate was not readily dissolved in the medium and/or 
could not be absorbed easily by the mycelium. The growth of the mycelium was 
certainly inhibited and a slight soapy film could be seen on the surface of the malt 
extract broth. Alternatively the 16-fluoropalmitate (117) may have been readily 
degraded to fluoroacetetate which would be toxic to the fungus. There was however no 
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evidence either for the incorporation of fluorine via fluoroacetate. Finally of course 
palmitate or another saturated fatty acid may not be a precursor. The study of 
fungichromin (115), 14 discussed above, identified oleic acid as a precursor, and an 
origin from this unsaturated fatty acid may exist for piliformic acid also. 
16-fluoropalmitate 
F 
Fig. 144 
The fatty acid or polyketide origin of the polyacetate Cg fragment of piliformic acid 
was next investigated by probing the cryptic stereochemistry of the enoyl reductase 
enzyme. 
6.5 Enoyl Reductase Enzymes 
The stereochemistry of fatty acid biosynthesis was investigated by Sedgewick and 
Cornforth during the late 1970s.l5,16 The fate of the hydrogen atoms from chiral 
acetate, when administered to various fatty acid synthases, was determined and it was 
revealed that carboxylation of acetyl-CoA (56) occurs with retention of configuration, 
that the decarboxylative condensation occurs with inversion of configuration and that 
reduction of the ~-ketoacyl-ACP (109) occurs to the si-face, followed by a syn-
elimination. The stereochemistry of these reactions would appear to be conserved in all 
organisms. However, the stereochemical course of the final reduction, mediated by the 
enoyl reductase, varies from organism to organism. These results are illustrated below 
(fig. 145) and all four possible stereochemical combinations are known, in different 
classes of organism. 
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There are several possibilities for the enoyl reductase stereochemistry. Hydride may be 
presented to either the si- or re- face of C-3, and either the si- of re- face of C-2 can be 
protonated (fig. 146). 
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Four fungal secondary metabolites have been studied where the stereochemistry 
of the polyketide synthase enoyl reductase has been compared with that of the fatty acid 
synthase enoyl reductase in the same organism. In each case [2-2H3]-acetate was 
administered to the systems and oleic acid and the polyketide metabolite were both 
141 
isolated. The stereochemical location of the acetate hydrogens was then determined 
either directly by NMR or indirectly after degradation to an a-deuterated aliphatic acid. 
This was achieved by generating a diastereomer for 2H NMR analysis by coupling to an 
enantiomer of methyl mandelate prior to analysis. 
The first metabolite to be studied in this manner was brefeldin-A (118), a 
macrolide elaborated by Penicillium brefeldianum11, 18(fig. 147). 
HO 
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This molecule is an octaketide with a macrocyclic ring rendering it structurally similar 
to the prostaglandins, although unlike the prostaglandins, it is not a modified fatty acid. 
Further examples are provided by Vederas on the fungal polyketides dehydrocurvularin 
(119), from Alternaria cineraria, antibiotic A26771B (120)19 from Penicillium 
turbatum and cladosporin (121)20, 21 from Cladosporium cladosporiodes (fig. 148). In 
all of these cases the deuterium retained from [2-2H3]:-acetate appeared at the pro-S site 
in the polyketide, indicating protonation to the re-face. In the fatty acid, oleic acid 
(122), the opposite stereochemistry is apparent, indicating protonation to the si-face. 
Although the sample size is small it would appear to be a general phenomenon in fungi 
that the stereochemical course of the protonations, mediated by the enoyl reductase 
enzymes, are opposite in the fatty acid and polyketide synthases of the same organism. 
It also appears that the polyketide or fatty acid synthases follow the same 
stereochemical course within this class of organism. This feature was used to delineate 
the fatty acid or polyketide origin of the polyacetate fragment in piliformic acid, by 
establishing the stereochemical location of deuterium atoms derived from acetate in the 
side chain. 
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A further example was a study on averufin (113) carried out by Townsend et 
a[.12 This polyketide was shown to incorporate hexanoate as a starter unit, as discussed 
above. The cryptic stereochemistry of both the hexanoate unit and oleic acid co-
produced by the organism was investigated. In the event the stereochemistries were the 
same, the deuterium from [2-2H3]-acetate appearing at the pro-R site in both instances 
(fig. 149). There are no fully reduced methylene sites in the rest of the averufin 
molecule amenable to stereochemical comparison. However, from the above result and 
the results known for other fungal metabolites, it was concluded that the hexanoate unit 
is a product of fatty acid degradation. 
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6.6 Piliformic Acid Enoyl Reductase Stereochemistry 
An analogous strategy was carried out to determine the origin of the polyacetate chain 
of piliformic acid. From experiments with both [ t-l3C,2-2H3]-acetate and [2-13C,2-
2H3]-acetate the labelling pattern from [2-2H3]-acetate was evaluated (fig. 150). 
D 
Fig. 150 
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The double bond between C-3 and C-4 provides a site in the molecule amenable to 
oxidative cleavage which was achieved using ruthenium tetroxide and potassium 
periodate. This relatively mild oxidation process has been applied to polyketide 
metabolites before by Sharpless22 and also used to investigate the stereochemistry of 
the methyl branched side chain of the fungal polyketide metabolite, tenellin (123)23,24 
(Fig. 151). 
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The polyketide was cleaved as shown and the stereochemistry of the resulting 
methylbutyric acid (124) determined by complexing with a chiral diamine (125)26 (fig. 
152) and NMR analysis the resulting complex. 
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As [2-2H3]-acetate is relatively cheap, several grams was fed to cultures of P. 
piliformis to generate :::::1g of isotopically enriched piliformic acid. Oxidative cleavage 
of the double bond then generated isotopically enriched hexanoic acid (126a), which 
was analysed by 2H NMR as its (2R)-methyl mandelate ester (scheme 15). 
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Scheme 15 
The configuration of deuterated hexanoic acid (126a) generated from piliformic acid 
could be determined by NMR because (2R)-methyl mandelate moiety renders the 
prochiral a-hydrogens I deuteriums non-equivalent (fig. 153). 
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The coupling patterns in the I H NMR spectrum of this molecule are complex but a 
single peak for each site is observed in the proton decoupled 2H NMR spectrum. The 
relative chemical shifts for a-deuterated carboxylic acid I mandelate esters have 
previously been established26,27 and comparison of the metabolite derived hexanoic 
acid (126a) with racemic (C-2) deuterated material (127b) (fig. 154) revealed the 
stereochemistry of the deuterated piliformic acid to be (R). 
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6.7 Methyl 0-Hexanoyl Mandelate from Piliformic Acid (127a) 
Piliformic acid, isolated after supplementing cultures of P. piliformis with [2-2H3]-
acetate at 15mmolar was oxidatively cleaved with ruthenium tetroxide and potassium 
periodate in a biphasic solution of water : acetonitrile : carbon tetrachloride (3: 1: 1) to 
give hexanoic acid in 77% yield. The hexanoic acid was then esterified with (2R)-
methyl mandelate, using DCC and a catalytic quantity of DMAP in 65% yield. 
6.8 Methyl (RSl-f2-2HJ-O-Hexanoyl-(2'Rl-mandelate (127bl 
Methyl hexanoate was deprotonated with LDA at -78"C. The anion was then quenched 
with MeOD to generate racemic a-deuterated methyl [2..2H]-hexanoate containing 
approximately 50% 2H at C-2, as judged by I H NMR analysis. Base hydrolysis of the 
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ester, by refluxing in a 1M KOD in D20 for 12 hours, generated (RS)-[2-2H]-hexanoic 
acid in 74% yield. This deuterium enriched acid was then coupled to (2R)-methyl 
mandelate in the same manner as that for piliformic acid derived hexanoic acid 
(scheme16). 
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6. 9 2H NMR Analysis of the Methyl 0-Hexanoylmandelate Derivatives 
The 2H NMR spectra of each of the deuterated mandelate derivatives (127a and 127b) 
were recorded. The piliformic acid derived material (127a) was then spiked with a 
small quantity of racemate such that a second peak at the a-position, became apparent 
to higher frequency of the existing peak. This confirmed the direction of the shift. 
These spectra are shown below (fig. 155 and fig. 156). The spectrum of the spiked 
material shows a small peak appearing to higher frequency of the existing peak. From 
previous assignments determined by Parker26,27 it was deduced that the deuterium in 
the metabolite derived hexanoate is situated exclusively in the pro-R site. Protonation 
by the enoyl reductase therefore occurs to the si-face. This study clearly suggests that 
the side chain of piliformic acid has a fatty acid, rather than a polyketide origin. 
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6.10 The Origin of the C3 Fragment of Piliformic Acid 
It is envisaged that piliformic acid is formed by the condensation of an activated 
octanoate unit with a suitably functionalised C3 or C4 fragment. Pyruvate (104) and 
oxaloacetate (106) are candidate intermediates in piliformic acid biosynthesis since 
both of these molecules provide a suitable electrophilic ketone moiety for condensation 
(fig. 157). 
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While pyruvate (104) and oxaloacetate (106) can interconvert in vivo28 their metabolic 
origin is quite different. Pyruvate (104) is the final product of glycolysis. Glycolysis29a 
is the sequence of reaction which converts glucose (130) to pyruvate (104) with the, 
concomitant production of ATP. This pathway is universal to almost all organisms and 
takes place in the cell cytosol. The reactions of the glycolytic pathway are summarised 
in fig.158 to illustrate how [2-14C]-:glucose is catabolised to [2-14C]-pyruvate. 
Oxaloacetate (106) is a dicarboxylic acid generated in the citric acid cycle. The 
citric acid cycle29b is the final common pathway for the oxidation of fuel molecules. 
Acetate enters the cycle as acetyl-CoA (56) and is completely oxidised to carbon 
dioxide and water. In aerobic organisms glycolysis and the citric acid cycle are linked 
by the decarboxylation of pyruvate. This reaction, and the reactions of the citric acid 
cycle, occur within the mitochondrial matrix. The reactions of the citric acid cycle 
result in the back to back coupling of acetate units. This is illustrated in fig. 159 , which 
follows the fate of [2-l3C]-acetate. In addition to its role in generating energy for the 
cell (by generating A TP) the citric acid cycle is a source of biosynthetic intermediates. 
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6.11 The Oriein of the C3 or C4 Fraement in Related Metabolites 
[ J-l4C]-Acetate incorporation into protolichesterinic acid (83)2,30,31 revealed the 
expected high level of labelling in the long chain fragment and also a lower level of 
labelling at C-1 (fig. 160) in the C3 fragment. This latter enrichment is consistent with 
the incorporation of acetate via a citric acid cycle dicarboxylic acid. It is interesting to 
note that positions C-2 and C-5 were also labelled in this experiment. This cannot 
however be the result of acetate metabolism through the citric acid cycle as 
incorporation by this pathway would result in the C-2 (methyl) carbons of acetate 
becoming joined, not the C-1 (carboxyl) carbons. Subsequently the citric acid cycle 
origin of this fragment was further implicated by the successful incorporation of [ 1 ,4-
l4Cz]-succinate (130) into protolichesterinic acid. 
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Comparing protolichesterinic acid (83) to the apparently related lichen metabolites 
caperatic acid (88) and rangiformic acid (89), reveals an important structural difference. 
In caperatic and rangiformic acids the non-acetate derived fragment is a four carbon 
unit, which provides circumstantial evidence that in these lichen metabolites, 
oxaloacetate (106) is the more likely precursor. 
Glauconic acid (95)3 provides further evidence of a citric acid cycle 
intermediate. Glauconic acid (95) is the product of two C9 fragments which are 
themselves constructed from C6 and C3 units as discussed in section 6.2. Here again the 
incorporation of both [1-14C]-ace'tate and [2-14C]-acetate was·entirely consistent with 
the involvement of a citric acid cycle intermediate. Subsequently succinate (130) 
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incorporation was also shown. In later experiments the incorporation of [2-14C]-
pyruvate (104) and [2-14C]-glucose (130), which would generate [2-14C]-pyruvate in 
vivo through glycolysis, were also shown. [2-14C]-Pyruvate is readily converted into [ l-
14C]-acetate in vivo, however, the high level of incorporation observed at C-6, 
compared to the sites enriched by acetate, indicate that this had largely not happened. 
This experiment therefore demonstrated that a symmetrical C4 intermediate, such as 
succinate (130) was not required, as such an intermediate would result in the 
scrambling of the label between C-6 and C-7. Thus of the citric acid cycle C4 
dicarboxylic acids, oxaloacetate (106) was the only candidate precursor, although a 
direct incorporation of pyruvate (104) is not precluded (fig. 161). 
0 / 
0 
Fig. 161 
/ 
0 
The citric acid cycle origin of the C3 fragment of avenaciolide (97) has also 
been demonstrated.4 Here [2-l3C]-acetate was incorporated at a sufficiently high level 
that coupling between C-11 and C-12 was apparent in the Be NMR (fig. 162). 
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However, only a cautious biosynthetic comparison between this metabolite and 
piliformic acid can be made as the mode of succinate incorporation is clearly quite 
different. This is inferred by the structural difference which suggests a condensation in 
the opposite direction to the ~-carbon, rather than the a.-carbon of the long chain moiety 
(fig. 163). 
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Another group of secondary metabolites for which a citric acid cycle 
dicarboxylic acid origin has been suggested are the tetronic acids, of which carlosic 
acid (131)32,33 is an illustrative example. Acetate was shown to label six of the carbons 
in a head to tail manner while [2,3-14Cz]-succinate (130) efficiently labelled C-4 and 
C-9 (fig. 164). 
155 
0 
' from acetate 
HO 
• from succinate 9 
Fig. 164 
Lei bing and Reio33 suggested that ~-keto-hexanoate condensed with malate (citric acid 
cycle) to generate carlosic acid (131) in Penicillium charlesii. However, this hypothesis 
was later modified by Bentley et af32 who suggested that malate might first condense 
with malonyl-CoA followed by the addition of an acetate I malonate derived C4 
fragment, to account for the co-production of smaller quanities of methyltetronic acid 
(132) by the fungus (fig. 165). It is noteworthy that labelled acetates were not 
incorporated in the c4 fragment of carlosic acid (131). 
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A further example of the incorporation of a citric acid cycle derived fragment is found 
in the fungal polyketide marticin (133),34 elaborated by Fusarium martii. From the 
incorporation of [1,2-13C2]-acetate a heptaketide with a C3 fragment of different origin 
was apparent, rather than a nonaketide having lost one carbon. C-16 and C-17 were 
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coupled, consistent with the intact incorporation of an acetate unit, whereas C-15 and 
C-16 showed smaller satellites indicating back to back coupling through the citric acid 
cycle (fig. 166). 
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6.12 Isotopic Incorporations into the C3 Fraa=ment of Piliformic Acid 
It has been demonstrated in a number of other metabolites that the C3 fragments 
incorporate acetate in a manner consitent with a citric acid cycle origin. In the case of 
glauconic acid (95) a possible glycolytic origin was also indicated.3 With this 
background the biosynthesis of the c3 fragment of piliformic acid was investigated. 
The first evidence for the origin of the C3 fragment of piliformic acid came from 
the initial acetate feeding experiments. 13C NMR studies of piliformic acid, 
supplemented with [1,2-13C2]-acetate, indicated that the isotope was principally 
incorporated into the side chain (section 6.3) and also at a lower level (0.48%) into the 
C3 unit. C-1 and C-2 were enriched, and coupled, indicating the incorporation of an 
intact acetate unit, and C-11 was enriched but divorced from an adjacent isotope, 
indicating the incorporation of one carbon of an acetate molecule. This is illustrated in 
fig. 167, showing incorporations into the C3 fragment only. This is consistent with the 
back to back coupling of acetate through the citric acid cycle to generate oxaloacetate 
(106), which has lost one carbon atom by decarboxylation. 
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When [2-BC, 2H3]-acetate was administered to P. pilifonnis C-2 and C-11 were 
again enriched and also a single low level deuterium enrichment was observed attached 
to the C-11 methyl group. The incorporations of [2-l3C, 2H3]-acetate into the C3 
fragment are illustrated in fig. 168. 
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These experiments do not however indicate whether decarboxylation of oxaloacetate 
had occurred before or after coupling with the octanoate fragment. 
To investigate the origin of this C3 fragment in greater detail, commercially 
available DL-[1-l3C]-alanine (105a) was administered to P. piliformis. The 
biosynthetic implications of alanine (105) incorporation are the same as for pyruvate 
(1 04) as the two can interconvert through transammination. In the event the Be 
enrichment of C-1 was small but apparent (0.09%) in the 13C NMR spectrum (fig. 169) 
indicating the expected regiospecific labelling. However, the low level of incorporation 
suggests that alanine (and therefore pyruvate) had only been incorporated rather 
inefficiently and possibly by an indirect route. 
6.13 Pyruvate or Oxaloacetate? 
In order to establish whether pyruvate (104) could indeed be incorporated 
without prior carboxylation to oxaloacetate it was proposed to feed [3-l3C, 2H3]-
pyruvate, with deuterium tagged to Be to enable detection by Be NMR analysis. 
Carboxylation would entail loss of one deuterium and therefore the retention of all three 
deuterium atoms would delineate oxaloacetate or pyruvate as the closer precursor (fig. 
170). 
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Initially a synthetic route to pyruvate via [2-13C, 2H3]-acetate was examined.35 
Unfortunately the low overall yield of this procedure meant that starting from an 
expensive label such as [2-13C, 2H3]-acetate would render the experiment too 
expensive. 
Another route was also investigated which utilised commercially available ethyl 
1 ,3-dithiane-2-carboxylate (134), introducing the label from [l3C, 2H3]-methyl iodide 
(scheme 17). The methylation was accomplished in almost quantitative yield. However 
attempts to hydrolyse the methylated dithiane product (135), to generate ethyl pyruvate 
(136), resulted only in the destruction of starting material under all of the conditions 
tried, including N-bromosuccinimide,36 mercuric oxide I boron trifluoride etherate37, 
silver oxide38, silver nitrate39 and trichlorocyanuric acid40. 
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Scheme 17 
As this pyruvate synthesis proved impractical [3-13C, 2H3]-alanine (105b) was 
prepared instead. It was judged that the retention of three deuterium atoms from this 
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precursor would provide a definitive result as in vivo transammination would lead to [3-
13C, 2H3]-pyruvate. In the first instance unlabelled DL-alanine (105) was synthesised 
from 1-benzyl-2-(t-butyl)-3-methylimidazolin-4-one (137) using the methodology 
developed by Seebach4l (scheme 18). 
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6.14 DL-1-Benzyl-2-(t-butyH-3-methylimidazolidin-4-one43, 44 
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Scheme 19 
Glycine methyl ester hydrochloride (139) was initially converted to the corresponding 
amide (140) by stirring in 8M ethanolic methylamine for 15h. After this time the crude 
product was used to generate oxime (141) with pivalaldehyde. The oxime was cyclised 
directly by stirring in methanolic HCl for 12h to generate 2-(t-butyl)-3-
methylimidazolidin-4-one in 49% yield, over 3 steps. 2-(t-Butyl)-3-methylimidazolidin-
4-one (142) was then treated with benzyl chloride to generate 1-benzyl-2-(t-butyl)-3-
methylimidazolidin-4-one (137) in 56% yield as shown in scheme 19. 
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6.15 DL-1-Benzyl-2-(t-butyl}-3.-methyl-[5-13~2!:b.methv0-imidazolidin-4-one 
(138a)4l 
DL-1-Benzyl-2-(t-butyl)-3-methylimidazolidin-4-one (137) was deprotonated with 
LOA at -78°C and the anion was then quenched with methyl iodide. After aqueous 
work-up a mixture of the required 1-benzyl-2-(t-butyl)-3,5-dimethylimidazolidin-4-one 
(138a) and a little unreacted starting material (137) was obtained. Although 
chromatographically similar the product was separable by repeated flash 
chromatography and DL-2-(t-butyl)-3-methyl-[5-l3C,2H3-methyl]-imidazolidin-4-one 
(138a) was isolated in 56% yield. 
6.16 DL-[3.13.c.._ 2!:131-Alanine (105b)44 
Seebach44 has demonstrated that alkylated imidazolidinones are difficult to 
hydrolyse, and that they require vigorous conditions. Consistent with this 1-benzyl-2-(t-
butyl)-3,5-dimethylirnidazolidin-4-one (138) did not hydrolyse even after refluxing in 
6N HCl for two hours, thus a more vigorous method was required. Success was 
achieved by heating a suspension of the methylated irnidazolidinone (138a) in 6N HCl 
at 180°C in a sealed tube for 12 hours. This produced the labelled alanine hydrochloride 
mixed with methylamine, hydrochloride. One concern was that the hydrolysis may 
generate the partially hydrolysed product, alanine N-methyl amide, but in the event this 
was not the case. The free amino acid (105b) was liberated by ion exchange 
chromatography, free from methylamine, and the identity of the product was confirmed 
by I H NMR and by TLC comparison to an authentic sample of DL-alanine. 
6.17 Incorporation of [3.13.c,_ 2HJJ-Alanine into Piliformic Acid 
The piliformic acid isolated from P. piliformis, supplemented with [3-13C, 2H3]-
alanine, was analysed by 13C(IH} and l3C{1H,2H}-NMR (fig. 171). There was no 
evidence for any incorporation of deuterium into piliformic acid although the C-11 
resonance appeared to have a low level of enrichment ("" 0.1% ), indicating 
incorporation with deuterium washout. Also, low level enhancements of the C-9, C-7, 
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C-5, C-3 resonances suggested that a small amount of nc had been incorporated into 
these sites via the oxidative decarboxylation of pyruvate to generate [2-l3C]-acetate. 
From this result it can only be concluded that L-alanine is not an efficient precursor to 
piliformic acid and the direct incorporation of pyruvate is by implication, negated. 
6.18 Incorporation of [2.3~2.ll4J~Succinic Acid into Piliformic Acid 
The low level and indirect incorporation of alanine (105), coupled with the conclusive 
evidence that acetate can be incorporated into the C3 fragment via a citric acid cycle 
intermediate, placed oxaloacetate (106) as a candidate precursor to piliformic acid. To 
test this hypothesis [2,3-2H4]-succinic acid (130a) was administered to P. piliformis. It 
was anticipated that metabolism of the deuterated succinate (106a), through the citric 
acid cycle, would furnish oxaloacetate bearing a single deuterium at C-3. Incorporation 
into piliformic acid, followed by decarboxylation would then label the C-11 methyl 
group with deuterium (fig. 172). 
D 
Fig. 172 
The resultant piliformic acid isolated was analysed by 2H NMR (fig. 173) and in this 
case revealed a prominent enhancement at 1.31 ppm. Three minor peaks at 0.87ppm, 
1.57ppm and 2.59ppm indicated some incorporation of deuterium into the Cg fragment 
consistent with the formation of [2-2H]-acetate in vivo, presumably via succinate (130) 
---+ oxaloacetate (106) ---+ pyruvate (104) ---+ acetate. The marked incorporation of [2,3-
2H4]-succinic acid clearly places oxaloacetate (106) as a bonafide intermediate. 
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6.19 Mechanismistic Considerations for the CouplinK of the Cs Fragment with 
Oxaloacetate 
As discussed previously the attachment of the octanoate (103) unit to oxaloacetate 
(106) requires the a-carbon of octanoate to be activated towards deprotonation. This 
could be satisfied with either a ~-keto-octanoate (107) or a a-carboxyoctanoate (108) 
intermediate. With the knowledge that the polyacetate chain is a degradation product of 
a fatty acid, the ~-keto-octanoate emerged as the more likely intermediate as this would 
arise by an extension of the normal ~-oxidation process. a-Carboxylation on the other 
hand would require a dedicated octanoate carboxylase. 
Delineation of these possibilities was probed by investigating deuterium 
retention at the ~-carbon of octanoate, which becomes the olefinic proton of piliformic 
acid. Clearly conversion to a ~-keto-octanoate (107), prior to incorporation, would 
result in the complete loss of deuterium from this site, whereas the alternative a-
carboxylation, to generate the a-carboxyoctanoate (108), would lead to deuterium 
retention. Of course only one deuterium would be retained in piliformic acid due to the 
introduction of the double bond. These mutually exclusive processes are illustrated in 
Fig. 174. 
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Commercially available perdeuterated octanoate was administered to cultures of P. 
piliformis. The use of perdeuterated material, instead of selectively labelling the ~­
carbon of octanoic acid meant that the intact incorporation of octanoate could be easily 
assessed by comparing enrichments at the sites of interest with other sites on the 
hydrocarbon chain. Perdeuterated hexanoate and butyrate were also administered to P. 
piliformis, in separate experiments to establish, or otherwise, if shorter acids could be 
incorporated directly as starter units. The 2 H NMR spectra from these three 
experiments are shown below (fig. 175 fig. 176 and fig. 177). Firstly, a background 
acetate labelling pattern can be clearly seen in the 2H NMR spectra from the hexanoate 
and butyrate feeding experiments, with no evidence of direct incorporation. Therefore 
in the shorter chain precursors only ~-oxidation to acetate has occurred. In the 
octanoate derived spectrum however all of the side chain proton sites are deuterium 
enriched showing again the intact incorporation of octanoate. A signal of particular 
interest is the enriched olefinic site at 7 .Oppm. This clearly indicates deuterium 
retention at the ~-carbon of octanoate showing that, although unprecedented, the 
octanoate intermediate must have been activated by a.-carboxylation. Thus, this result 
implies that a dedicated octanoate carboxylase is operating during the biosynthesis and 
that hypotheses involving a ~-keto-octanaoate become redundant. 
Another mechanistically revealing and unexpected enrichment is seen at the 
methine site of the C3 fragment (C-2 of piliformic acid). The occurrence of the 
deuterium atom here indicates the operation of a 1 ,3-hydrogen shift occurring during 
the biosynthesis. This deuterium integrates fully as one, thus no loss or exchange with 
the medium has occurred. The transfer of a deuterium atom while the piliformic acid is 
tightly held in the active site of an enzyme would explain this complete transfer. On the 
basis of these results a mechanism for the coupling of the C3 and Cs fragments is 
proposed below (fig. 178). It is envisaged that the decarboxylation is driven by the loss 
of the hydroxyl moiety. The migration of the double bond is then required to furnish the 
piliformic acid skeleton. One 1 ,3-hydrogen shift has already been demonstrated and is 
shown. It is possible that a prior 1 ,3-hydrogen shift is involved in the first double bond 
migration to generate 144 from 145. 
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The incorporations of [2H15]-octanoic acid allow the fate of all the deuteriums 
from this precursor to be followed except those at C-2. The C-2 of octanoic acid is 
incorporated to furnish C-3 of piliformic acid, which does not have any hydrogens 
attached (fig. 179). To be confident that the deuterium enrichment at the methine s~te of 
piliformic acid did not arise from the C-2 deuterium atoms of [2H15]-octanoic acid, [1-
l3C, 2-2H]-octanoic acid (106b) was administered toP. piliformis. 
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This substrate was synthesised from [ 1-l3C]-octanoic acid following the procedure 
described for [2-2H]-hexanoic acid in section 6.8 (scheme 20). 
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The expected high level of intact incorporation was seen by 13C NMR analysis (fig. 
180) (4.9%) with a lower level of incorporation via [1-13C, 2-2H]-acetate (1.4%). 2H 
NMR analysis revealed that deuterium had only been incorporated into piliformic acid 
via [1-13C, 2-2H]-acetate as predicted (fig. 181). This result in no way contradicts the 
conclusion that the deuterium incorporation into the methine site of piliformic acid 
from [2H 15]-octanoic acid was a consequence of a 1,3 shift from C-4 as described 
above. 
The mechanism proposed may also explain the different optical rotations of 
piliformic acid obtained from different biological sources. The metabolite isolated from 
P. piliformis, X. longipes and X. polymorpha has a strong negative rotation which 
suggests that piliformic acid from these sources is the same enantiomer and the 
stereochemistry of hydrogen delivery to the methine site is tightly controlled. The 
racemic material isolated from X. mali and X. hypoxylon suggests an intermediate 
which is less tightly held and is free to invert. Correspondingly the material from H. 
deustum with a rotation smaller in magnitude than P. piliformis' metabolite suggests 
again a less rigidly held system but with preferential hydrogen delivery to the opposite 
face. It was anticipated that if hydrogen was delivered equally to either face of 
piliformic acid at C-2 after double bond migration that only 50% of the deuterium from 
C-4 would appear at the methine site in racemic piliformic acid. 
172 
-...l 
I..H 
..J.~ 
-, '1' 
I • '---r 
180 lfi) 
•I' 
14rJ 
I . 
120 
.. ' 
10') 
I ' ' ' ' • ' r ' f ; 
BO 60 
I l'. I· 
40 
13C NMR spectrum of pili formic acid after feeding [ l-13C, 2-2H]-octanoic acid 
Fig. 180 
I 
c. Cl ;:piT' 
-.J 
~ 
dichloromethane 
ppm 1. 5 !. 0 0. 5 
,] 
~!(I~( 
a 1 s s 4 3 2 1 --. 
2H NMR spectrum of piliformic acid after feeding [ 1-i3C, 2-2H]-octanoic acid 
Fig. 181 
-l 
VI 
/ 
I I 
DMSO 
( 
; 
~~( II!~ ~:':!"_/ , .. ~ A~ ~,- ,~r ·~ .. .,, "• . ~ ~· " . ~- /"" _) a 7 6 ·-· ··-· H j§j 5 - .. 
4 I 3 2 
2H NMR spectrum of piliformic acid isolated from X. mali 
after feeding perdeuterated octanoic acid 
Fig. 182 
-----. ----. 
I 
To investigate this possibility [2H ts]-octanoic acid was administered to Xylaria mali 
and the racemic piliformic acid isolated for 2H NMR analysis (fig. 182). Once again the 
intact incorporation of octanoate into the Cg fragment was apparent and significantly 
the olefinic and me thine sites were enhanced at an equal level ( 1: 1) indicating that 
complete transfer had again occurred. At present this interesting observation is not 
satisfactorily explained. 
6.20 Conclusions 
Piliformic acid is demonstrated to be of mixed biosynthetic origin, comprising a Cg 
polyacetate and a C3 fragment. It has further been shown that the octanoate chain is the 
product of a fatty acid synthase and that the C3 fragment is almost certainly derived 
from oxaloacetate. Experiments with perdeuterated octanoic acid have revealed an 
intriguing 1 ,3-hydrogen shift in two producing organisms. 
Another interesting aspect of these findings is apparent when piliformic acid is 
compared to some structurally related fungal and lichen metabolites. The lichen 
metabolites with very long chains: protolichesterinic acid (83), lichesterinic acid (84), 
nephromopsic acid (85), caperatic acid (88), rangiformic acid (89), nephrosterinic acid 
(86) and nephrosteranic acid (87) are all oxygenated at the ~-position of their 
polyacetate chains. The presence of oxygen at this particular site strongly suggests that 
the activated form of these acids, which condenses with the C3/C4 unit, is indeed the ~­
ketoacid, the ketone then being reduced to an alcohol and forming a lactone with one of 
the carboxyl groups as proposed by Bloomer et af2 (fig. 183). 
Inspection of the related fungal metabolites 2-methyl-3-carboxyhexanoic (92) 
acid, 3-butyl-4-methylfuran-2(5H)-one (93) and 3-butyl-4-methylenefuran-2(5H)-one 
(94) and also glauconic acid (95) reveals that they, and piliformic acid, are not 
oxygenated at the P- site. This difference, and the shorter length of the chains, 
highlights the possibility that the mechanisms of assembly of the lichen metabolites 
may differ from the shorter chain fungal metabolites. 
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CHAPTER7 
Experimental 
7.1 General 
IR spectra were recorded on a Perkin-Elmer F.T. 1720X or 1600 spectrometer. Low 
resolution mass spectra were recorded on a VG Analytical 7070E Organic mass 
spectrometer. NMR spectra were recorded on Varian Gemini 200MHz (lH at 
199.977MHz, 13C at 50.30MHz), Varian XL-200 (lH at 200.057MHz) Varian VXR-
400(S) (IH at 399.952 13C at 100.577MHz), Bruker AMX-500MHz (lH at 
500.137MHz, 13C at 125.759MHz, 2H at 76.775MHz), Bruker AC-250 (1 H at 
250.133MHz, 13C at 62.257MHz) and Varian VXR-600, (13C at 150.869MHz, 
University of Edinburgh) spectrometers. Chemical shifts are quoted relative to TMS 
(0=0). Radioactive analysis was carried out using a Packard 1600TR scintillation 
analyser in Ecoscint A. GC-MS was recorded on a VG TRIO-IS mass spectrometer 
(VG Masslab Ltd, Manchester) fitted with a Hewlett Packard 5890 series II gas 
chromatograph (Hewlett Packard Inc. Fort Collins USA) and a DB17 column (J&W 
Scientific, Folsom, USA) was used for separation. Flash chromatography was carried 
out using Fluka silica gel-60 (35-70mm) or Sorbsil-C60-H (40-60mm). Melting points 
were determined using a digital Gallenkamp melting point apparatus and are 
uncorrected. The solvents used in reactions were dried and distilled prior to use: 
tetrahydrofuran and diethyl ether (sodium benzophenone, under nitrogen), 
dichloromethane (calcium hydride, stored over molecular sieves), triethylamine 
(calcium hydride), diisopropylamine (calcium hydride) and pyridine (calcium hydride). 
Petrol refers to petroleum ether (30-60"C) and ether refers to diethyl ether. Non-
aqueous reactions were carried out under an atmosphere of dry nitrogen or dry argon. 
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7.2 Growth of D. stramonium and Isolation of Hyoscyamine 
Transformed root culture of D. stramonium were subcultured at= 0.5g per flask (50ml 
B50 medium) after 10-14 days growth.l The phenyllactates were pulse fed in sterile, 
neutral solution on days 5, 7 and 9 to a final concentration of 0.42 - 0.60mmoldm-3 in 
the medium. The roots were harvested after 17 days and freeze dried. The freeze dried 
roots were then ground with acid washed sand and extracted into 5% H2S04 (lOml per 
0.5g dry weight) by stirring for 15min. The aqueous extract was then made basic with 
35% ammonia solution, filtered through Kieselguhr (Varian Bondelut) and eluted with 
chloroform : methanol (20 : 1). The eluant was evaporated under reduced pressure to 
give a brown oil. Purification by preparative TLC (chloroform : diethylamine (9: 1)) 
afforded hyoscyamine, usually contaminated with trace amounts of littorine and lipids. 
oc(CDC13)2.3 24.20 (C-6 or C-7), 24.76 (C-6 or C-7), 34.85 (C-2 or C-4), 35.06 (C-2 or 
C-4), 42.22 (-Me), 54.24 (C-2'), 60.50 (C-1 or C-5), 60.61 (C-1 or C-5), 64.05 (C-3'), 
66.57 (C-3), 127.94 (C-7'), 128.09 (C-5'), 129.03 (C-6'), 135.38 (C-4'), 171.87 (C-1') 
7.2.1 Sodium (RS)-£2.13h 2Hl-Pbenyllactate 
0 
OH 
Sodium (RS)-[2-BC, 2H]-phenyllactate was pulse fed to transformed root cultures of D. 
stramonium (9x50ml) to a final concentration of 0.47mmoldm-3. Hyoscyamine (18mg), 
contaminated with trace amounts of littorine, was isolated with incorporations of 
16.95% (13C and 2H) and 5.69% (13C only) as analysed by CG-MS. The littorine in the 
hyoscyamine sample had incorporations of 18.03% (13C and 2H) and 5.05% (13C only). 
The values for incorporations into hyoscyamine determined by NMR analysis were 
13% (13C and 2H) and 9% (13C only) (fig. 38 and fig. 39). 
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7.2.2 Sodium (Rl-D-f2.13c_ 2HJ-Phenyllactate 
0 
OH 
Sodium (R)-D-[2-13C, 2H]-phenyllactate was pulse fed to transformed root cultures of 
D. stramonium (5x50ml) to a final concentration of 0.42mmoldm-3. On day six baterial 
contamination was apparent and was controlled by the addition of the antibiotic 
ampicillin (250J!l, 25mgml-l ). Hyoscyamine (20mg), contaminated with trace amounts 
of littorine, was isolated with incorporations of 21.7% (13C and 2H) and 0.8% ( 13C 
only) as analysed by CG-MS. The littorine in the hyoscyamine sample had 
incorporations of 29.8% (13C and 2H) and 1.5% (13C only). The values for 
incorporations into hyoscyamine, determined by NMR analysis, were 25% (13C and 
2H) and 4% ( 13C only) (fig. 53). 
7.2.3 Sodium (Sl-L-f2-13c_ 2ffi.Phenyllactate 
0 
OH 
Sodium (S)-L-[2-13C, 2H]-phenyllactate was pulse fed to transformed root cultures of 
D. stramonium (10x50ml) to a final concentration of 0.47mmoldm-3. Hyoscyamine 
(30mg), contaminated with trace amounts of littorine, was isolated with an 
incorporation of 5.1% ( 13C only) as analysed by CG-MS. The littorine in the 
hyoscyamine sample had an incorporation of 10.3% (13C only). The values for 
incorporation into hyoscyamine determined by NMR analysis were 16% (13C only) 
(fig. 54). 
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7.2.4 Sodium fRS)-£2-3HJ-Phenyllactate 
0 
OH 
Sodium (RS)-[2-3H]-phenyllactate (918fleimmoi-l) was pulse fed to transformed root 
cultures of D. stramonium (22x50ml) to a final concentration of 0.54mmoldm-3. 
Hyoscyamine (50mg, 214meif..Lmol-l ), was isolated with an incorporation of 22%, 
analysed scintillation counting. 
7.2.5 Sodium f2R. 2S)-£2-13C, J-2H, rinr-2HsJ-Phenyllactate 
0 
OH 
Sodium (2R, 2S)-[2-Be, 3-2H, ring-2Hs]-phenyllactate was pulse fed to transformed 
root cultures of D. stramonium (9x50ml) to a final concentration of 0.58mmoldm-3. 
Hyoscyamine (22mg), contaminated with trace amounts of littorine, was isolated with 
an incorporation of 42% (Be only, ~-shifted) as analysed by Be NMR (fig. 72). 
7.2.6 Sodium f2R. 3R)-£2-13.c._ 2H, J-2HJ-Phenyllactate 
D 0 
OH 
Sodium (2R, 3R)-[2-Be, 2H, 3-2H]-phenyllactate was pulse fed to transformed root 
cultures of D. stramonium (5x50ml) to a final concentration of 0.54mmoldm-3. 
Hyoscyamine (18mg) was isolated with incorporations of 14% (Be and 2H, not ~­
shifted) and 6% (Be only, not ~-shifted) as analysed by Be NMR (fig. 74). 
184 
7.2.7 Sodium (RSl-£2-lJC, 3-2H21-Phenyllactate 
OH 
Sodium (RS)-[2-l3C, 3-2H2]-phenyllactate was pulse fed to transformed root cultures of 
D. stramonium (5x50ml) to a final concentration of 0.60mmoldm-3. Hyoscyamine 
( lOmg) was isolated with incorporations of 28% ( 13C only, ~-shifted) and 17% ( 13C 
only, not ~-shifted) as analysed by 13C NMR (fig. 76). 
7.2.8 Sodium (RS)-f2-13CJ-Phenyllactate and Sodium (RS)-(J.2Hzl-Phenyllactate 
0 
OH + OH 
Sodium (RS)-[2-13C]-phenyllactate and sodium (RS)-[3-2H2]-phenyllactate were pulse 
fed to transformed root cultures of D. stramonium (8x50ml) as an admixture, to a final 
concentration of 0.30mmoldm-3 of each phenyllactate. Hyoscyamine (14mg) was 
isolated with incorporations of 26% (13C only) (fig. 78). 
7.3 Methyl Phenylacetate ( 42) 
A solution of phenylacetic acid (2.5g, 18.36mol) in ether (60ml) was quenched with an 
excess of diazomethane (25mmol) generated from Diazald (5.35g, 25mmol) and 
potassium hydroxide (2g, 35.71 mmol) in ether (lOOml). The excess diazomethane was 
quenched by the addition of a few drops of glacial acetic acid such that the yellow 
colour disappeared. The solution was dried (MgS04), filtered and evaporated under 
reduced pressure. The residue was chromatographed over silica gel eluting with 
dichloromethane (100%) to give methyl phenylacetate as a clear colourless oil (2.70g, 
98%). Vmax: 3031, 2952, 1738, 1257, 1160, 704. m/z(EI+) 150 (M+, 21.41 %), 91 (M+-
59, 100%). BH(CDCl3): 3.63 (2H, s, -CH2), 3.69 (3H, s, -OMe), 7.29 (5H, m, -Ar). 
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8c(CDCI3): 41.68 (C-2), 52.56 C-OMe), 127.61 (C-6), 129.08 (C-4), 129.77 (C-5), 
134.45 (C-3), 172.52 (C-1). Found 150.06823, C9H1002 required 150.06807. 
7.4 Methyl fi.13CJ-Phenylacetate (42a) 
[1- 13C]-Phenylacetic acid (2.0g, 14.58mmol) was methylated according to the 
procedure described in section 7.3 to give methyl [1-13C]-phenylacetic acid (2.22g, 
100%). Vmax: 3031,2951, 1696, 1235, 1138,704. m/z(EI+) 151 (M+, 35.75%), 91 (M+-
60, 100%). 8H(CDC3): 3.64, (2H, d, J1H13c 7.9Hz, -CH2), 3.70 (3H, d, J1H13c 3.6Hz 
-OMe), ?.29Hz (5H, m, -Ar). 8c(CDCI3): 41.19 (d J13c13c 28.7Hz C-2), 52.06 (-OMe), 
127.10 (C-6), 138.38 (C-4), 129.25 (C-5), 134.45 (C-3), 172.03 (C-1). 
7.5 Methyl f2.2H,J-Phenylacetate (42c) 
Methyl phenylacetate (l.Og 6.66mmol) was added dropwise over a period of 5min to a 
stirred solution of LDA (16.65mmol), generated from n-butyllithium (10.40ml, 1.6M in 
hexanes, 16.65mmol) and diisopropylamine ( 1.68g, 2.18ml, 16.65mmol), in THF 
(20ml) at -78·c. The temperature of the solution was kept below -6o·c during the 
addition. When all the methyl phenylacetate was added the solution became a deep blue 
colour. The solution was left to stir at this temperature for 30min then MeOD (5ml, 
excess) was added dropwise and the blue colour then disappeared. The solution was left 
to warm to 18·c and was then stirred at this temperature for a further 1h. The reaction 
mixture was poured into a saturated solution of ammonium chloride (30ml) and then 
was extracted into ether (2x30ml). The combined organic extracts were dried (MgS04), 
filtered and evaporated under reduced pressure, and the residue was chromatographed 
over silica gel, eluting with dichloromethane ( 100%) to give methyl [2-2H2]-
phenylacetate as a yellow oil (819mg, 81%). Vmax: 3028,2952, 1740, 1253, 1214,699. 
m/z(EI+) 152 (M+ CD2, 50.68%), 151 (M+ -CHD, 10.30%), 93 (M+ -59 -CD2, 100%), 
92 (M+ -59 CHD, 23.65%). 8H(CDCl3): 3.62 (0.27H, t, -CHD), 3.70 (3H, s, -OMe), 
7.30 (5H, m, -Ar). 8c(CDCl3): 40.82 (m, C-2), 51.92 (-OMe) 1'27.03 (C-6), 128.50 (C-
4), 129.41 (C-5), 133.83, (C-3), 171.93 (C-1). 
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7.6 Methyl f1-13C, 2-2Hzl-Phenylacetate (42b) 
Methyl [ I-l3C]-phenylacetate ( 1.03g, 6.80mmol) was deprotonated using LOA 
( 17mmol) and quenched with MeOD (5ml, excess) according to the procedure 
described in section 7.5 to give methyl [l-l3C, 2-2H2]-phenylacetate (811mg, 78%). 
vmax: 3028, 2952, 1695, 1207, 1151, 701). m/z(EI+) 153 (M+ _l3co2, 25.36%), 152 
(M+ -13CHD, 20.0%), 93 (M+ -59 _l3CD2), 92 (M+ -59, 84%). 0H(CDCl3): 3.62, 
(0.2H, m, -CHD), 3.69 (3H, d, JIHI3c 3.9Hz -OMe), 7.29 (5H, m, -Ar). oc(CDCl3): 
40.89 (m, C-2), 52.04 (-OMe), 127.09 (C-6), 128.56 (C-4), 129.19 (C-5), 133.99 (C-3), 
172.03 (C-1). 
7.7 2-Phenylethanol (43) 
Methyl phenylactetate (1.85g, 12.32mmol) was added, dropwise to a stirred suspension 
of lithium aluminium hydride (1.87g, 49.21mmol) in ether (50ml) and the mixture was 
heated under reflux for 2h. After cooling to 18·c the reaction was quenched by the 
addition of wet ether (30ml) then the reaction mixture was poured into 5% sulphuric 
acid (50ml). The ether layer was retained and the aqueous layer extracted into ether 
(2x50ml). The combined organic extracts were dried (MgS04), filtered and evaporated 
under reduced pressure and the residue was chromatographed over silica gel, eluting 
with dichloromethane (100%) to give 2-phenylethanol (1.32g, 88%). Vmax: 3340br, 
2941, 2375, 1496, 1453, 1045, 696. m/z(EI+) 122 (M+ 18.53%), 91 (M+ -31, 100%). 
OH (CDC13):2.78 (2H, t, lvic 6.8Hz, -CH2), 2.97 (lH, s, -OH), 3.74 (2H, t, lvic 6.8Hz, 
-CH2), 7.20 (5H, m, -Ar). oc (CDC13): 39.7 (C-2), 64.04 (C-1), 126.92 (C-6), 129.06 
(C-4), 129.60 (C-5), 139.23 (C-3). Found: 122.06698, CsHwO required: 122.07316. 
7.8 [1.2Hzl-2-Phenylethanol (43c) 
Methyl phenylacetate(2.20g, 14.68mmol) was reduced using lithium aluminium 
deuteride (1.90g, 45.24 mmol) according to the procedure described in section 7.7 to 
give [1-2H2]-2-phenylethanol (1.56g, 85%). Vmax: 3338br, 3086, 2862, 2208, 1604, 
1496, 1454. mlz (EI+) 124 (M+ 39.05%), 91 (M+ -32, 100%). OH (CDCI3): 1.94 (lH, s, 
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-OH), 2.81 (2H, s, -CH2), 2.71 (5H, m, -Ar). Oc (CDCI3): 38.97 (C-2), 62.85 (p, Jl3c_ 
2H 21.7Hz C-1), 126.40 (C-6), 128.80 (C-4), 129.01 (C-5), 138.54 (C-3). 
7.9 f1.13.c,_ 2H2l-2-Phenylethanol (43a) 
Methyl [1-l3C]-phenylacetate (2.22g, 14.58mmol) was reduced using lithium 
aluminium deuteride (2.45g, 58.32mmol) according to the procedure described in 
section 7.7 to give [1-BC, 2H2]-2-phenylethanol (1.56g, 86%).Vmax: 3346br, 3027, 
2931, 2190, 2090, 1603, 1496, 1453. mlz (EI+) 125 (M+ 38.60%), 91 (M+ -35, 100%). 
8H (CDCI3): 2.15 (lH, s, -OH), 2.81 (2H, d, 11Hl3c 5.3Hz -CH2), 7.25 (5H, m, -Ar). Be 
(CDCI3): 39.49 (d, Jl3cl3c 35.8Hz C-2), 63.37 (p, Jl3c2H 21.9Hz C-1), 126.93 (C-6), 
129.06 (C-4), 129.54 (C-5), 139.10 (C-3). 
7.10 f1.13CJ-2-Phenylethanol (43d) 
Methyl [1-13C]-phenylacetate (998mg 6.60mmol) was reduced using lithium 
aluminium deuteride ( 1.00g, 26.4mmol) according to the procedure described in section 
7.7 to give [1-BC]-2-phenylethanol (832mg 99%). Vmax: 3346br, 2937, 2865, 1496, 
1453, 1027, 698. m/z(EI+) 125 (M+ 38.60%), 91 (M+ -32, 100%). 8H(CDCIJ): 1.37 
(lH, dt, JlHlH 6.2Hz 11Hl3C 2.9Hz, -OH), 2.88 (2H, td, lvic 12.4Hz, -11Hl3C 6.1Hz, 
-CH2), 3.87 (2H, dtd 11Hl3c 143.3Hz, lvic 12.4Hz, 11HlH 6.2Hz, -CH2), 7.29 (5H, m, 
-Ar). 8c(CDC}J): 39.19 (d, Jl3cl3c 17.85Hz, C-2), 63.79 (C-1), 126.50 (C-6). 128.59 
(C-4), 129.03 (C-5), 139.20 (C-3). 
7.11 [2.2H2l-2-Phenylethanol (43e) 
Methyl [2-2H2]-phenylacetate (819mg, 5.39mmol) was reduced using lithium 
aluminium hydride (818mg, 21.56mmol) according to the procedure described in 
section 7.7 to give [2-2H2]-2-phenylethanol (612mg 93%). Vmax: 3345br, 2925, 2877, 
1496, 1448, 1059, 698. m/z(EI+) 124 (M+ -CD2, 27.94%), 123 (M+ -CHD, 7.26%), 93 
(M+ -31 -CD2. 100%) 92 (M+ -31 -CHD 29.78%). 8H(CDC13): 1.17 (lH, S, -OH), 
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2.84 (0.2H, dt, -CHD), 3.83 (2H, S, -CH2). 7.26, (5H,m,-Ar). oc(CDC13): 38.82 (m, C-
2), 63.56 (C-1), 126.45 (C-6), 128.56 (C-4), 129.01 (C-5), 138.40 (C-3). 
Methyl [ 1-l3C, 2-2H2]-phenylacetate (745mg, 4.87mmol) was reduced using lithium 
aluminium hydride (740mg, 19.48mmol) according to the procedure described in 
section 7.7 to give [1-l3C, 2-2H2]-2-phenylethanol (459mg, 75%). Vmax: 3346br, 2917, 
2860, 1495, 1448, 1028, 699. m/z(EI+) 125 (M+ _13CD2, 13.61 %), 124 (M+ _13CHD, 
6.78%), 93 (M+ -32 _13CD2, 100%), 92 (M+ -32 _l3CHD, 52.92%). OH(CDCI)): 1.40 
(lH, td 11HlH 5.93Hz, 11Hl3c 2.84Hz, -OH), 2.85 (0.3H, m, -CHD), 3.86 (2H, dd 
11Hl3c 143.7Hz, 11HlH 5.93Hz, -CH2) 7.29 (5H, m, -Ar). 0c(CDCl3): 38.79 (m, C-2), 
63.63 (C-1), 126.46 (C-6), 128.57 (C-4), 129.00 (C-5), 138.34 (C-3). 
7.13 Phenylacetaldehyde (44)4 
2-Phenylethanol was added dropwise to a stirred suspension of pyridinium 
chlorochromate (PCC) (5.29g, 24.56mmol) and molecular sieves (150g, 3A Sigma, 
1116" pellets, dried and ground) in dichloromethane (200ml) at 18oC and the reaction 
mixture was left to stir at this temperature for 2h. The molecular sieves were then 
removed by filtration and the filtrate was washed through a thick silica pad, washing 
liberally with dichloromethane ( =500ml). The solvent was evaporated under reduced 
pressure and the residue was purified by bulb to bulb distillation (0.2mmHg, furnace 
temperature 40°C) to give phenylacetaldehyde (859mg, 69%).Vmax: 3020, 1725, 1500, 
1455, 750, 700. m/z(EI+) 120 (M+ 20.78%), 19 (M+-29 100%) OH (CDCI3): 3.66 (2H, 
d, 1vic 2.3Hz -CH2), 7.30 (5H, m, -Ar), 9.72 (1H, t, 2.3Hz -CHO). Oc (CDC13): 50 54 
(C-2), 127.38 (C-6), 129.98 (C-4), 129.62 (C-5), 131.88 (C-3), 199.38 (C-1). 
As this product is susceptible to polymerisation to give polymeric material the products 
from labelled reactions was used directly after distillation without full characterisation. 
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7.14 Preparation ofPhenylacetaldehyde usin& Ru04 (44)5 
2-Phenylethanol (2.05g, 16.38mmol) was added to a vigorously stirred biphasic 
solution of potassium periodate (14g, 61mmol) and ruthenium trichloride (34mg) in 
H20 : CH3CN : CCl4 (3: 1:1) and the reaction was left to stir for 24h. The reaction 
mixture was then transferred to a separatory funnel where ether (60ml) and water 
(60ml) were added. The organic layer was separated and the aqueous layer washed with 
two further portions of ether (2x60ml). The organic extracts were combined, dried 
(MgS04), filtered and evaporated under reduced pressure. The crude product was 
chromatographed over silica gel eluting with dichloromethane : hexane (2: 1) to give 
phenylacetaldehyde as a clear oil, (590mg, 33% ). This material had identical 
spectroscopic data to that described above. 
7.15 rt-2HJ-Phenylacetaldehyde ( 44c) 
[1-2H2]-2-Phenylethanol (763mg, 6.25mmol) was oxidised using PCC (2.69g 
12.48mmol) and 3A molecular sieves (35g) according to the procedure described in 
section 7.13 to give [1-2H]-phenylacetaldehyde (578mg, 76%). BH(CDC13): 3.71 (2H, s, 
-CH2), 7.30 (5H, m, -Ar). 
7.16 [1.13k 2HJ-Phenylacetaldehyde <44al 
[l-13C, 2H2]-2-Phenylethanol (1.56g, 12.47mmol) was oxidised using PCC (5.38g 
24.94mmol) and 3A molecular sieves (150g) according to the procedure described in 
section 7.13 to give [I-2H]-phenylacetaldehyde (578mg, 76%). BH(CDCI)): 3.60 (2H, 
d, JIH13c 7.2Hz, -CH2), 7.30 (5H, m-Ar). 
7.17 rt-13CJ-Phenylacetaldehyde (44d) 
[t-l3C]-2-Phenylethanol (812mg, 6.60mmol) was oxidised using PCC (2.85g, 
2.85mmol) and 3A molecular sieves (80g) according to the procedure described in 
section 7.13 to give [J-13C]-phenylacetaldehyde (720mg, 90%). BH(CDCI3): 3.69 (2H, 
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dd, JlH13c 7.16Hz, Jvic 2.38Hz, -CH2), 7.30 (SH, m, -Ar), 9.75 (lH, dt, J1H13c 
175.5Hz, Jvic 2.38Hz, -CHO). 
[2-2H2]-2-Phenylethanol (545mg, 4.39mmol) was oxidised using PCC (1.89g, 
8.78mmol) and 3A molecular sieves (50g) according to the procedure described in 
section 7.13 to give [2-2H2]-phenylacetaldehyde (499mg, 91%). aH(CDCI)): 3.67 
(0.3H, m, -CHD), 7.30 (5H, m, -Ar), 9.80 (lH, s, -CHO). 
[1-13C, 2-2H2]-2-Phenylethanol (447mg, 3.57mmol) was oxidised using PCC (1.54g, 
7 .14mmol) and 3A molecular sieves ( 43g) according to the procedure described in 
section 7.13 to give [1-13C, 2-2H2]-phenylacetaldehyde (385mg, 88%). aH(CDCI)): 
3.67 (0.35H, m, CHD), 7.30 (5H, m, -Ar), 9.75 (lH, d, JtH13c 175.3Hz, -CHO). 
7.20 Phenyllactic Acid (32) 
A solution of sodium metabisulfite (3.26g, 17.16mmol) in water (lOml) was added to 
phenylacetaldehyde (2.05g, 2.0ml, 17.16mmol) and the mixture shaken vigorously for 
lOmin at t8•c, after which time the bisulfite adduct formed as a white precipitate. 
Sodium cyanide (2.l0g, 42.9mmol) was added to the mixture in several portions while 
swirling the flask gently. The white precipitate dissolved and the cyanohydrin was seen 
forming as clear, oily droplets.6 The solution was extracted into benzene (3x30ml) and 
the combined organic extracts were dried (MgS04), filtered, and evaporated under 
reduced pressure to give the cyanohydrin as a clear oil, which was immediately covered 
with 50% HCl (30ml) and the stirred solution heated under reflux for 2.5h. After 
cooling, the solution was extracted into ether (3x30ml) and the combined organic 
extracts were dried (MgS04), fil~ered, and evaporated under. reduced pressure. The 
residue was recrystallised form chloroform to give phenyllactic acid as a white solid 
(1.14g, 43%). m.p. 96-98•C lit. 97-98•C,7 Vmax: 3348, 2956, 1732, 1240, 1191, 1091, 
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1062. mlz(CI+) 184 (M++18, 8.92%). OH(CDCI3): 2.98 (lH, dd, lgem 14.0Hz, lvic. 
6.9Hz, -CH2), 3.19 (lH, dd, lgem 14.0Hz, lvic 4.2Hz, -CH2), 4.50, (lH, dd, lvic 6.9Hz, 
lvic 4.2Hz, -CH), 7.30 (5H, m, -Ar). oc(CDCI3): 40.1 (C-3), 71.0 (C-2), 127.1 (C-7), 
129.6 (C-5), 129.5 (C-6), 135.8 (C-4), 178.6 (C-1). Found: C 64.7%, H 5.9% CgHw03 
requires: C 65.0%, H 6.02%. 
7.21 [2.2HJ-Phenyllactic Acid (321) 
[1-2H]-Phenylacetaldehyde (578mg, 4.77mmol) was reacted with sodium metabisulfite 
(906mg, 4.77mmol) and sodium cyanide (584mg, 11.93mmol) according to the 
procedure described in section 7.20 to give [2-2H]-phenyllactic acid (198mg, 25% ). 
m.p. 97.5-98.5°C,Vmax: 3350, 2966, 1731, 1287, 1190, 1109, 1059. mlz(CI+) 185 
(M++NH3, 1.15%), 167 (M+, 0.9%), OH(CDCIJ): 2.99 (lH, d, lgem 14.0Hz, -CH2). 3.21 
(lH, d, lgem 14.0Hz, -CH2), 7.30 (5H, M, -Ar). oc(CDCl3): 40.07 (C-3), 70.61 (t, 
Jl3c2H 22.6Hz, C-2), 127.14 (C-7), 128.58 (C-5), 129 50 (C-6), 135.77 (C-4), 178.17 
(C-1). 
7.22 [2.13C, 2-2HJ.Phenyllactic Acid (32a) 
[1-13C, 2H]-Phenylacetaldehyde (1.29g, 10.40mmol) was reacted with sodium 
metabisulfite (1.98g, 10.40tnmol) and sodium cyanide (1.27g, 26.0mmol) according to 
the procedure described in section 7.20 to give [2-13C, 2H]-phenyllactic acid (319mg, 
18%). m.p. 97-99oC, Vmax: 3346, 2962, 1740, 1262, 1190, 1098, 1024. m/z(CI+) 186 
(M++NH3, 2.68%), 168 (M+ 0.31%), OH(CDCl3): 2.99 (lH, dd lgem 14.0Hz, J1H13C 
4.8Hz, -CH2), 3.20 (lH, d, lgem. 14.0Hz, J1H13c 4.4Hz, -CH2), 7.30 (5H, m, -Ar). 
oc(CDCI3): 40.03 (d, Jncnc 34.6Hz, C-3), 70.62 (t, J13c2H 22.7Hz, C-2), 127.11 (C-
7), 128.56 (C-5), 129.47 (C-6), 135.47 (d Jncnc 2.6Hz, C-4), 178.34 (d, Jl3c13c 
57.5Hz, C-1). 
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7.23 [2a13CJaPhenyllactic Acid (32j) 
[t-13C]-Phenylacetaldehyde (720mg, 5.95mmol) was reacted with sodium metabisulfite 
(1.13mg, 5.95mmol) and sodium cyanide (729mg, 14.88mmol) according to the 
procedure described in section 7.20 to give [2-13C]-phenyllactic acid (512mg, 
3.06mmol) 51%. m.p. 95-9TC, Vmax; 3349, 2956, 1728, 1240, 1188, 1084, 1057. 
m/z(CI+) 185 (M++18, 10.37%). OH(CDCI)): 2.99 (lH, ddd, 1gem 14.0Hz, 1vic 7.0Hz, 
J1H13C 4.8Hz, -CH2), 3.20 (lH, ddd 1gem 14.0Hz, 1vic 4.4Hz, 11H13c 4.4Hz, -CH2), 
4.51 (lH ddd, 11H13c 148.6Hz, Jvic 7.0Hz, 1vic 4.4Hz, -CH), 7.30 (5H, m -Ar). 
oc(D20): 40.04 (d J13c13c 35.5Hz, C-3), 71.16 (C-2), 126.36 (C-7), 128 28 (C-5), 
129.21 (C-6), 137.91 (C-7), 180.44 (d, J13c13c 54.5Hz, C-1). 
7.24 [J.2H21-Phenyllactic Acid (32kl (preparation 1l 
[2-2H2]-Phenylacetaldehyde (446mg, 3.65mmol) was reacted with sodium 
metabisulfite (694mg, 3.65mmol) and sodium cyanide (447mg, 9.13mmol) according to 
the procedure described in section 7.20 to give [2-2H2]-phenyllactic acid (323mg, 
53%). m.p. 95-9TC, Vmax: 3447, 2962, 1733, 1262, 1231, 1054, 1028. m/z(CI+) 186 
(M++18 -CD2, 100%), 185 (M++18 -CHD, 33.2%). OH(CDCl3) 2.99 (0.2H, m, -CHD), 
3.20 (0.2H, m, -CHD), 4.50 (lH, s, -CH), 7.30 (5H, m, -Ar). oc(D20): 39.38 (m, C-3), 
73.07 (C-2), 126.38 (C-7), 128.29 (C-5), 129.21 (C-6), 137.85 (C-3), 180 47 (C-7). 
[1-13C, 2-2H2]-Phenylacetaldehyde (385mg, 3.13mmol) was reacted with sodium 
metabisulfite (595mg, 3.13mmol) and sodium cyanide (383mg, 7.83mmol) according to 
the procedure described in section 7.20 to give [2-13C, 3-2H2]-phenyllactic acid 
(298mg, 1.76 mmol) 36%. m.p. 95-96·c, Vmax: 3347, 2950, 1733, 1776, 1231, 1091, 
1058. rnlz(CI+) 187 (M++NH3, 3.13%) 169 (M+ 0.76%), OH(CDCl3): 2.99 (0.2H, m, 
-CHD), 3.20 (0.2H, m, -CHD), 4.41 (lH, d, 11H13c 148.6Hz, -CH), 7.30 (5H, m, -Ar). 
oc(CDCl3): 40.25 (m, C-3), 71.43 (C-2). 127.63 (C-7), 129.07 (C-5), 130.02 (C-6), 
136.29 (C-4), 179.07 (d, J13c13c 57.7Hz, C-1). 
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7.26 Methyl [J.2H21-Phenyllactate (52a) 
A solution of phenylpyruvic acid (300mg, 1.83mml) in DzO (30ml) was adjusted to 
pHil with KzC03 and left at 4 ·c for 48h. The solution was then acidified by the 
careful addition of DzS04 (cone) and extracted into ether (3x30ml). The combined 
organic extracts were dried (MgS04), filtered and evaporated under reduced pressure. 
The residue was dissolved in MeOD (30ml) at o·c and a solution of sodium 
borohydride (600mg 12.12mmol) in DzO (12ml) and 1M KOD (3ml) was added 
dropwise, maintaining the temperature below 5·c during the addition. The reaction 
mixture was allowed to warm to 18·c and was then left to stir for 12h. The methanol 
was evaporated, the residue dissolved in 10% hydrochloric acid (30ml) and the solution 
extracted into ether (3x30ml). The combined organic extracts were dried (MgS04), 
filtered and evaporated under reduced pressure and the residue was re-dissolved in ether 
(20ml) and quenched with an excess of an ethereal solution of diazomethane ( 10mmol). 
The excess diazomethane was removed by the addition of a few drops of glacial acetic 
acid, so that the yellow colour disappeared and the solution was dried (MgS04), filtered 
and evaporated under reduced pressure. The residue was chromatographed over silica 
gel, eluting with dichloromethane (100%) to give methyl [3-2Hz] phenyllactate (104mg, 
31% ). Vma.x: 3455br, 3038, 2954, 2630, 1740, 1236, 1112. m/z(EI+) 182 (M+ 1.85% ), 
93 (M+-89, 100%). BH(CDCI]): 2.70 (IH, s, -OH), 3.69 (lH, s, -OMe), 4.37 (lH, s, 
-CH), 7.19 (5H, m, -Ar). Bc(CDCl3): 40.38 (p Jt3c2H 19.1Hz, C-3), 52.96 (-
OMe), 71.69 (C-2), 127.41 (C-7), 128.92 (C-5), 129.95 (C-6), 136.76 (C-4), 175.08 (C-
1 ). 
7.27 [J.2H,J-Phenyllactic Acid (32k) (preparation 2> 
Methyl [3-2Hz]-phenyllactate (84.7mg, 0.465mmol) was covered with 1M KOH (6ml) 
and heated under reflux for 12h. The solution was then acidified with 10% HCl and 
extracted into ether (3x15ml). The combined organic extracts were dried (MgS04), 
filtered and evaporated under reduced pressure to give [3-2Hz]-phenyllactic acid 
(77.3mg, 0.465mmol) 100%. m.p. 96-98·c. Vma.x: 3343, 2348, 1729, 1261, 1232, 1108. 
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m/z(CI+) 186 (M++18, 100%). 0H(D20): 4.19 (lH, s, -CH), 7.30 (5H, m, -Ar). 
oc(D20): 39.38 (m, C-3), 73.07 (C-2), 126.38 (C-7), 128.29 (C-5), 129.21 (C-6), 
137.85 (C-3), 180 47 (C-7). 
7.28 Resolution of CRSl-Phenyllactic Acid to Obtain (Rl-Phenyllactic Acid (32b)8 
(RS)-Phenyllactic acid (200mg, 1.2mmol) and (S)-2-phenylglycinol ( 165mg 1.2mmol) 
(99%ee, Aldrich Chemical Co.) were dissolved in refluxing ethyl acetate : isopropanol 
(7:2) (10.8ml) and the solution cooled to OOC for 4h. The white precipitate was 
collected and recrystallised to constant optical rotation from ethyl acetate : isopropanol 
(2: 1). The salt was then decomposed by stirring with 10% HCl (5ml) for 5min at 18°C 
and then the aqueous solution was extracted into ether (3 x 1 Oml). The combined 
organic extracts were dried (MgS04), filtered and evaporated under reduced pressure to 
generate (R)-phenylactic acid as a white solid. This material was recrystallised from 
chloroform (22.2mg, 22%). m.p. 121-122°C lit. 124-125°C,9 Vmax: 3348, 2956, 1734, 
1243, 1192, 1092, 795, 701, m/z(CI+): 184 (M++NH3, 100%), BH(CDCl3): 2.92 (lH, 
dd, Jgem• 14.0Hz, Jvic 7.0Hz, -CH2), 3.13 (lH, dd, Jgem 14.0Hz, Jvic. 4.2Hz, -CH2), 
4.44 (lH, dd, Jvic 7.0Hz, Jvic 4.2Hz, -CH), 7.22 (5H, m, -Ar), Oc(CDCl3): 40.65 (C-3), 
71.49 (C-2), 127.66 (C-7), 129.09 (C-5), 130.03 (C-6), 136.32 (C-4), 178.69 (C-1), 
[a]0 2l"C +21.81° (c=0.055, EtOH), lit. [a]0 25"C +19° (c = 3.1 EtOH)9 Found C 
65.12%, H 6.42%, CgHw03 requires C 65.05%, H 6.07%. 
7.29 Resolution of (RSl-Phenyllactic Acid to Obtain (Sl-Phenyllactic Acid (32c) 
(RS)-Phenyllactic acid (150mg, 0.90mmol), was resolved using (R)-2-phenylglycinol 
(125mg, 0.90mmol) (Aldrich Chemical Co. 99%ee) according to the procedure 
described in section 7.28 to generate (S)-phenyllactic acid as a white crystalline solid 
(14.8mg, 20%). m.p. 122-124°C lit 123-124°C,8 BH(CDC13):2.93 (IH, dd, Jgem 13.8hz, 
Jvic 6.9Hz, -CH2,), 3.15 (IH, dd, Jgem 13.8Hz, Jvic. 4.2Hz, -CH2), 4.45 (lH, dd, Jvic 
6.9Hz, Jvic. 4.2Hz, -CH), 7.19 (5H, m-Ar), odCDCl3): 40.65 (C-3), 71.49 (C-2), 
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127.66 (C-7), 129.09 (C-5), 130.03 (C-6), 136.32 (C-4), 178.69 (C-1), [a.]0 2t"C -21.28 
(c=0.024, EtOH) lit. [a.]o12"C -18.7" (c = 2.9, EtOH).7 
7.30 Resolution of £RS)a[2a13~2HJaPhenyllactate to Obtain (R)a£2a13~2HJa 
lPhenyllactic Acid (32d) 
(RS)-[2-13C,2H]-Phenyllactic acid (200mg, 1.19mmol) was resolved, using (S)-2-
phenylglycinol (163mg, 1.19mmol) according to the procedure described in section 
7.28, to generate (R)-[2-13C,2H]-phenyllactic acid (16.2mg, 16%). This material was 
converted to its sodium salt with 0.1M sodium hydroxide, prior to feeding. m.p. 119-
121 ·c, (5H(D20) 2.74 (IH, dd, 1gem 14.1Hz J13c1H 5.0Hz, -CH2), 2.97 (IH, dd, 1gem 
14.1Hz, Jl3clH 3.5Hz, -CH2), 7.20 (5H, m, -Ar), (5c(D20): 42.55 (d, Jt3cl3c 35Hz C-
3), 75.88 (t, J13c2H 22,45Hz, C-2), 129.46 (C-7), 131.38 (C-5), 132.29 (C-6), 141.00 
(D, Jl3cl3c 2.5Hz, C-4), 183.56 (d J13cl3c 55Hz, C-1) [a.]0 2t"C +19.78. (c=0.015, 
EtOH) 
7.31 Resolytion of £RS)-[2-13~2HJ-Phenyllactic Acid to Obtain (S)-[2al3,C,.2HJ-
Phenyllactic Acid (32e) 
(RS)-[2-13C,2H]-Phenyllactic acid (199mg, 1.185mmol) was resolved using (R)-2-
phenylglycinol (163mg 1.185mmol), according to the procedure described in section 
7.28, to generate (S)-[2-13C,2H]-phenyllactic acid (50mg, 50%). This material was 
converted to its sodium salt with 0.1M sodium hydroxide prior to feeding. m.p. 120-
121 ·c, (5H(D20): 2.73 (lH, dd, 1gem l4.0Hz, J13c1H 5.07 -CH2), 2.97 (IH, dd, Jgem 
14.0Hz Jt3c1H 3.7Hz -CH2), 7.19 (5H, m, -Ar), (5c(D20) 43.06 (d, Jt3c13c 35Hz, C-
3), 75.89 (t, J13c2H, 22.7Hz, C-2), 129.47 (C-7), 131.39(C-5), 132.30 (C-6), 140.99 (d, 
Jt3c13c 2.5Hz, C-4), 183 57 (d, J13ct3c 54.4Hz), [a.]o21"C -16.00" (c=O.IO EtOH). 
7.32 (RS>-Methyl 0-Acetylphenyllactate (50) 
A stirred solution of phenyllactic acid (185mg, 1.11mmol) in ether was quenched with 
an ethereal solution of diazomethane (excess) at 18"C, so that the bright yellow colour 
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remained. The excess diazomethane was removed by the addition of a few drops of 
glacial acetic acid and then the solution was dried (MgS04), filtered and evaporated 
under reduced pressure. The residue was chromatographed over silica gel eluting with 
dichloromethane (1 00%) to give (RS)-methyl phenyllactate as a white solid. (RS)-
Methyl phenyllactate (200mg, l.llmmol) and dicyclohexylcarbodiimide (229mg, 
1.11 mmol) were added to a stirred solution of acetic acid (67mg, 1.11 mmol) and 4-
dimethylaminopyridine (4mg, 0.033mmol) in dichloromethane (6ml), at -10"C, and the 
reaction mixture was left to stir at this temperature for 3h. The resultant precipitate was 
removed by filtration and the filtrate concentrated under reduced pressure. The residue 
was then redissolved in dichloromethane (3ml), filtered again and the filtrate 
concentrated under reduced pressure The residue was chromatographed over silica gel 
eluting with dichloromethane (100%) to give (RS)-methyl 0-acetylphenyllactate as a 
colourless oil (209mg, 84%). Vmax: 3030, 2954, 1746, 1374, 1218, 1082, m/z(EI+) 223 
(M++I, 0.46%) 0H(CDC13): 2.10 (3H, s, -Me), 3.10 (lH, dd, Jgem. 14.4Hz, Jvic 8.4Hz, 
-CH2), 3.21 (lH, dd, Jgem 14.4Hz, Jvic 4.8Hz, -CH2), 3.75 (3H, s, -OMe), 5.24 (lH, dd, 
Ivic 8.4Hz, Jvic, 4.8Hz, -CH), 7.30 (5H, m, -Ar), with (+)-Eu(hfch -Me: (R)- to lower 
frequency, -OMe (S)- to higher frequency, Oc(CDCl3): 21.09 (C-9), 37.86 (C-3), 52.81 
(-OMe), 73.46 (C-2), 127.54 (C-7), 128.97 (C-5), 129.76 (C-6), 136.40 (C-4), 170.65 
(C-1). Found 223.09761, C12Hts04 (M++1) requires 223.09703. 
7.33 (Rl-Methyl O•Acetylphenyllactate- (50a) 
(R)-Phenyllactic acid (24mg 0.145mmol) was methylated and acetylated according to 
the procedure described in section 7.32 to generate (R)-methyl 0-acetylphenyllactate 
(14mg, 44%). Selected spectroscopic data: OH(CDCh): 2.01 (3H, s, -Me), 3.01 (lH, dd, 
Igem 14.4Hz Ivic 8.4 Hz, -CH2), 3.12 (1H, dd, Jgem 14.54Hz, Ivic 4.8Hz, -CH2), 3.67 
(3H, s, -OMe), 5.15 (lH, dd, Ivic 8.4Hz, Jvic 4.8Hz, -CH), 7.20 (5H, m, -Ar). Using 
Eu(hfc3), no splitting was visible until 10% racemate (5% other enantiomer) had been 
added. This was obvious as an additional set of singlet resonances to lower frequency 
of the methyl ester and to higher frequency of the acetyl methyl peaks. 
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7.34 <S>-Methyl 0-Acetylphenyllactate (50b) 
(S)-Phenyllactate (14.8mg, 0.086mmol) was methylated and acetylated according to the 
procedure described in section 7.33 to give (S)-methyl 0-acetylphenyllactate ( 10.4mg, 
54%). Selected spectroscopic data: OH(CDC}J): 2.10 (3H, s, -Me), 3.01 (lH, dd, lgem 
l4.5Hz, lvic 9.0Hz, -CH2), 3.20 (lH, dd, lgem l4.5Hz, lvic 4.1Hz, -CH2), 3.74 (3H, s, 
-OMe), 5.22 (lH, dd, Jvic 9.0Hz, lvic. 4.1Hz, -CH), 7.28 (5H, m, -Ar). Using Eu(hfq), 
no splitting was visible until 10% racemate (5% other enantiomer) had been added this 
was obvious as an additional set of singlet resonances to higher frequency of the 
methyl ester and to lower frequency of the acetyl methyl peaks. 
7.35 Methyl Phenyllactate (52) 
A solution of sodium borohydride (600mg, excess) in water (lOml) and sodium 
hydroxide (2ml, 1M aqueous solution) was added dropwise, to a stirred solution of 
phenylpyruvic acid (300mg, 1.82mmol) in methanol (50rnl) at O-s·c over a period of 
30 min. The reaction mixture was allowed to warm to 18·c and was left to stir 
overnight. The reaction was then quenched by addition of 10% hydrochloric acid 
(20ml) at 0°C and the methanol was evaporated under reduced pressure. Water (50rnl) 
was added and the phenyllactic acid extracted into ether (3 x 50ml). The combined 
organic extracts were dried (MgS04), filtered and evaporated under reduced pressure. 
The residue was dissolved in ether (60rnl) then methylated directly by quenching with 
an excess of ethereal diazomethane (9.35mmol), generated from Diazald (2g) and 
potassium hydroxide (0.8g), in ether (60rnl). The excess diazomethane was removed by 
bubbling a stream of dry N2 through the solution until the yellow colour had completely 
disappeared. The solution was then dried (MgS04), filtered and the solvent evaporated 
under reduced pressure. The residue was chromatographed over silica gel, eluting with 
dichloromethane ( 100%) to give methyl phenyllactate, (264mg, 80%) as a waxy solid. 
Vmax: 3470br 3030, 2953 1740, 1497, 1455, 1275, 1097, 817, 748. m/z(CI+) 198 (M+ 
+ NH4, 14.0%) BH(CDC}J): 2.96 (lH, dd, 1gem 13.8Hz, lvic 6.9Hz -CH2), 3.13 (lH, dd, 
lgem 13.8Hz, lvic 4.6 -CH2), 3.24 (lH, s, -OH), 3.73 (3H, s, -Me), 4.44 (lH, dd, lvic 
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6.9Hz, Jvic 4.6Hz, -CH), 7.27 (5H,m -Ar). Be (CDCl3): 40.05 (C-3), 52.88 (-Me), 71.85 
(C-2), 127.37 (C-7), 128.92 (C-7),129.80 (C-5), 136.93 (C-4), 175.10 (C-1). Found 
180.07626, CwH1203 requires 180.07864. 
7.36 Methyl f2a2 Hla Phenyllactate (52b) 
Phenylpyruvic acid (300mg, 1.82mmol) was reduced using sodium boro-[2H4]-hydride 
(500mg, excess) according to the procedure described in section 7.35, to generate 
methyl [2-2H]-phenyllactate (252mg, 76%). Vmax: 3469br, 3030, 2954, 1741, 1605, 
746, 701 m/z(CI+) 199 (M+1+NH3, 100%) 0H(CDCl3): 2.81 (1H, s, -OH), 2.84 (lH,d, 
1gem 1l.6Hz, -CH2), 3.00 (lH,d, Jgem 11.6Hz, -CH2) 3.63 (3H, S, Me), 7.14 (5H, m, 
-Ar). oc(CDCl3): 40.98 (C-3), 52.86 (C-2), 71.5 (t, J13c-2H 23Hz), 27.37 (C-7), 128.91 
(C-5), 129.98 (C-6), 136.93 (C-4), 175.09 (C-1). 
7.37 Methyl f2-3HJ- Phenyllactate (52c) 
Phenylpyruvic acid (300mg, 1.82mmol), was reduced using sodium boro-[3H4]-hydride 
( 100mCi) with cold carrier sodium borohydride (600mg, excess) according to the 
procedure described in section 7.35, to generate methyl [2-3H]-phenyllactate (252mg, 
77%), with a specific activity of 9l8J.1.Cimmol-l (radiochemical yield, 0.9%). 
OH(CDCl3): 2.94 (lH, dd, 1gem 13.9 Hz, Jvic 6.9Hz -CH2), 2.79 (lH, s, -OH), 3.12 (lH, 
dd, Jgem 13.9Hz, Jvic 4.5Hz-CH2) 3.73 (3H, s, -Me), 4.42 (lH, dd, Jvic 6.9Hz, Jvic 
4.5Hz-CH2), 7.21 (5H, m, -Ar), oc(CDC13):41.05 (C-3), 52.89 (-Me), 71.86 (C-2), 
127.37 (C-7), 128.91(C-5), 129.99 (C-6), 136.97 (C-4), 175.10 (C-1). 
7.38 Sodium Phenyllactate (32) 
Bromotrimethylsilane (2.77mmol, 425mg), was added to a stirred solution of methyl 
phenyllactate (200mg, 1.11mmol) in dry dichloromethane at o·c and the mixture was 
left to stir for 2h at 18°C. The volatiles were removed under reduced pressure and then 
the residue was dissolved in chloroform (20rnl), washed with 10% hydrochloric acid 
(20ml) and the solvents removed again under reduced pressure. The residue was 
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resuspended in choroform (4ml), distilled water (lOml) was added and the aqueous 
layer was adjusted to pH7 by the addition of dilute sodium hydroxide solution. The 
aqueous layer was then separated and evaporated under reduced pressure to give 
sodium phenyllactate, (174mg 83%) as an amorphous white solid. Vmax 3395br, 3032, 
2959, 2908, 1156, 1417, 1311, 1090, 699. mlz(FAB) 165 (M+-23, 100%), 0H(D20): 
2.75 (lH, dd, lgem l3.8Hz lvic 7.9Hz -CH2), 2.98 (lH, dd, lgem 13.8Hz, Jvic 4.2Hz, 
-CH2), 4.13 (lH, dd, lvic 7.9Hz, lvic 4.2Hz, -CH), 7.21 (5H, m, -Ar). oc(D20): 43.20 
(C-3), 76.28 (C-2), 129.48 (C-7), 131.40 (C-5), 132.26 (C-6), 141.02 (C-4), 183.55 
(C-5). 
7.39 Sodium £2-2HJ-Phenyllactate (321) 
Methyl [2-2H]-phenyllactate (0.227g 1.25mmol) was hydrolysed according to the 
procedure described in section 7.38 to give sodium [2-2H]-phenyllactate, (82mg, 
0.438mmol 35%). Vmax: 3395br, 3253br, 3034, 2859, 2918, 1563, 1407, 1219, 1113, 
698. m/z (EI+) 149 (M-39, 48.47%) 0H(D20): 2.74 (lH, d, lgem 13.9Hz, -CH2), 2.97 
(1H, d lgem 13.9Hz, -CH2), 7.21 (5H, m, -Ar). oc(D20): 43.04 (C-3), 75.87 (t, Jl3c2H 
22.3, C-2), 129.45 (C-7), 131.37 (C-6), 140.98 (C-4), 183.54 (C-1). 
7.40 Sodium £2-3HJ-Phenyllactate (320 
Methyl [2-3H]-phenyllactate (0.252g, 1.40mfiiol) was hydrolysed according to the 
procedure described in section 7.37 to give [2-3H]-phenyllactic acid, (251mg, 95%) as 
an amorphous white solid. 0H(D20): 2.77(1H, dd lgem 13.9Hz, lvic 7.5Hz, -CH2), 2.99 
(lH, dd, lgem 13.9Hz, lvic 3.9Hz, -CH2), 4.18 (lH, dd, lvic 7.5Hz, lvic 3.9Hz, -CH), 
7.22 (5H, m, -Ar), oc(D20): 43.09 (C-3), 75.95 (C-2), 129.56 (C-7), 131.44 (C-5), 
132.23 (C-6), 140.85 (C-4), 183.58 (C-1). 
7.41 Hydrolysis of Hyoscyamine 
Commercial hyoscyamine (500mg, 1, 13mmol), was dissolved in saturated barium 
hydroxide solution (25ml) and heated under reflux for 30min. The solution was allowed 
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to cool and was then extracted into ether (3x30ml). The aqueous extract was acidified 
with cone. HCl and was also extracted into ether (3x30ml). The combined organic 
extracts from the second extraction were dried (MgS04), filtered and evaporated under 
reduced pressure to give tropic acid, which was recrystallised from chloroform, 
(221mg, 77%). m.p. 117-118°C, lit: 118°C,l0 Vmax: 3404, 2899, 1707, 1261, 1274, 
1019. m/z(CI+) 184 (M++NH3, 47.32%), 8H(DMSO): 3.4 (lH, s, br, -OH), 3.60 (2H, 
m, -CH2), 3.93 (1H, dd, 1vic 8.4 Hz, -CH), 7.30 (5H, m, Ar). 8{:(DMSO): 54.60 (C-3), 
63.70 (C-2), 127.34 (C-7), 128.33 (C-5), 128.70 (C-6), 137.34 (C-4), 174.03 (C-1). 
Found 166.06285, C9H1003 requires 166.06299. 
7.42 Methyl Tropate (60) 
An ethereal solution of diazomethane (9.35mmol), generated from Diazald (2.0g, 
9.35mmol) and potassium hydroxide (0.8g) in ether (60rnl), was added to a solution of 
tropic acid, (500mg, 3.00mmol) in ether (60ml). The excess diazomethane was 
removed by the addition of a few drops of glacial acetic acid until the yellow colour 
completely disappeared. The solution was dried (MgS04), filtered and evaporated 
under reduced pressure and the residue was chromatographed over silica gel, eluting 
with dichloromethane :ether (5%) to yield methyl tropate as a colourless oil, (539mg, 
100%). Vmax: 3441br, 3031, 2953, 1736, 1168, 1045, 737, 701. m/z (EI+) 181 (M+1, 
96.5%), 150 (M-30, 100%), 118 (M-62, 81 %). SH (CDCl3): 3.59 (lH, dd, Jgem lO.OHz, 
1vic 5.2Hz, -CH2), 3.86 (1H, dd, 1vic 8.3Hz, 1vic 5.2 Hz, -CH), 4.14 (lH, dd, Jgem 
lO.OHz, 1vic 8.3Hz, -CH2), 7.27 (5H, M, -Ar). Sc (CDC}J): 52.73 (-Me), 54.43 (C-2), 
65.08 (C-3), 128.28 (C-7), 128.66 (C-5), 129.38 (C-6), 136.07 (C-4), 174.15 (C-1). 
7.43 Hydrolysis of [J.3HJ-Hyoscyamine: Methyl [J.3HJ-Trqpate (60al 
Cold carrier hyoscyamine (500mg, 1,73mmol) was added to the [3-3H]-hyoscyamine 
(47mg, 0.162mmol, 204J.LCimmol-1) isolated from the root cultures. The mixture was 
then stirred in saturated barium hydroxide solution (25ml) until dissolved and heated 
under reflux for 1h. The solution was cooled and then extracted into ether (3x30ml). 
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The aqueous extract was acidified with 50% HCl and further extracted into ether 
(3x30ml). The combined organic extracts were dried (MgS04), filtered and evaporated 
under reduced pressure to give crude tropic acid. This material was used directly 
without further purification. An ethereal solution of diazomethane (9.35mmol), 
generated from Diazald (2.0g, 9.35mmol) and potassium hydroxide (0.8g), in ether 
(60ml) was added to a solution of the tropic acid, in ether (60ml). The reaction was 
quenched by the addition of a few drops of glacial acetic acid until the yellow solution 
became colourless. The solution was dried (MgS04), filtered and evaporated under 
reduced pressure and then the residue was chromatographed over silica gel eluting with 
dichloromethane : ether (5%) to give methyl [3-3H]-tropate as a colourless oil (0.23g, 
67%). BH (CDCb): 3.59 (IH, dd, Jgem lO.OHz, 1vic 5.2Hz, -CH2), 3.86 (IH, dd, 1vic 
8.3Hz, 1vic 5.2 Hz, -CH), 4.14 (IH, dd, 1gem 10.0Hz, 1vic 8.3Hz, -CH2), 7.27 (5H, M, 
-Ar). Be (CDCl3): 52.73 (-Me), 54.43 (C-2), 65.08 (C-3), 128.28 (C-7), 128.66 (C-5), 
129.38 (C-6), 136.07 (C-4), 174.15 (C-1). 
7.44 Methyl f2.2HJ-Tropate (60bl 
A small piece of sodium metal ( = 250mg) was added to a stirred solution of methyl 
tropate (l.Og, 6.0mmol) in MeOD (15ml) and the reaction was left to stir at 18°C for 
2h. The solution was adjusted to pH4 with 5% D2S04 in ~0, the solvent evaporated 
under reduced pressure and the residue was dissolved in water (30ml) and extracted into 
ether (3 x 30ml). The combined organic extracts were dried (MgS04), filtered and 
evaporated under reduced pressure. The residue was re-suspended in ether (50ml) and 
was re-methylated by adding an ethereal solution of diazomethane (= 8mmol, excess), 
until the solution remained bright yellow. The reaction was quenched after 5min by the 
dropwise addition of glacial acetic acid until the solution just became colourless. The 
solvent was removed under reduced pressure and the residue chromatographed over 
silica gel, eluting with dichloromethane : ether (9: 1), to give methyl [2-2H]-tropate as a 
colourless oil, (876mg, 81%). Vmax: 3447br, 1734,1450, 1436,700. m/z (EI+) 182 
(M++l 41.52%), 151 (100%), 119 (86.68%). BH (CDCI3): 3.06 (3H, s -Me), 3.78 (lH, 
d, Jgem 11.0Hz, -CH2), 4.14 (IH, d, Jgem 11.0Hz, -CH2), 7.29 (5H, m, -J\r). Be 
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(CDCl3): 52.61 (-Me), 54.22 (t, Je-D 19.7Hz, C-2), 64.80 (C-3), 128.22 (C-7), 128.66 
(C-5), 129.31 (C-6), 136.18 (C-4), 174.11 (C-1). 
7.45 Methyl2-Phenyl3-methanesulphonylpropionate (61) 
Methanesulphonyl chloride (687mg, 6.00mmol) was added to a stirred solution of 
methyl tropate (540mg 3.00mmol) and DMAP (36mg, 0.30mmol) in pyridine (lOml) at 
18°C and the mixture was stirred for 30min. The reaction was quenched by the addition 
of 10% HCl (30ml) and then dichloromethane (30ml) was added. The organic extract 
was washed sequentially with 10% HCl (30ml) and saturated copper sulphate solution 
(30ml), dried (MgS04), filtered and evaporated under reduced pressure. The residue 
was chromatographed over silica gel eluting with dichloromethane ( 100%) and the 
product recrystallised from ethanol to give methyl 2-phenyl-3-
methanesulphonylpropionate as a white crystalline solid, (574mg, 74%). m.p. 59-60°C, 
Vmax: 3020, 2970, 1740, 1345, 1180, 1170, 990, 815, 700, 515, 500. m/z (EI+) 259 
(M++1 34.94%), 162 (89.79%), 121 (100%). BH (CDC}J): 2.97 (3H, s, -S02CH3), 3.72 
(3H, s, -OCH3), 4.03 (lH, dd, lvic 5.45Hz, lvic 9.55Hz, -CH), 4.37 (lH, dd, lgem 
9.95Hz, lvic 5.45Hz -CH2), 4.72 (lH, dd, lgem 9.95Hz, lvic 9.55Hz, -Cll2), 7.35 (5H, 
m, -Ar). Be (CDC~}): 37.73 (-S02CH3), 51.26 (C-2), 53.05 (-OMe), 70.41 (C-3), 128.56 
(C-5), 129.02 (C-7), 129.67 (C-6), 134.05 (C-4), 171.78 (C-1). Found C 51.21%, H 
5.37%, N 0%, CuH140sS requires C 51.15%, H 5.46%, N 0%. 
7.46 Methyl2-Phenyl [J.3HJ-3-methanesulphonylpropionate (61a) 
Methyl [3-3H]-tropate (228mg 1.27mmol) and DMAP (0.13mmol, 15mg) in pyridine 
(5ml) were reacted with methanesulphonyl chloride (290mg, 2.54mmol) according to 
the procedure described in section 7.45, to give methyl 2-phenyl-[3-3H]-3-
methanesulphonylpropionate as a white crystaltalline solid, (574mg, 55%) m.p. 58-
590C. BH(CDCl): 2.96 (3H, s, -S02Me), 3.72 (3H, s, -Me), 4.04 (lH, dd, lvic 5.43Hz, 
lvic 9.57Hz, -CH), 4.37 (1H, dd, lgem 9.99Hz, lvic 5.43 Hz -CH2), 4.72 (lH, dd, lgem 
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9.99Hz, lvic 9.57Hz, -CH2), 7.34 (5H, m, -Ar), OC(CDCl3): 37.74 (-S02Me), 51.24 (C-
2), 53.02 (Me), 70.41 (C-3), 128.56 (C-5), 129.02 (C-7), 129.67 (C-6), 134.04 (C-4), 
171.79 (C-1). 
7.47 Methyl [2.2HJ-2-Phenyl-3-methanesulphonylpropionate (61b) 
Methyl [2-2H]-tropate (300mg, 1.66mmol) and DMAP (20mg 0.166mmol), in pyridine 
(lOml), were reacted with methanesulphonyl chloride (368mg, 3.32mmol) according to 
the procedure described in section 7.45 to give methyl [2-2H]-2-phenyl-3-
methanesulphonylpropionate, as a white crystalline solid (263mg, 61 %). m.p. 59-6o·c 
Vmax: 1758, 1540, 1258, 1178. m/z (CI+) 277 (M+ + 18, 72.55%). 8H (CDCl3): 2.88 
(3H, s, -S02Me), 3.63 (3H,s, -OMe), 4.29 (lH,d, lgem 7.2Hz, -CH2) 4.64 (lH, d, lgem 
7.2Hz, -CH2), 7.23 (5H, m, -Ar). 8C (CDCl3): 37.69 (-S02Me), 50.88 (t, Je-D 17Hz), 
53.04 (-OMe), 128.55 (C-5), 128.92 (C-7), 129.67 (C-6), 134.01 (C-4), 171.78 (C-1). 
7.48 Methyl2-Phenyl-3-g-toluenesulphonylpropionate (64) (preparation 1l 
p-Toluenesulphonyl chloride (620mg, 3.26mmol), was added to a stirred solution of 
methyl tropate (532mg, 2.96mmol) in pyridine (6ml) at 0°C and the reaction mixture 
left to stir at 20°C for 2h. Dichloromethane ( 1 OOrnl) was added, and the solution was 
washed with 10% hydrochloric acid (3x lOOrnl). The organic extracts were dried 
(MgS04), filtered and evaporated under reduced pressure and the residue was 
chromatographed over silica gel eluting with ethyl acetate: hexane (1 :4). Unreacted 
starting material was recovered and methyl 2-phenyl-3-p-toluenesulphonylpropionoate, 
which was recrystallised from ethanol, gave white, needle-shaped crystals ( 195mg, 
23%). m.p. 93•c lit. 88•C,ll Vma.x: 2955, 1730, 1595, 1360, 1170, 995, 835, 545. m/z 
(EI+) 335 (M++1, 57%), 162 (100%), 91 (92%). 8H (CDCl3): 2.2 (3H, s, Ar-CH3), 3.65 
(3H, s, -OCH3), 3.97 (lH, dd, lvic 9.2Hz, lvic 5.8 Hz, -CH), 4.19 (lH, dd, Jgem 9.8Hz, 
lvic 5.8Hz, -CH2), 4.52 (lH, dd, 1gem 9.8Hz, 1vic 9.2Hz, -CH2), 7.22 (7H, m, -Ar), 7.70 
(2H, d, 1vic 7Hz, -Ar). ~ (CDCl3): 21.63 (Ar-CH3), 50.71 (C-2), 52.42 (OMe), 70.03, 
(C-3), 127.93, (C-5), 127.98 (C-6), 128.27 (C-7), 128.95 (C-3' or C-2'), 129.81 (C-2' or 
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C-3'), 132.53 (C-4'), 133.69 (C-4), 144.81 (C-1'), 170.99 (C-1). Found C 61.35%, H 
5.51%, N 0%, C11HtsOsS requires C 61.06%, H 5.42%, N 0%. 
1.49 Methyi2-Phenyla3-p-toluenesulphonylpropionate (64) (preparation 2) 
Triethylamine (287mg, 2.84mmol) and p-toluenesulphonylchloride (454mg, 2.38mmol) 
were added to a stirred solution of methyl tropate (410mg, 2.27mmol) in 
dichloromethane (30ml), at -20°C. The reaction was left to stir at -20°C for 15h. TLC 
analysis indicated that both methyl 2-phenyl-3-tosylpropionate and the eliminated 
product, methyl 2-phenylacrylate, as well as a little residual starting material were 
present. TLC analysis after a further 3h showed an increase in the eliminated product 
w.r.t. the desired product. The solution was washed with aqueous tartaric acid solution 
(10%, 30ml) and brine (30ml). The organic extract was dried (MgS04), filtered and 
evaporated under reduced pressure and the residue was chromatographed over silica 
gel, eluting with dichloromethane (100%) to yield methyl2-phenyl-3-tosylpropionoate, 
which was recrystallised from ethanol (145mg, 19% ). This material had identical 
spectroscopic data to that described above. 
7.50 2-Phenylpropanol ( 62) 
2-Phenyl-3-methanesulphonylpropionate (180mg, 0.70mmol) in ether (lOml) was 
added drop wise to a stirred suspension of lithium aluminium hydride ( 1 06mg, 
2.79mmol) in ether (25ml) and the mixture heated under reflux for 2h. The reaction was 
quenched by the addition of wet ether (20ml) and then poured into 5% HzS04. The 
product was extracted into ether (2x 30ml) and the combined organic extracts were 
dried (MgS04), filtered and evaporated under reduced pressure. The residue was 
chromatographed over silica gel, eluting with dichloromethane ( 100%) to give 2-
phenylpropanol as a clear, colourless oil (150mg, 88%).v max: 3368br, 3029, 3028, 
1494,1453, 1014, 762, 701. m/z(EI+) 136 (M+ 30.66%), 105 (M-31 100%). ()H 
(CDCl3): 1.28 (3H, d, 1vic 7.0 Hz, -CH3), 1.55 (lH, s, -OH), 2.97 (lH, m, -CH), 3.7 
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(2H, d, 1vic 6.8 Hz, -CH2), 7.25 (5H, m, -Ar). Be (CDCl3): 18.08 (C-3), 42.93 (C-2), 
69.19 (C-3), 127.17 (C-7), 127.99 (C-5), 128.66 (C-4), 129.13 (C-6). Found 136.08891, 
CgH 120 requires 136.08881. 
7.51 f1.2H2, J-2HJ-2-Phenylpropanol (62a) 
Methyl 2-phenyl-3-methanesulphonylpropionate (180mg, 0.70mmol) was reduced with 
lithium aluminium deuteride (117mg, 2.79mmol) according to the procedure described 
in section 7.50 to give [1-2H2, 3-2H]-2-phenylpropanol as a clear, colourless liquid, 
(80mg,829b). v~: 3345br,3027,2928, 1492,1452,970, 749,698,m/z(EI+) 139(M+ 
l6.569b), 0H(CDC13):1.17 (3H, dt 1IH1H 7.0Hz, 1IH2H 1.8Hz, -CH2D), 1.50 (lH, s, 
-OH), 2.83 (lH, t, 1vic 7.0Hz -CH), 7.17 (5H, m, -Ar), oc(CDCl3): 17.22 (t, Jl3c2H 
19.18 Hz, C-3), 42.14 (C-2), 67.88 (p, JI3c2H 21.7Hz, C-1), 126.61 (C-7), 127.44 (C-
5), 128.59 (C-6), 143.62 (C-4). 
7.52 f1.2u,, J.2JL3HJ-2-Phenylpropanol (62b) 
Methyl 2-phenyl-3-methanesulphonyl-[3-3H]-propionate (156mg, 0.6mmol) was 
reduced wjth lithium aluminium deuteride (102mg, 2.42mmol) according to the 
procedure described in section 7.50 to give [1-2H2, 3-2H,3H]-2-phenylpropanol (80mg, 
969b). 0H(CDCl3) 1.25 (3H, dt JlHlH 7.0Hz, 11H2H 1.8Hz -CHDT(H)) 1.44 (lH, s, 
-OH), 2.92 (lH, t, 1vic 7.0Hz -CH), 7.30 (5H, m, -Ar), Oc(CDC13) 17.19 (t Jl3c2H 
19.25Hz C-3), 42.10 (C-2), 60.80 (p Jl3c2H 21.7Hz C-1), 126.56 (C-7), 127.31 (C-5) 
128.54 (C-6), 143.64 (C-4). 
7.53 f2.2HJ-2-Phenylpropanol (62c) 
Methyl 2-[2H]-2-phenyl-3-mesylpropionate was reduced with lithium aluminium 
hydride (150mg, 4.00mmol) according to the procedure described in section 7.50 to 
give [2-2H]-2-phenylpropanol (105mg, 779b). v~: 3354br, 3924, 2928, 1493, 1446, 
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1090, 756, 699. m/z(EI+) 137 (M+ 12.84%), 106 (100%). OH (CDCl3): 1.18 (3H, s, 
-CH3), 1.59 (lH, s, -OH), 3.60, (2H, s, -CH2), 7.20 (5H, m, -Ar). oc (CDC13): 16.46 
(C-3), 40.95 (t, le-D 17.43Hz, C-2), 67.55 (C-1), 125.61 (C-7), 126.44 (C-5), 127.58 
(C-6), 142.64 (C-4). 
7.54 Periodate/Permana=anate Oxidation of 2aPhenylpropanol: Sodium Acetate (5) 
2-Phenylpropanol (232mg, 1.7mmol) was added to a stirred solution of potassium 
periodate (30g, 0.13mol) and potassium permanganate (80mg, 0.51 mmol) in distilled 
water (200ml). The reaction mixture was left to stir vigorously at 18·c for 4 days, then 
the insoluble salts were removed by filtration. The filtrate was made basic with 1M 
sodium hydroxide solution and the solvent evaporated under reduced pressure. The 
residue was re-dissolved in 5% sulphuric acid and lyophilised. The lyophilisate was 
then adjusted to pH8.5 with 0.01M sodium hydroxide solution. The water was 
evaporated under reduced pressure to give a white solid (50mg) which contained 
sodium acetate (43%) and sodium formate (57%) (calculated from NMR integrals). 
Yield of acetate 17%. 0H(D20): 1.76 (3H, s) 8.31 (1.3H, s), oc(D20): 26.15, (C-2), 
173.94 (C-1). 
7.54.1p-Phenylphenacyl Acetate (67) 
2-Bromo-4'-phenylacetophenone (80mg, 0.29mmol), was dissolved in warm ethanol 
(2ml) and was added to a stirred solution of the sodium acetate (24mg 0.29mmol) in 
water (lml) and the mixture was heated under reflux for 1h. The solution was cooled to 
o·c and after the addition of a few drops of water a white precipitate formed and was 
collected by filtration. The precipitate was dissolved in dichloromethane (lOml), 
washed with water ( 1 Oml) then the solution was dried (MgS04), filtered and evaporated 
under reduced pressure. The residue was chromatographed over silica gel, eluting with 
dichloromethane ( 100%) to give 2-acetyl-4'-phenylacetophenone (17mg, 0.067mmol) 
33%. m.p. 109-111·c, lit:l11·c,l2vmax: 2961,2933,2360, 1754, 1746, 1701, 1600, 
120, 1091, 760. rnlz(CI+) 272 (M++18, 0.70%), 255 (M++1, 2.53%), formate 
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derivative: 141 (M+, 0.56%) OH(CDCl3): 2.25 (3H, s, -CH3), 5.38 (2H, -CH2), 7.60 
(9H, m, -Ar). Oc(CDCl3): 20.62 (C-1), 66.03 (-CH3), 127.27 (-Ar), 127.47 (-Ar), 
128.34 (-Ar), 128.99 (-Ar), 132.82 (-Ar), 139.60 (-Ar), 170.47 (CO), 191.73 (CO). 
7.55 Periodate/Permanganate of [le2fu, 3e2l:L3HJe2ePhenylpropanol: Sodium [2a 
2H.3HJeAcetate (Sa) 
2-Phenyl-[I-2H2, 3-2H,3H]-propanol (80mg, 0.59mmol) was treated with periodate 
/permanganate according to the procedure described in section 7.54 to give a white 
solid (62mg) which contained deuterated acetate (43%), non-deuterated acetate (29%) 
and formate (28%). OH(~O): 1.89 (2H, t, J1H-2H 2.15Hz), 1.90 (2.1 H, s), 8.44 (0.7H, 
s). 
7.56 Periodate!Permanganate Oxidation of Cumene 
Cumene (200mg, 1.7mmol) was added to a stirred solution of potassium periodate (30g, 
0.13mol) and potassium permanganate (80mg, 0.51 mmol) in distilled water (200ml). 
The reaction mixture was left to stir vigorously at 18·c for 2h and then the insoluble 
salts were removed by filtration. The filtrate was made basic with 1M sodium 
hydroxide solution and the solvent evaporated under reduced pressure. The residue was 
re-dissolved in 5% sulphuric acid and lyophilised. The lyophilisate was adjusted to 
pH8.5 with O.OlM sodium hydroxide solution and the water was evaporated under 
reduced pressure to give a white solid (50mg) containing sodium acetate ( 41%) 
contaminated with sodium formate (59%) (calculated from NMR integration): yield of 
acetate 16%. 0H(D20): 1.8 (3H, s, acetate), 8.3 (1.4H, s, formate). 8cCD20) 26.16 (C-
2), 173.96 (C-1). 
7.56.1p-Phenylphenacyl Acetate (67) 
2-Bromo-4'-phenylacetophenone (12J.Lg 42J.Lmol) in warm ethanol (500J.Ll) was added to 
a stirred solution of the product (3.5mg) in water (lOOJ.Ll). The solution was heated 
under reflux for lh then cooled to o·c. The white precipitate was collected by filtration, 
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re-dissolved in dichloromethane (lml) and washed with water (lml). The organic layer 
was dried (MgS04), filtered and evaporated under reduced pressure. The crude product 
was chromatographed over silica gel eluting with dichloromethane ( 100%) and the 
product was analysed by MS: acetate derivative: m/z(CI+): 273 (M++18, 2.32%), 255 
(M++1, 5.95%), formate derivative: m/z(CI+): 259 (M++18, 3.18%), 241 (M+, 4.36%). 
7.57 Hydrolysis of Methyl [2.2HJ-Tropate : Exchanae of Deuterium from C-2 
A stirred solution of methyl [2-2H]-tropate (93mg, 0.51 mmol) in saturated barium 
hydroxide solution was heated under reflux for 30min. The reaction mixture was then 
poured into 50% HCl (20ml) and extracted into ether (3 x 20ml). The combined 
ethereal extracts were dried (MgS04), filtered and evaporated under reduced pressure to 
give [2-2H]-tropic acid (68mg, 80%) containing 8% [2-lH]-tropic acid as determined 
by lH NMR. 
This material was then heated under reflux in 10% sodium hydroxide solution 
(25ml), removing aliquots (6ml) after 5, 10 20 and 30min. The solution removed was 
poured into 50% HCl (20ml) and the tropic acid extracted as described above. 
Spectroscopic data for tropic acid are given in section 7.41 and the 1 H NMR of the 
methine region is shown in fig. 85. 
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7.58 Growth of Poronia piliformis and the Isolation of Piliformic Acid 13 
Poronia piliformis was cultured on malt extract solution (3%, Oxoid) in Thompson 
bottles (300ml per bottle) at 24·c. Substrates were administered in sterile neutral 
solution 2-4 days after subculturing, when new growth was apparent. The supernatant 
was harvested after 6 weeks and separated from the mycelium by filtration. The filtrate 
was acidified (cone. HCl) and extracted into ethyl acetate (3x300ml per bottle). The 
combined organic extracts were then dried, filtered and evaporated under reduced 
pressure to give a brown gum. This was resuspended in ether and filtered to remove any 
insoluble material. The filtrate was then evaporated under reduced pressure and the 
residue chromatographed over silica gel, eluting with toluene : ethyl formate : formic 
acid 50: 49 : 1. The oily residue after solvent evaporation was recrystallised from 
nitromethane to give piliformic acid as an amorphous solid, typically about 55mg per 
bottle. OH(CDCl3): 0.90 (3H, t, -CH3), 1.28 (7H, m, -(CH2h and -CH3-), 1.34 (2H, m, 
-CH2), 2.24 (2H, m, -CH2). 3.63 (1H, q, -CH), 7.02 (lH, d, -CH), 10.80 (2H, s, 
-C02H). oc(CDCI]): 14.41 (C-9), 15.14 (C-11), 22.91 (C-8), 28.58 (C-6), 29.34 (C-5), 
31.98 (C-7), 37.95 (C-2), 131.54 (C-3), 147.91 (C-4), 172.53 (C-10), 180.65 (C-1). 
[a]n -86° (c = 0.067 in MeOH), lit -89° (c = 1.0 in MeOH)l 
7 .58.1 Sodium £1.2-13C2l·Acetate 
Sodium [1,2-13C2]-acetate was administered toP. piliformis cultures (2x200ml) at a 
concentration of 15mmoldm-3. Piliformic acid (36mg) was isolated with an 
incorporation of 5.7% into the Cg fragment and 0.48% into the C3 fragment (fig. 131). 
7.58.2 Sodium [1.13C, 2-2HJJ-Acetate 
Sodium [1-l3C, 2-2H3]-acetate was administered toP. piliformis cultures (2x200ml) at 
a concentration of 15mmoldm-3. Piliformic acid (96mg) was isolated with an 
incorporation of 4.6% into the Cg fragment (fig. 134, fig. 135, fig. 137). 
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Sodium [2-l3C, 2H3]-acetate was administered toP. piliformis cultures (2x300ml) at a 
concentration of 4.8mmoldm-3. Piliformic acid (108mg) was isolated with an 
incorporation of 2.4% into the Cg fragment (fig. 139). 
7.58.4 Sodium [f.l3CJ-Octanoate 
Sodium [ I-13C]-octanoate was administered to P. piliformis cultures (2x300ml) at a 
concentration of 2.87mmoldm-3. Piliformic acid (54mg) was isolated with an intact 
incorporation of 5.5% into the Cg fragment and 2% incorporation into the C8 fragment 
via [t-13C]-acetate (fig. 140). 
7.58.5-Sodium [2.2fuJ-Acetate 
Sodium [2-2H3]-acetate was administered to P. piliformis cultures (21 x300ml) at a 
concentration of 15mmoldm-3. Piliformic acid (1.16g) was isolated and degraded to 
hexanoic acid as described in section 7 .60. 
7.58.6 Sodium 16-Fiuoropalmitate 
Sodium 16-fluoropalmitate was administered to P. piliformis cultures (2x300ml) at a 
concentration of 1.13mmoldm-3. The piliformic acid (30mg) isolated showed no 
incorporation of fluorine. 
7.58.7 Sodium [2H71-Butyrate 
Sodium [2H7 ]-butyrate was administered to P. piliformis cultures (lx300ml) at a 
concentration of 4.2mmoldm-3. Piliformic acid (23mg) was isolated (fig. 177). 
7.58.8 Sodium £2Hul-Hexanoate 
Sodium [2H11]-hexanoate was administered to P. piliformis cultures (lx300ml) at a 
concentration of 2.6mmoldm-3. Piliformic acid (47mg) was isolated (fig. 176). 
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7 .58.9 Sodium f2H tsl-Octanoate 
Sodium [2Hts]-octanoate was administered to P. piliformis cultures (lx300ml) at a 
concentration of 2.6mmoldm-3. Piliformic acid (50mg) was isolated (fig. 175). 
7.58.10 Sodium f2HtslDOctanoate 
Sodium [2H ts]-octanoate was administered to X, mali cultures (3x300ml) at a 
concentration of 1.84mmoldm-3. This strain was cultured in an identical manner to P. 
piliformis as described in section 7.58 Piliformic acid (16mg) was isolated (fig. 182). 
7.58.11 Sodium f1.13c, 2-2Hl-Octanoate 
Sodium [ 1-13C, 2-2H]-octanoate was administered to P. piliformis cultures (2x300ml) 
at a concentration of 2.51mmoldm-3 and piliformic acid (54mg) was isolated (fig) with 
an intact incorporation of 4.9% and 1.4% as [1-13C]-acetate (fig. 180, fig. 181). 
7.58.12 DL-f1.13CJ-Alanine 
DL-[ 1-13C]-Alanine was administered to P. piliformis cultures (2x300ml) at a 
concentration of 4.6mmoldm· 3. Piliformic acid (79mg) was isolated with an 
incorporation of 0.09% at C-1 (fig. 169). 
7.58.13 DL-fJ.13h 21:1JJ-Alanine 
DL-[3-13C, 2H3]-Alanine was administered to P. piliformis cultures (lx300ml) at a 
concentration of 4.5mmoldm-3. Piliformic acid ( 42mg) was isolated (fig. 171 ). 
7.58.14 Sodium f2.3-2H4J-Succinate 
Sodium [2,3-2H4]-succinate was administered to P. piliformis cultures (2x300ml) at a 
concentration of 6.8mmoldm-3 Piliformic acid (34mg) was isolated (fig. 173). 
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7.59 Deeradation of Piliformic Acid to Hexanoic Acid (126)5 
Piliformic acid (300mg, 1.4mmol) was added to a vigorously stirred solution of 
potassium periodate (12,5g, 50mmol) and ruthenium trichloride (32mg, 0.154mmol) in 
water : acetonitrile : tetrachloromethane (3: 1: 1, lOOml). The reaction mixture was left 
to stir at 18°C for 48 hours and then filtered through a celite pad. The organic phase was 
separated, and the hexanoic acid, extracted into ether (3x60ml) and evaporated under 
reduced pressure. The residue was suspended in chloroform (2ml), covered with water 
(20ml) and then the aqueous layer was adjusted to pHS with 0.1M sodium hydroxide 
solution. The aqueous phase was then separated, re-acidified with 50% hydrochloric 
acid and re-extracted into ether (3x30ml). The combined organic extracts were dried 
(MgS04), filtered and evaporated under reduced pressure to give hexanoic acid as a 
yellow oil, which was used without further purification (135mg, 83%). Vma.x: 3013br, 
2966, 2942, 2872, 2672, 1706, 1418. m/z(EI+) 117 (M++1, 0.24%), 60 (M+-56, 100%) 
OH(CDCI)): 0.83 (3H, t, 1vic 6.6Hz, -CH3), 0.125 (4H, m, -(CH2)2-), 1.57 (2H, m, 
-CH2), 2.28 (2H, t, 1vic 7.5Hz, -CH2), 9.36 (lH, s, -CO:zH), oc(CDCI3): 14.33 (C-6), 
22.77 (C-5), 24.84 (C-4), 31.68 (C-3), 34.54 (C-2), 180.69 (C-1). 
7.60 Deeradation of Piliformic Acid from Sodium £2-2HJJ-Acetate fed P. piliformis 
f126a) 
Piliformic acid (900mg, 4.4 mmol) was degraded according to the procedure described 
in section 7.59 to give hexanoic acid (371mg 77%). Yma.x: 3013br, 2958, 2932, 2873, 
1713, 1414. m/z(EI+) 118 (M++1 (CHD), 60 (M+-56, 100%), 0.32%), 117 (M++1 
(CH2) 0.04%), OH(CDCI3); 0.89 (3H, t 1vic 6.6Hz, -CH3), 1.32 (4H, m, -(CH2)2-), 1.63 
(2H, m, -CH2), 2.33 (2H, t, 1vic 7.5Hz, -CH2), 11.0 (lH, s, -C02H), Oc(CDCI3): 14.31 
(C-6), 22.75 (C-5), 24.82 (C-4), 31.66 (C-3), 34.56 (C-2), 181.18 (C-1). 
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7.61 Methyl <RS)a[2a2HJaHexanoate (128) 
Methyl hexanoate ( l.Og, 1.13ml, 7.68mmol) was added dropwise to a stirred solution of 
LDA (23.0mmol), generated from diisopropylamine (2.33g, 3.22ml, 23.0mmol) and n-
butyllithium (14.38ml, 23.0mmol, 1.6M in hexanes), in THF (20ml) at -78°C. The 
solution was allowed to warm slowly to 18°C and was left to stir at this temperature for 
1h. The reaction was then quenched by the addition of MeOD (2ml, excess) and the 
solution left to stir for a further 1h. The reaction mixture was then poured into saturated 
ammonium chloride solution (30ml) and the aqueous phase separated and extracted into 
ether (2x30ml). The combined organic extracts were dried (MgS04), filtered and 
evaporated under reduced pressure and the residue was purified by bulb to bulb 
distillation (0.03mbar, furnace temperature 50°C) to give methyl (RS)-[2-2H]-hexanoate 
as a colourless oil (249mg, 25%). Vmax: 2958, 2934, 2870, 1714, 1462, 1435, 1218. 
m/z(EI+) 131 (M+ 11.86%) 87 (M+-44) OH(CDCl3): 0.89 (3H, t, Jvic 6.7Hz, -CH3), 1.30 
(4H, m, -(CHz)z), 1.63 (2H, m, -CHz), 2.29, (lH, m, -CHD), 3.65, (3H, s, -OMe). 
oc(CDC13): 13.88 (C-6), 22.30 (C-5), 24.56 (C-4), 31.28 (C-3), 33.37 (t, Jl3c2H 
19.3Hz, -CHD, C-2), 34.06 -CHz, C-2), 51.42 (-OMe), 174.35 (C-1). 
7.62 £2.2HJ-Hexanoic Acid (126bl 
(RS )-Me thy 1 [2-2H]-hexanoate ( 150mg, 1.15mmol) was covered with a 1M solution of 
KOD in DzO ( lOml) and the stirred solution heated tinder reflux for 12h. The solution 
was left to cool to 18°C, and was then washed with ether (2x20ml). The aqueous 
solution was acidified with 50% HCl and extracted into ether (3x20ml) and the 
combined organic extracts from the second extraction were dried (MgS04), filtered and 
evaporated under reduced pressure to give [2-2H]-hexanoic acid as a colourless oil 
(99mg, 74%). Vmax: 3068br, 2958,2932,2873, 1704, 1413, 1290. m/z(EI+) 118 (M++1, 
0.26%) 0H(CDCl3): 0.89 (3H, t, 1vic 6.7Hz, -CH3), 1.33 (4H, m, -(CHz)z), 1.63 (2H, m, 
-CHz), 2.34 (lH, m, -CHD). Bc(CDCI3): 13.86 (C-6), 22.28 (C-5), 24.34 (C-4), 31.35 
(C-3), 33.75 (t, Jt3c2H 19.5Hz, -CHD, C-2), 34.04 (-CH2, C-2), 180.38 (C-1). 
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7.63 Methyl 0-Hexanoylmandelate <127)14 
(RS)-Methyl mandelate (332mg, 2.00mmol) and dicyclohexylcarbodiimide (412mg, 
2.00mmol), were added to a stirred solution of hexanoic acid (232mg, 0.215ml, 
2.00mmol) and a catalytic quantity of 4-dimethylaminopyridine (5mg, 0.04mmol) in 
dichloromethane (lOml) at -10°C. The reaction mixture was left to stir at this 
temperature for 3h and the precipitated urea removed by filtration. The solvent was re-
evaporated under reduced pressure and the residue suspended in dichloromethane (4ml) 
and re-filtered. The solvent was evaporated under reduced pressure and the residue 
chromatographed over silica gel eluting with dichloromethane (100%) to give methyl 
0-hexanoylmandelate as a colourless oil (412mg, 78%). Vmax: 2255, 2232, 1744, 1456, 
1216, 1160, m/z(EI+) 264 (M+ 0.69%), 99 (M+-165, 100%) OH(CDCh): 0.89 (3H, t, 
lvic 6.8Hz, -CH3), 1.31 ( 4H, m, -(CH2)z-), 1.72 (2H, m, -CHz), 2.45 (2H, m, -CH2), 
3.71 (3H, s, -CH3) 5.94 (lH, s, -CH), 7.40 (5H, m, -Ar), 8c(CDCI3): 14.38 (C-12), 
22.77 (C-11), 29.94 (C-10), 31.66 (C-9), 34.11 (C-8), 53.05 (-OMe), 74.73 (C-2), 
128.09 (C-4), 129.26 (C-5), 129.68 (C-6), 134.39 (C-3), 169.88 (C-7 or C-1), 173.65 
(C-1 or C-7). Found 265.14260, CtsH2104 (M++l) requires 265.14398 
7.64 Methyl 0-Hexanoylmandelate from Deuterated Piliformic Acid Derived 
Hexanoic Acid <127al 
Hexanoic acid from the [2-2H3]-acetate feeding experiment on piliformic acid was 
coupled with (R)-methyl mandelate according to the procedure described in section 
7.63, to generate deuterated methyl 0-hexanoylmandelate (227mg, 65%).vmax: 2955, 
2932, 2861, 1745, 1455, 1438, 1216, 1160, mlz(CI+) 285 ((M+3)++18, 3.1 %), 284 
((M+2)++18, 3.71%), 283 ((M+l)++ 18, 13.95%), 282 (M+ +18, 40.88%), 166 (M+ 
-99, 100%). OH(CDCl3): 0.90 (3H, t, lvic 6.8Hz), 1.33 (4H, m, -(CH2)z), 1.70 (2H, m, 
-CH2), 2.47 (2H, m, -CHz), 3.72 (3H, s, -OMe), 5.95 (lH, s, -CH) 7.40 (5H, m, -Ar), 
8c(CDCl3): 14.39, (C-12 ), 22.78 (C-11), 24.96 (C-10), 31.67 (C-9), 34.42 9C-8), 53.06 
(-OMe), 74.70 (C-2), 128.10 (C-4), 129.27 (C-5), 129.60 (C-6), 134.38 (C-3), 169.80 
(C-7 or C-1), 173.65 (C-1 or C-7), 02H(CC14):0.92 ( -CD3), 1.39 ( -CHD), 2.46 ( -CHD). 
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7.65 Methyl <RSl-£2.2HJ-O-Hexanoyl-2'-(Rl-mandelate (127bl 
[2-2H]-Hexanoic acid (l30mg, 1.10mmol) was coupled to (R)-methyl mandelate 
according to the procedure described in section 7.63 to give methyl (RS)-[2-2H]-O-
hexanoyl-2-(R)-mandelate (250mg, 86%). Vmax: 2932, 2871, 1744, 1455, 1438, 1215, 
1170,733, 696. mlz(CI+) 284 ((M+2)+ +18, 12.07%), 283 ((M+l)+ +18, 19.99%), 282 
(M++18, 10.19%), 166 (M+ -99, 38 97%). OH(CDCb): 0.90 (3H, t, 1vic 6.8Hz, -CH3)-
1.33 (4H, m, -CH2)2-), 1.70 (2H, m, -CH2), 2.46 (lH, m, CHD), 3.71 (3H, s, -OMe), 
5.94 (lH, S, -CH), 7.37 (5H, m, -Ar), oc(CDC13): 14.39 (C-12), 22.78 (C-11), 24.89 (C-
10), 31.61 (C-9), 34.01 (C-8, t, Jl3c-2H 20Hz), 53.04 (-OMe), 74.73 (C-2), 128.10 (C-
4), 129.27 (C-5), 129.69 (C-6), 134.40 (C-3), 169.87 (C-7 or C-1), 173.64 (C-1 or C-7), 
02H(CCl4): 2.50 ( -CHD), 2.56 ( -CHD). 
2.66 Ethyl2-Methyl-1,3-dithiane-2-carboxylate (134) 
n-Butyllithium (4.22ml, 8.45mmol, 2M in pentane) was added dropwise to a stirred 
solution of ethyl 1,3-dithiane-2-carboxylate (1.49g, 7.75mmol) in THF at -78°C. The 
reaction mixture was allowed to warm to OOC and was left to stir at this temperature for 
1h. The solution was cooled again to -78°C and methyl iodide (l.Og, 7.04mmol) was 
added dropwise. The reaction mixture was allowed to warm to OoC and left to stir at this 
temperature for 20min. The reaction was quenched by the careful addition of saturated 
ammonium chloride solution (20ml), the layers were separated and the aqueous layer 
extracted into ether (2x30ml). The combined organic extracts were dried (MgS04), 
filtered and evaporated under reduced pressure to give a yellow oil, which was 
chromatographed over silica gel, eluting with dichloromethane : petrol ( 1: 1) to generate 
ethyl2-methyl-1,3-dithiane-2-carboxylate as a colourless oil (1.46g, 91%).Vmax: 2969 
1739, 1234, 1035,701. m/z(EI+) 206 (21.21%, M+). OH(CDCI]): 1.27 (3H, t, 1vic 7Hz, 
-CH3), 1.59 (3H, s, -CH3), 1.80 (m, 1H, -CH2), 2.12 (lH, m, -CH2), 2.58 (2H, dt 
-CH2S), 3.32 (2H, td, -CH2S), 4.17 (2H, q, 1vic 7Hz). Oc:(lH}(CDCl3): 13.94 (C-8), 
28.88 (C-4 or C-5), 25.29 (C-4 or C-5), 27.84 (C-3) 45.86 (C:-2), 62.44 (C-7) 171.18 
(C-1). Found 206.04353, CsH1402S2 requires 206.04352. 
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7.67 2-(t-Butyll-3-methylimidazolidin-4-one l14Zl 15 
Glycine methyl ester hydrochloride (13.14g, O.llmol)) was added to a stirred solution 
of 8M ethanolic methylamine (40ml), at o·c and the solution was left to stir at 18·c for 
12h. After this time the reaction mixture was concentrated under reduced pressure and 
the residue co-evaporated with dichloromethane (3x50ml). Pivalaldehyde (19.83g, 
0.23mol), and triethylamine (30ml) were added to a stirred solution of the residue in 
dichloromethane (90ml) and the solution was heated under reflux for 12h. The cooled 
mixture was filtered through a celite pad, washed with ether (200ml) and the filtrate 
concentrated under reduced pressure. The residue was re-suspended in ether (60ml) and 
filtered again to remove further precipitated material and the solvent was then removed 
under reduced pressure. A saturated solution of HCI in methanol (60ml) was added to a 
stirred solution of the above residue in methanol (25ml) at o·c and the reaction mixture 
was left to stir at this temperature for 30min, allowed to warm to 18·c and left to stir 
overnight. The solvent was removed under reduced pressure and the residue dissolved 
in dichloromethane (80ml). The solution was washed with 3M sodium hydroxide 
solution (60ml) which was then extracted again with dichloromethane (60ml). The 
combined organic extracts were filtered through a phase separating paper and 
concentrated under reduced pressure to give 2-(t-butyl)-3-methylimidazolidin-4-one 
(7.96g, 49%) an oil which formed a waxy solid upon cooling. Vmax: 2360 1684, 1466, 
mlz(CI+) 157 (M++I, 100%), 0H(CDCl3): 0.91 (9H, s, -t-Bu), 2.04 (IH, -NH), 2.89 
(3H, s, -CH3), 3.41 (2H, d, lvic 0.56Hz, -CH2), 4.07 (IH, s, -CH), oc(CDCl)): 26.00 
( -(CH3)3), 31.58 ( -CMe3), 38.01 ( -NMe), 49.62 (C-5), 83.53 (C-2), 175.23 (C-1). 
Found 157.13417, CsH170N2 (M++l) requires 157.13408 
7.681-Benzyl-2-ft-butyll-3-methylimidazolidin-4-one (137)16 
Benzoyl chloride ( 4.09g, 3.37ml, 29.07mmol) and 1M sodium hydroxide solution 
( 16ml) were added to a stirred solution of 2-(t-butyl)-3-methylimidazolidin-4-one 
( 4.13g, 26.4mmol) in dichloromethane ( 40ml) and the mixture was left to stir 
vigorously for 12h. The organic phase was separated and filtered through a phase 
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separating filter paper and the filtrate concentrated under reduced pressure. The residue 
was chromatographed over silica gel eluting with ether : petrol : methanol (60:30:5) to 
give, after evaporation, a white solid which was recrystallised from 
dichloromethane/petrol, 1-benzyl-2-(t-butyl)-3-methylimidazolidin-4-one (6.49g,94% ). 
m.p. 141-143°C, lit: 143-144°Cl6 Vmax: 3516,3387,3275,2984, 1687, 1647. m/z(CI+) 
261 (M++1, 100%). OH(CDCl3): 1.10 (9H, s, -t-Bu), 3.05, (3H, s, NMe), 3.83 (lH, d, 
Jgem 15.4Hz, -CH2), 4.12 (lH, d, 1gem 15.4Hz, -CH2), 5.59 (lH, s, -CH), 7.50 (5H, m, 
-Ar). oc(CDCl3): 26.54 ( -(CH3)3), 32.11 ( -CMe3), 40.25 ( -NMe), 53.50 (C-5), 81.36 
(C-2), 128.54 (C-3'), 129.10 (C-4'), 132.05 (C-5'), 134.84 (C-2'), 169.73 (C-1 or C-1') 
172.14 (C-1' or C-1). 
7.69 1-Benzyl-2-(t-butyll-3,5-dimethylimidazolidin-4-one <138)17 
A solution of LDA (l4.79mmol), generated from diisopropylamine (1.5g, 2.07ml, 
14.79mmol) and n-butyllithium (9.24ml, 14.79mmol, 1.6M in hexanes) in THF (10ml) 
was transferred into a stirred solution of 1-benzyl-2-(t-butyl)-3-methylimidazolidin-4-
one (3.5g, 13.4mmol) in THF (135ml) at -78°C. The reaction mixture was left to stir at 
this temperature for 1h and then methyl iodide (1.91g, 0.84ml, 13.4mmol) was added 
dropwise. The solution was left to stir at -78°C for a further 45min, allowed to warm 
gradually to 18°C and then stirred for 12h at this temperature. The reaction was 
quenched by the addition of half saturated ammonium chloride solution (135ml) and 
then the layers were separated. The aqueous layer was extracted into ether (2x 150ml) 
and the combined organic extracts were dried (MgS04), filtered and evaporated 
under reduced pressure. The crude product was chromatographed over silica gel 
eluting with ether : petrol : methanol (60:35:5) to give 1-benzyl-2(t-butyl)-3,5-
dimethylimidazolidin-4-one as a white solid (2.08g 56%). mp: found 145.5-146.5°C lit: 
145.6-146.2oCl7 Vmax: 2954, 2867, 1704, 1629. mlz(CI+): 275 (M++1, 76.85%). 
OH(CDCl3): 0.97 (3H, d, Jvic 6.6Hz, -CH3), 1.06 (9H, s, -t-Bu), 3.07 (3H, s, -NMe), 
4.25 (lH, q, Jvic 6.6Hz -CH), 5.66 (lH, s, -CH), 7.50 (5H, m, -Ar), Oc(CDCl3): 19.91 
(-Me), 26.78 (-(CH3)3), 32.57 (-CMe3), 41.23 (-NMe), 57.83 (C-5), 80.34 (C-2), 128.11 
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(C-3'), 129.39 (C-4'), 132.00 (C-5'), 137.46 (C-2'), 171.59 (C-1 or C-1'), 172.77 (C-1' or 
C-1), CHN Found C 69.90% H 8.15% N 10.01%, CtsH2o02N2 requires C 70.04%, H 
8.08% N 10.21%. 
7. 70 1-Benzyl-2-(t-butyl}-3-methyl-fS-13h 2fu-methvD-imidazolidin-4-one (139al 
1-Benzyl-2-(t-butyl)-3-methylimidazolidin-4-one (1.62g, 6.23mmol) was added to 
LDA (6.85mmol) in THF solution and then [1-13C, 2H3]-methyl iodide (l.Og, 
6.85mmol) was added according to the procedure described in section 7.69 to give 1-
benzyl-2-(t-butyl)-3-methyl-[5-13C, 2H 3]-imidazolidin-4-one (977mg, 56%). Vmax: 
2974, 2869, 1699, 1633. mlz(CI+) 279 (M++1, 100%) OH(CDCI3): 1.06 (9H, s, -t-Bu), 
3.07 (3H, s, -NMe), 4.24 (lH, s, -CH), 5.66 (lH, 2, -CH), 7.50 (5H, m, -Ar). 
Oc(CDCb): 19.16 (septet Jl3c2H 19.5Hz -CD3), 26.79 (-(CH3)3), 32.57 (CMe3), 41.24 
(-NMe), 57.68 (d, Jl3cl3c, C-5), 80.37 (C-2), 128.11 (C-3'), 129.39 (C-4'), 132.00 (C-
5'), 127.47 (C-2'), 171.59 (C-1' or C-4), 172.80 (C-1' or C-4). 
7.71 DL-Alanine 005)18 
1-Benzyl-2(t-butyl)-3,5-dimethylimidazolidin-4-one (500mg, 1.82mmol) was heated 
with 6N HCI (6ml) to 18o·c in a sealed tube for 12h. The solution was then removed 
from the tube by washing out with water (lOml) and then with dichloromethane (15rnl). 
The aqueous solution was concentrated under reduced pressure to give DL-alanine 
hydrochloride contaminated with methylamine hydrochloride. The mixture was then 
purified by ion exchange chromatography (Dowex 50X2-400) to give DL-alanine as a 
white solid (146mg, 90%). m.p. 288-289·c (dec) lit. 295-296·c (dec)19 Vmax: 3421, 
3094, 2756, 2306, 2174, 2094, 1595, 1408, 1340. mlz(CI+) 90 (M++1 24.16%). 
0H(D20): 1.31 (3H, d, Jvic 7.2Hz, -CH3), 5.43 {lH, q, Jvic 7.2Hz, -CH), &:;(D20): 
18.98, 53.53 (C-2), 178.65 (C-1). 
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7.72 DL-[3.13.c,_ 2fuJ-Alanine flOSa) 
1-Benzyl-2-(t-butyl)-3-methyl-[S-13C,2H3]-imidazolidin-4-one (972mg, 3.50mmol) 
was hydrolysed according to the procedure described in section 7.71 to give DL-[3-l3C, 
2H3]-alanine (254mg, 79%.) m.p. 289-290(dec), Vmax: 3550br, 3091, 2774, 2708, 2106, 
1626, 1592. m/z(Cl+) 94 (M++1, 100%), BH(D20): 3.62 (lH, m, -CH). Bc(D20): 18.20 
(septet, Jl3c2H 19.6Hz, C-3), 53.13 (d, JI3cl3c 34.7Hz, C-2), 178.63 (C-1). 
7.73 Methyl Octanoate (143) 
A solution of diazomethane (50mmol) in ether (400ml) was added to a solution of 
octanoic acid (5.5g, 38mmol) in ether (50ml) such that the yellow colour persisted. The 
excess diazomethane was then removed by the addition of a few drops of glacial acetic 
acid to generate a colourless solution. The solution was then washed with 0.1M sodium 
hydroxide (2x150ml), dried (MgS04), filtered and evaporated under reduced pressure. 
The residue was purified by bulb to bulb distillation (0.005mbar, furnace temperature 
SOOC) to give methyl octanoate (5.19g, 98%). Vmax: 2954, 2926, 2857, 1740, 1461, 
1436, 1168. m/z(El+) 159 (M++1, 5.27%) BH(CDCl3): 0.88 (3H, t, 1vic 6.5Hz, -CH3), 
1.28 (8H, m, -(CH2)4), 1.62 (2H, m, -CH2), 2.31 (3H, t, 1vic 7.5Hz, -CH2), 3.67 (3H, s, 
-OMe). Bc(CDC}J): 14.07 (C-8), 22.61 (C-7), 24.98 (C-6), 28.94 (C-5), 29.13 (C-4), 
31.67 (C-3), 34.13 (C-4 ), 54.44 ( -OMe ), 174.35 (C-1 ). Found 159.13772, C9H 1902 
(M++1) requires 159.13850 
7.74 Methyl (1.13CJ-Octanoate f143a) 
A solution of diazomethane (20mmol), in ether (50ml) was added to a solution of [1-
13C]-octanoic acid ( l.Og, 6.89mmol) in ether (50ml) such that the yellow colour 
persisted. The excess diazomethane was removed by bubbling a slow stream of N2 
through the solution until the yellow colour disappeared. The solution was then dried 
(MgS04), filtered and evaporated under reduced pressure and the residue purified by 
bulb to bulb distillation (0.15mbar, furnace temperature 50°C) to give methyl [t-13C]-
octanoate (964mg, 88%). Vmax: 2955, 2921, 2851, 1701, 1461, 1152. m/z(Cl+): 160 
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(M+ + 1, 100% ). 8H(CDCI]): 0.87 (3H, t, 1 vic 6.5Hz, -CH3), 1.27 (8H, m, -(CH2)4), 1.61 
(2H, m, -CH2), 2.30 (2H, dt, 11H13c 7.3Hz, 1vic 7.3Hz, -CH2), 3.66 (3H, d, 11H13c 
3.8Hz -OMe). 8c(CDCl3): 14.04 (C-8), 22.58 (C-7), 24.96 (C-5), 28.73 (C-4), 29.13 
(C-3), 34.09 (d, J13cl3c 57.2Hz, C-2), 51.45 (-OMe), 174.36 (C-1). 
7.75 Methyl [2~2HJgOctanoate (143b) 
Methyl octanoate ( l.Og, 1.14ml, 6.32mmol) was added dropwise to a stirred solution of 
LDA (12.64mmol), generated from diisopropylamine (1.28g, 1.65ml, 12.64mmol), and 
n-butyllithium (7 .89ml, 1.6M solution in hexanes) in THF (50ml) at -7o·c. After 5min 
the reaction mixture was allowed to warm to 18·c and was left to stir at this 
temperature for 1h. MeOD (5ml, excess) was added and the solution left to stir for a 
further 1 h. The reaction mixture was then poured into a saturated solution of 
ammonium chloride (50ml). The aqueous layer was extracted into ether (2x50ml) and 
the combined organic extracts were dried (MgS04), filtered and evaporated under 
reduced pressure. The residue was purified by bulb to bulb distillation (0.01mbar, 
furnace temperature 50.C) to give methyl [2-2H]-octanoate. Deuterium incorporation at 
the a-carbon was =35%, as determined by lH NMR, (735mg, 73%). Vma.x: 2954, 2929, 
2857, 1741, 1461, 1255. m/z(EI+) 159 (M+, -CHD, 24.09%), 158 (M+, -CH2, 40.55%). 
8H(CDCl3): 0.88 (3H, t, 1vic 6.5Hz, -CH3), 1.28 (8H, m, -(CH2)4), 1.62 (2H, m, -CH2), 
2.31 (1.3H, m, -CHD), 3.67 (3H, s, -OMe). ~c(CDCl3): 14.03 (C-8), 22.57 (C-7), 24.93 
(C-6), 28.89 (C-5), 29.08 (C-4), 31.63 (C-3), 33.79 (t, J13c2H 19.7Hz, -CHD, C-2), 
34.09 (-CH2, C-2), 51.40 (-OMe), 174.32 (C-1). 
7.76 Methyl £1.13C, 2-2HJ-Octanoate <143c) 
Methyl [1-13C]-octanoate (942mg, 5.91mmol) was deprotonated with LDA 
( 11.84mmol) and quenched with MeOD (5ml) according to the procedure described in 
section 7.75 to give methyl [1-13C, 2-2H]-octanoate (501mg, 53%). Vma.x: 2955, 2926, 
2855, 1695, 1458, 1177. mlz (EI+) 160 (M+, -CHD, 19.07%), 159 (M+, -CH2, 
35.45%). OH(CDCIJ): 0.87 (3H, t, 1vic 6.6Hz, -CH3), 1.27 (8H, m, -(CH2)4), 1.61 (2H, 
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m, -CH2), 2.30 (0.9H, m, -CHD), 3.65 (3H, d, 1IHI3c 3.8Hz, -OMe). Bc(CDCI3): 14.06 
(C-8), 22.58 (C-7), 24.90 (C-6), 28.91 (C-5), 29.10 (C-4), 31.64 (C-3), 33.80 (dt, 
Jl3ct3c 57. 1Hz, Jl3c2H, 19.1Hz, -CHD, C-2), 34.09 (d, JI3ct3c 57. 1Hz, -CH2, C-2), 
51.44(-0Me), 174.41 (C-1). 
7.77 f2-2HJ-Octanoic Acid (106a) 
Methyl [2-2H]-octanoate (735mg, 4.59mmol) was covered with a 1M solution of KOD 
in D20 (20ml) and heated under reflux for 12h. The solution was allowed to cool and 
was then washed with ether (2x20ml). The aqueous solution was acidified with 50% 
HCl and was then extracted into ether (3x20ml). The combined ethereal extracts were 
dried (MgS04), filtered and evaporated under reduced pressure to give [2-2H]-octanoic 
acid as a clear oil (590mg, 88%). Vmax: 3044br, 2955, 2926, 2857, 1709, 1414, 1290. 
m/z(EI+), 145 (M+, -CHD, 1.78%), 144 (M+, -CH2, 0.79%). DH(CDCIJ): 0.86 (3H, t, 
1vic 6.6Hz, -CH3), 1.28 (8H, m, -(CH2)4), 1.62 (2H, m, -CH2), 2.33 (1.1H, m, -CHD). 
Bc(CDCI3): 13.99 (C-8), 22.57 (C-7), 24.58 (C-6), 28.89 (C-5), 28.98 (C-4), 31.62 (C-
3), 33.38 (t, Jl3c2H 19.1Hz, -CHD, C-2), 24.08 (-CH2, C-2), 180.51 (C-1). 
7.78t-13C. 2-2HJ-Octanoic Acid (106b) 
Methyl [1-13C, 2-2H]-octanoate was hydrolysed according to the procedure described 
in section 7.77 to give [1-13C, 2-2H]-octanoic acid (287mg, 65%). Vmax: 3049br, 2956, 
2928, 2857, 1668, 1395, 1272. m/z(EI+) 146 (M+, -CHD, 0.99%), 145 (M+, -CH2, 
0.51% ). DH(CDCI3): 0.88 (3H, t, I vic 6.5Hz, -CH3), 1.28 (8H, m, -(CH2)4), 1.61 (2H, 
m, -CH2), 2.34 (1.1H, m, -CHD). Bc(CDCI3): 14.05 (C-8), 22.58 (C-7), 24.61 (C-6), 
28.89 (C-5), 29.00 (C-4), 31.61 (C-3), 33.75 (dt, Jl3cl3c 54.6Hz, J13c2H 19.3Hz, 
-CHD, C-2), 34.04 (d, JI3ci3c 54.6Hz, -CH2, C-2), 180.28 (C-1). 
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The Biosynthesis of Hyoscyamine: the Process by which Littorine Rearranges 
to Hyoscyamine 
Richard J. Robins, *·t·8 Nicola C. J. E. Chesters,b David O'Hagan,b Adrian J. Parr,8 
Nicholas J. Walton 8 and Jack G. Woolleyc 
a Institute of Food Research (Norwich Laboratory), Norwich Research Park, Colney, Norwich NR4 7UA UK 
b Department of Chemistry, University of Durham, Science Laboratories, South Road, Durham DH1 3LE, UK 
c Natural Products Research, School of Applied Sciences, De Montfort University, The Gateway, 
Leicester LET 9BH, UK 
The incorporation of isotope from specifically-labelled 3-phenyllactic acid 4 or littorine 7 into 3oc-
phenylacetoxytropane 10, 3ix-phenylacetoxy-6~,7~-epoxytropane and 3oc- (2' -hydroxyacetoxy)-
tropane 9 has been demonstrated. TranSformed root cultures of Datura stramonium or Brugmansia 
(Datura) candida x B. aurea incorporated fed (RS)-3-pheny1[1,3- 13C2]1actic acid 4 into 3oc-
phenylacetoxytropane 10 and 3oc-phenylacetoxy-6~. 7~-epoxytropane with the efficient retention of 
both 13C nuclei. In contrast. no label was incorporated into these two compounds from (RS)-3-
pheny1[2-13C,2-2H]Iactate 4. From this evidence it can be deduced that 3-phenyllactic acid 4 is not 
incorporated into 3oc-phenylacetoxytropane .1 0 via free phenylacetic acid 6. a route which would result 
in the loss of the C-1 of 3-phenyllactic acid 4. Furthermore. (RS)- (3' -phenyl [1 ',3' - 13C2]1actoyl) [methy/-
2H3]tropine (littorine 7) was incorporated into 3oc-phenylacetoxytropane 10. at up to 4% specific 
incorporation. with the retention of all the 13C and 2H nuclei. Label was also incorporated into "3oc- (2'-
hydroxyacetoxy)tropane 9 from (RS)-3-phenyl [1 ,3- 13C2] lactic acid 4 and (RS)- (3' -phenyl [1 ',3'-
13C2] lactoyl) [methyf-2H 3]tropine 7. We propose. on the basis of these observations. a putative process 
for the rearrangement of littorine 7 to hyoscyamine 8 and suggest that both 3oc-phenylacetoxytropane 10 
and 3oc- (2' -hydroxyacetoxy)tropane 9 arise as by-products of the rearrangement process. 
The aromatic moiety of the tropane alkaloids, hyoscyamine 8 
and hyoscine, is (S)-tropic acid. During the biosynthesis of the 
tropoyl moiety from (R)-phenylalanine, a carbon skeletal 
rearrangement of the linear propanoid side chain occurs, 
forming the isopropanoid side chain characteristic of tropic 
acid. 1 It was clearly demonstrated that this rearrangement is 
intramolecular, since hyoscyamine 8 isolated from plants of 
Datura innoxia fed (RS)-phenyl[l ,3-13C2]a:Ianine.had contigu-
ous C-C coupling at the C-1' and C-2' positions in the NMR 
spectrum. Furthermore, it was shown 2·3 that a I ,2-vicinal 
interchange occurs;-the-carboxy residue migrating to C-3 with 
retention of configuration and the 3-pro-(S) proton of (R)-
phenylalanine migrating in the counter direction. 
Aspects of the route by which phenylalanine is incorporated 
into hyoscyamine 8 have been established by a series of recent 
studies. It has been demonstrated that 3-phenyllactic acid 4 is an 
obligatory intermediate; 4·5 alternative putative routes, via such 
intermediates as cinnamic acid, 6 3-hydroxy-3-phenylpropanoic 
acid,6 or 3-amino-2-phenylpropanoic acid 7 have now been 
discarded as improbable. The intermediacy of 3-phenyllactic 
acid was effectively shown by feeding (RS)-3-phenyl[I,3-
13C2]1actic acid 4 both to whole plants of D. stramonium 8 and 
to transformed root cultures of D. stramonium or Brugmansia 
(Datura) candida x B. au rea. 9 In these experiments, contiguity of 
the C-I'.and C-2' in the derived hyoscyamine 8 was observed, 
mimicking the incorporation seen previously from phenyi[I,3-
13C2]alanine.1 That 3-phenyllactic acid 4 is incorporated 
without the intermediacy of phenylpyruvic acid 5 has also been 
shown, firstly by the unaltered 3H: 14C ratio in the derived 
hyoscyamine 8 when (RS)-3-phenyi[I- 14C,2-3H]lactic acid 4 
was fed 4 and, unequivocally, by the incorporation from (RS)-3-
t Present address: Laboratoire de RMN-RC, URA-CNRS 472, Faculte 
des Sciences, 2 rue de Ia Houssiniere, F-44072 Nantes, France. 
phenyi[2- 13C,2-2H]lactic acid 4 of the intact 13C-2H bond into 
the C-3' of the derived hyoscyamine 8. 5 
From these data it may be deduced that the carbon skeletal 
rearrangement occurs subsequent to the intermediacy of 3-
phenyllactic acid 4. One possibility is that free 3-phenyllactic 
acid 4 could be rearranged to form free tropic acid. However, we 
have recently presented evidence 9 • 10 that this is not the case. 
Firstly, the effects of tropic acid on the relative extents to which 
(RS)-3-phenyi[I,3-13C2]lactic acid 4 is incorporated into 
hyoscyamine 8 and littorine 7 by transformed root cultures 
of D. stramonium and B. candida x B. aurea are incompatible-
with free tropic acid being an intermediate in this pathway. 9 
Secondly, littorine 7 has been shown to be a direct precursor for 
hyoscyamine 8, as (RS)-(3' -phenyl[l ',3'- 13C2]lactoyl)[methy/-
2H3]tropine 7 is efficiently converted into hyoscyamine 8 
without loss of label in transformed root cultures of D. 
stramonium. 10 Littorine 7 is, therefore, rearranged directly to 
form hyoscyamine 8. 
We now report the incorporations from (RS)-3-phenyl[I,3-
13C2]lactic acid 4, (RS)-3-phenyi[2-13C,2-2H]Iactic acid 4 
and (RS)-(3' -phenyl[! ',3'-13C2]lactoyl)[methyPH3]tropine 7 
into 3oc-phenylacetoxytropane 10, 3oc-phenylacetoxy-6~, 7~­
epoxytropane and 3oc-(2' -hydroxyacetoxy)tropane 9, as deter-
mined by GC-MS, and discuss the biosynthetic implications o 
the labelling patterns found. These bases all occur as mino 
alkaloids in extracts from transformed root cultures of D. 
stramonium or B. candida x B. aurea, as. well as from othe 
tropane-alkaloid-producing species. 11 3oc-Phenylacetoxytro 
pane 10 could arise from the esterification of tropine 2 wit 
phenylacetyl-coenzyme A 3 (Scheme I). An enzyme capable o 
carrying out this esterification has been found 12 at low level 
in a number of solanaceous species but has so far prove 
intransigent to purification. Similarly, 3oc-(2'-hydroxyacetoxy) 
tropane 9 could arise by the esterification of tropine 2 wit 
2-hydroxyacetyl-coenzyme A in a manner analogous to tha 
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Table 1 The incorporations of(RS)-3-pheny1[1,3- 13C2]lactic acid into tropane alkaloids in transformed root cultures of D. stramonium 
Specific incorporation (%)• 
3a:-(2'-Hydroxyacetoxy)- 3oc-Phenylacetoxy- Hyoscyamine 
tropane 9 tropane 10 8 
Additional acid fed 
(mmol dm-3)b M +I M+ I M + 2 M+ I M + 2 
None 43.3 16.4 37.2 6.1 41.0 
(S)-3-Phenyllactic acid 4 (1.0) 35.7 8.8 33.2 5.0 38.9 
(RS)-3-Phenyllactic acid 4 ( 1.0) 45.1 10.2 44.3 7.2 45.4 
(RS)-Tropic acid (1.0) 48.8 16.0 32.8 7.6 48.5 
a Specific incorporation (%) = 100 X (Excess of isotope in the isolated product)j(Excess of isotope in the precursor). b (RS)-3-Phenyl[1,3-
13C2]1actic acid 4 was fed to all cultures at 0.25 mmol dm-3. 
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Scheme I Alternative putative pathways for the biosynthesis of 3:x-
phenylacetoxytropane 
shown for the formation of 3a-acetoxytropane, 3P-acetoxy-
tropane and 3j3-tigloyloxytropane.13•14 However, the incor-
poration patterns observed in 3a-phenylacetoxytropane ]@, 
3oc-phenylacetoxy-6p, 7p-epoxytropane ·and 3oc-(2'-hydroxy-
acetoxy)tropane 9 are incompatible with the alkaloids arising 
by such routes. Rather, all compounds contain 13C at levels 
that indicate that they have arisen as by-products of the 
rearrangement oflittorine to hyoscyamine. 
JResunlt§ mnclll!)i§Cussiolll 
(RS)-3-Phenyl[I,3- 13C2]1actic acid 4 (0.25 mmol dm-3) was fed 
to 4 day-old ,transformed root cultures of D. stramonium (7 mg 
per flask; 2 flasks; grown on to 14 days) or B. candida x B. aurea 
(7 mg per flask; 4 flasks; grown on to 7 days). The crude 
alkaloidal fractions (3.8 mg from 9~6 g fresh mass and 15.4 mg 
from 19.4 g fresh mass, respectively) were isolated and 
examined by GC-MS. 9 •15 The mass spectra obtained from 
several replicate feedings to D. stramonium all showed a high 
specific incorporation of the label into 3oc-phenylacetoxytro-
pane 10 with the retention of both 13C nuclei (Table 1). The 
specific incorporation observed was not diminished by diluting 
the fed phenyllactic acid to only 16% isotopic excess. Nor was 
the specific incorporation reduced by feeding the culture tropic 
acid, the acidic moiety of hyoscyamine 3: In the Brugmansia 
hybrid, both 3oc-phenylacetoxytropane 110 and 3oc-phenyl-
acetoxy-6p,7p-epoxytropane were labelled (Table 2). Again, 
there was no substantial diminution of specific incorJ,oration 
by added tropic acid. This is the first demonstration that 3-
phenyllactic acid 4 can act as a precursor for 3oc-phenylacetox-
ytropane no and 3occphenylacetoxy-6p,7p-epoxytropane. The 
slightly lower incorporation into 3oc-phenylacetoxy-6p,7p-epox-
ytropane is probably indicative of this compound being a 
metabolite of 3oc-phenylacetoxytropane 10. 16 
The specific incorporations seen in the M + 2 ions of these 
compounds are comparable with those observed in hyoscy-
amine 3 and hyoscine (Tables I and 2).Therefore, the fed (RS)-
3-phenyl[l,3•13C2]lactic acid .:8 cannot have been metabolised 
to 3oc-phenylacetoxytropane no and 3oc-phenylacetoxy-6p,7p-
epoxytropane via free phenylacetic acid 6 (Scheme l) because 
decarboxylation at C-1 of (RS)-3-phenyl[l ,3- 13C2]lactic acid .:8 
would lead to the loss of the enriched nucleus at this position 
and a consequent lack of a M + 2 ion in any subsequent 
metabolites; only an M + I ion would be observed. In fact, 
there is a small enhancement over the natural abundance of the 
M + 1. However, this is much lower than the incorporation 
at the M + 2 level and some enhancement of the M + 1 is to 
be expected, as the (RS)-3-phenyl[l ,3- 13C2]lactic acid 4 used 
contains about 9% (RS)-3-phenyl[l- 13C]Iactic acid and (RS)-
3-pheny1[3-13C]Iactic acid as a result of the synthetic method 
used in its preparation. 8 Incorporation from this source is 
strongly suggested by the comparable M + I incorporations 
into hyoscyamine ~ and hyoscine. In D. stramonium, the 3oc-
phenylacetoxytropane Hl does show a higher M + l than the 
hyoscyamine 3, making it feasible that a route via free 
phenylacetic acid 6 might have made a small contribution 
in this species.~ Nevertheless, the data can only imply that 
it is primarily C-2 of 3-phenyllactic acid 4l that is lost, not 
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Table 2 The specific incorporations of (RS)-3-phenyl[l ,3- 13C2)lactic acid 4 into tropane alkaloids in transformed root cultures of a Brugmansia 
(Datura) candida x B. aurea hybrid 
Specific incorporation (%)a 
3cx-(2' -Hydroxy- 3<X-Phenylacetoxy- Hyoscyamine 3<X-Phenylacetoxy-
acetoxy)tropane 9 tropane 10 8 6(3, 7(3-epoxytropane Hyoscine 
Additional acid fed 
(mmol dm-3)• M +I M+ I M + 2 M +I M + 2 M +I M + 2 M+ I M + 2 
None 41.7 9.5 40.9 7.5 41.3 8.5 32.3 6.8 33.3 
(RS)-Tropic acid (0.25) 30.4 7.6 34.1 8.8 35.0 G 7.5 27.3 6.0 27.9 
(RS)-Tropic acid (0.75) 30.3 5.4 34.8 9.4 36.9 3.9 14.3 3.6 15.2 
a See Table I. • (RS)-Phenyl[l,3- 13C2)lactic acid 4 was fed to cultures at 0.25 mmol dm-3 . 
Table 3 The percentage isotopic excess in tropane alkaloids extracted from transformed root cultures of D. stramonium fed with (RS)-(3'-
phenyl[l ',3'- 13C2)lactoyl)[methyPH 3)tropine (littorine 7) 
Percent isotopic excess a 
3<X-(2'-Hydroxy-
acetoxy)tropane 9 3<X-Phenylacetoxytropane 10 Hyoscyamine 8 
Additional precursor fed 
(mmol dm-3)• M + 3 M +4 M + 2 M + 3 M +4 M + 5 M + 2 M + 3 M + 4 M + 5 
None 5.1 13.0< n.d! n.d. n.d. n.d. 3.3 4.8 1.4 4.5 
Tropine 2 (0.25) 4.9 18.9 2.2 1.9 0.0 4.0 4.3 3.8 2.0 6.5 
(RS)-3-Phenyllactic acid 4 
(0.25) 4.1 16.0 1.8 1.6 0.0 3.3 4.0 3.5 1.8 6.1 
a 100 x Enhancement ofthe isotopic abundance (corrected for natural abundance) relative to the M ion. • (RS)-(3'-Phenyl[1,3- 13C2]lactoyl)-
[methyPH3]tropine (littorine 7) was fed to cultures at 0.125 mmol dm-3 . c Areas under theM + 5 peaks of 3a-(2'-hydroxyacetoxy)tropane 9 
are very small. d n.d. = insufficient area under the peak for quantitation. 
C-1 as would be the case were metabolism to take place via 
6. 
Confirmatory evidence that the C-2 of 3-phenyllactic acid 4 
is not incorporated into 3cx-phenylacetoxytropane 10 was 
obtained in an experiment in which (RS)-3-phenyi[2-13C, 
2-2 H]Iactic acid 4 (0.4 mmol dm-3) was fed to 4 day-old root 
cultures of D. stramoniwn ( 1.2 mg, per flask; 9 flasks, pulse-fed; 
grown on to 19 days). 5 The alkaloid extracted from these 
cultures (40.5 mg) had no mass enhancement of the extracted 
3cx-phenylacetoxytropane 10, even though some oxidation of 
the fed (RS)-3-pheny1[2-13C,2-2H]Iactic acid 4 to phenyl-
pyruvic acid 5 had apparently occurred. In contrast, high 
incorporations into hyoscyamine 8, littorine 7 and apoatropine 
were observed byGC-MS and NMR. 5 IfC-1 were lost, as in the 
route via 5 and 6, then the derived 3cx-phenylacetoxytropane 1 
would have shown a strong M + I enrichment. Thus, it is 
demonstrated directly that during incorporation C-2 of 
phenyllactic acid 4 is lost. 
It is therefore indicated that the biosynthesis of 3cx-
phenylacetoxytropane 10 proceeds via a mechanism which does 
not involve free phenylpyruvic acid 6. Rather, the close 
correlations of the levels of incorporation observed into 
hyoscyamine 8/3<X-phenylacetoxytropane 10 and hyoscine/3<X-
phenylacetoxy-6p, 7P-epoxytropane (Tables I and 2) strongly 
suggest that the mechanism of biosynthesis of these alkaloids 
is closely linked. 
Evidence that hyoscyamine 8 and 3<X-phenylacetoxytropane 
10 have a common biosynthetic origin is provided by the 
incorporation patterns seen after feeding (RS)-(3'-phenyl[l ',3'-
13C2]lactoyl)[methyf-2H3]tropine 7 to cultures of D. stramon-
ium. 10 This quintuply-labelled littorine is incorporated effec-
tively into hyoscyamine 8 (Table 3), indicating that littorine 7 
has rearranged directly. 3<X-Phenylacetoxytropane 10 extracted 
from these cultures is also found to have a significant 
simultaneous incorporation of two 13C and three 2H nuclei to 
give a M + 5 mass ion (Table 3). The level of incorporation of 
the quintuply-labelled littorine 7 into the M + 5 ion of 3<X-
phenylacetoxytropane 10 is lower than into the M + 5 of 
hyoscyamine 8, but still much higher than could have occurred 
via hydrolysis and partial re-use of the labelled material. If label 
from (RS)-(3' -phenyl[!' ,3' - 13C2]lactoyl)[methyPH3]tropine 7 
only enters tropane alkaloids following hydrolysis and the 
separate reincorporation of the two parts of the precursor 
molecule, then products with M + 2 and M + 3 mass spectral 
peaks should be much more prominent than those with 
M + 5. 10 Incorporations into the M + 2 and M + 3 of 
3<X-phenylacetoxytropane 10 are, however, much smaller than 
into the M + 5 (Table 3) and, as a proportion of the total 
incorporation observed, are comparable with those determined 
for theM + 2 arid M + 3 ofhyoscyarnine8. Therefore; it can-
be concluded that littorine 7 acts not only as a direct precursor 
for hyoscyamine 8, as shown previously/ 0 but also as a 
precursor for 3<X-phenylacetoxytropane 10. 
In addition, we have observed that label from (RS)-3-
phenyi[I,3-13C2]lactic acid 4 (Tables I and 2) or (RS)-(3'-
phenyl[l',3'-13C2]lactoyl)[methyf-2H3]tropine 7 (Table 3) is 
incorporated effectively into a M + 1 or M + 4 ion, respec-
tively, of 3<X-(2' -hydroxyacetoxy)tropane 9. As can be seen, the 
level to which this base is labelled is comparable with the 
labelling of both hyoscyamine 8 and 3<X-phenylacetoxytropane · 
10. This would be extremely improbable were it to be derived 
by the esterification of tropine 2 with 2-hydroxyacetyl-
coenzyme A. Furthermore, since no M + 5 ion was seen in 
3<X-(2' -hydroxyacetoxy)tropane 9 it cannot be derived by the 
degradation of hyoscyamine 8, either endogenously or durin 
extraction. Moreover, were 3<X-(2' -hydroxyacetoxy )tropane 
to be derived by the degradation of hyoscyamine, it is likely tha 
3<X-(2' -hydroxyacetoxy)-6p, 7P-epoxytropane, the equivalen 
degradation product of hyoscine, would simultaneously b 
detected. The absence of 3<X-(2' -hydroxyacetoxy)-6p, 7P-epoxy 
tropane from the alkaloidal extract of Brugmansia supports th 
argument that 3<X-(2'-hydroxyacetoxy)tropane 9 is a natura 
metabolite. 
We deduce from these observations that the rearrangement 
484 
of littorine 7 to hyoscyamine 8 involves a reaction mechanism 
which, rarely, results in the loss of the C-2' oflittorine 7, yielding 
3et-phenylacetoxytropane llO or, again rarely, the loss of the 
{C-3' + phenyl}, giving 3et-(2'-hydroxyacetoxy)tropane 9. A 
putative process is indicated in Scheme 2. Retention of the C-1 ', 
C-2' and C-3' of littorine 7 after direct rearrangement to 
hyoscyamine 8 is the predominant outcome. 
8 
o• O~OR] 
.k-Jr "'-.of 1'·2'bond 
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Scheme 2 A putative mechanism for the rearrangement of littorine to 
hyoscyamine (R = tropine; numbering refers to littorine) 
It has been demonstrated 1-3 that the rearrangement involves 
the migration of the C-1 carboxy to C-3 and _the simultaneous 
counter-migration of the 3-pro-(S)-H of phenylalanine (and 
therefore implicitly of 3-phenyllactate 4) to the C-2' of 
hyoscyamine 8. We suggest, theref9re, that the rearrangement is 
initiated by the abstraction of the 3'-pro-(S)-H from liitorine 7. 
·.This process may be anionic or radical in nature. Anionic carbon 
skeletal rearrangements are rare in bioche~istry, whereas 
radical processes have precedent. 17 The potential similarity 
of this vicinal interchange process to methylmalonyl-CoA 
,mutase 18 has been widely discussed. 3•19 Coenzyme 8 12, 
however, isnot associat¢ with Datura plants, 19 which clearly 
limits development of an hypothesis involvi~g this co-factor. 
More reasonably, we suggest thatthe_ radjcal process might be 
initiated by a haem-thiolate enzyme ,(cytochrome P4SO) as 
.described for the flavanone-isoflavapone jsomerisation. 20 In 
r~h~ ligbt of the eviden~ discussed.by, Hakamatsuka et al. 20 that 
;"~uc\1 process~ may account for several o.ther ryarrangements in 
:~plants, we favour a free-radical procesSflS out!Jned in Scheme 2 
:;~nd summarised in Scheme 3. Homolytic abstraction ofthe 3'-
§cheme3 
OH 
'I/ 
"' Fe /'-. 
..... "" .. ,minor 
·,.,. 
bro-(S)-H of littorine 1 would generate a radical at C-3', which 
~ay find stability by transient formation of a cyclopropyl 
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alkoxyl radical. Cleavage of the bond between C-1' and C"2' 
would result in a rearranged free radical at the:C-2' position. 
Return of the sequestered 3' -pro-(S)-H proton from the enzyme 
(or cofactor) to this centre, as demonstrated by Leete, 3 would 
then generate hyoscyamine 8. This is the major reaction. 
Supporting evidence for the involvement of a haem-thiolate 
protein is provided by the presence of 9 and 10 as minor co-
metabolites. In two minor pathways, if the pre- and post-
rearranged radicals are quenched by a hydroxyl radical, rather 
than by a hydrogen radical, then further oxidative processing 
would account for 9 and 10, respectively as- the end products 
of these oxidative pathways. 
The putative intermediacy of 2-formylphenylacetic acid 
between hyoscyamine 8 and 10 has also been suggested 21 and 
is consistent with our hypothesis. The extreme lability of this 
compound in neutral aqueous solution, however, renders it 
impossible to use in feeding experiments . 
The loss of the hydroxymethyl group of the tropate moiety 
could in principle occur subsequent to hyoscyamine 8 
formation. Small amounts of 3et-phenylacetoxytropane 10 and 
3et-phenylacetoxy-6p,7p-epoxytropane can be generated from 
hyoscyamine and hyoscine, respectively, by thermal degradation 
in the heated split/splitless injector during analysis by GC-
MS.11 Several lines of evidence, however, indicate that this is 
not the cause of the isotopic incorporations seen here. Firstly, 
3et-phenylacetoxytropane !0 is detected as a natural product in 
these extracts in GC profiles obtained using a cold on-column 
injector. Standard hyoscyamine 8 and hyoscine do not degrade 
under these conditions. Secondly, no 3«-(2' -hydroxyacetox..y)-
tropane 9 occurs in standard hyoscyamine analysed by Ge-
MS. Thirdly, the M + 4 of 3et-(2'-hydroxyacetoxy)tropane 9 
isolated following.the feeding of quintuply-labelled littorine 7 
has a higher level of incorporation than found in the recovered 
littorine 1 or hyoscyamine fJ: if it were an artifact this could not 
occur. Thus, it can be concluded that the labelling patterns seen 
are not due to post-extraction artifacts but arise from the 
metabolic processes involved in hyoscyamine 8 formation. 
In conclusion, we propose that the unique rearrangement by 
which hyoscyamine 8 is formed from littorine 1 is a free radical 
process initiated by a haem-thiolate enzyme. Additionally, :the 
pre• and post-rearranged radicals are adventitiously· quenched 
by hydroxyl radicals to generate 9 and to after further oxidative 
processes. 
JEx,enimellltal 
Genera/.-{RS)-3-Phenyl[l,3-qC2]lactic acid (atom excess: 
81 ± 2% at M + 2 ion) 8 (RS)-phenyi[2-13C;2-2H]lactic acid 
(atom excess: 99% at M + 2 ion) 5 and (RSH3'.·phenyl[I',3'-
13C2]1actoyl)[methyPH3]tropine (atom;excess: 0% at M ion, 
OYoatM + lion,0.3%atM + 2ion, l.8%atM t- 3ion, 183% 
at M + 4 ion, 81 ± 2% at M + 5 ion) 10 were prepared as 
described. (RS)-3"Phenyllactic acid and tropine were from 
Sigma Ghemical Company (Poole, Dorset, UK). and Aldrich 
Chemical Company (Gillingham, Kent, UK), respectively. 
Cultures.-Root cultures of Datura stramonium'L. Dl5/5 22 
and Brugmansia (Datura) candida X B. aurea 23 were,grown as 
described. Feeding experiments were performed as described 
previously. 
Alkaloid Separation and Identification. -Alkaloids were 
extracted and analysed by GC:-MS essentially as described 
previously. 9 ·1 5 
A:cl!nullwB~iillg~mme:m~§ 
We are gcit~ful rto ·Dr. Peter Qachmann for assistance with 
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feeding experiment; to John Eagles (IFR) and Louise Tatton 
(IFR) for assistance with running the GC-MS analyses; to 
Birgit Drager for valuable discussions; to Abbi Peerless for 
maintaining the cultures; to Morteza Ansarin for the synthesis 
of (RS)-3-phenyi[I,3- 13C2]lactic acid; to the Nuffield Found-
ation, London, for financial support to J. G. W. and to the 
SERC, and the University ofDurham for support toN. C. J. E. C. 
Note in Proof-The stereochemistry of this process is now 
fully established. 24- 26 
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The Biosynthesis of Tropic Acid In Plants: Evidence for the Direct 
Rearrangement of 3-Phenyllactate to Tropate 
Nicola C. J. E. Chesters,a David O'Hagan •.a and Richard J. Robins •.b 
a University of Durham. Department of Chemistry. Science Laboratories. South Road. Durham DH1 3LE. 
UK 
b Plant Biotechnology Group, Department of Genetics and Microbiology, Institute of Food Research. 
Norwich Research Park, Cotney Lane, Norwich NR4 lUA. UK 
Dual labelled sodium (RS) -3-phenyi[2- 13C,2~2H]Iactate was incubated with transformed root 
cultures of Datura stramonium and the incorporation of the label into the tropic acid ester moiety of 
hyoscyamine was assessed by 13C{1H} and 13C{'H,2H} NMR spectroscopy and by GC-MS analysis. 
It is demonstrated that the 13C-2 H bond of sodium (RS)-3-phenyi[2- 13C,2-2 H]Iactate is incorporated 
(GC-MS. M + 2. 17%) intact into the hydroxymethyl group at C~3' of the (S)-tropoyl moiety. This 
result demonstrates unambiguously that 3-phenyllactate is a closer precursor to the tropate ester 
than phenylpyruvate or phenylalanine. 
There has been considerable interest over many years in the 
biosynthesis of (S)-tropic acid 1, the ester moiety of the tropane 
alkaloids hyoscyamine 2 and scopolamine 3. 1·2 It is now well 
established that tropic acid has an origin in (S)-phenylalanine. 3 
Perhaps the most intriguing feature of tropic acid biosynthesis is 
a carbon skeletal rearrangement of (S)-phenylanine to give 
tropic acid (Scheme 1). This was established in a definitive 
study 4 by Leete et al., who fed (RS)-phenyi[I ,J-1 3C2]alanine to 
Datura innoxia plants, and demonstrated that the two labelled 
carbons became contiguous, generating the [1,2-13C2]-tropic 
acid ester in the alkaloids. Subsequent studies 5•6 have 
established that the carboxylate group riugrates with retention 
of configuration at C-3 and that the 3-pro-S hydrogen of (S)-
phen:ylalanine migrates in the reverse direction. This I ,2-vicinal 
interchange process is illustrated in Scheme I. 
L -phenylalanine 
Scheme I 
2 3 
Considerable effort has been expended on identifying. the 
intermediates between phenylalanine and the tropoyl moiety of 
hyoscyamine, scopolamine and other aromatic esters oftropine. 
It ;was demonstrated some time ago that cinnamic acid 7 4, its 
epoxide 8 5 and 3-hydroxy-3-phenylpropanoic acid 9 6 were not 
precursors and we have established 10 that (~S)-3-aqiino-2-
phenylpropionic acid 7, the rearranged product of phenyl-
alanine, is not involved in the process. In contrast, feeding 
experiments with both whole plants 11-13 and root cultures 14 
have established that phenylpyruvic and 3-phenyllactic acids 
VC02H 
0 ~C02H 
h h 
4 5 
OH co2-~co~ d'i~· h 
6 7 
are readily incorporated into a range of tropane alkaloids. The 
rearrangement of 3-phenyllactic acid (or an ester) would give 
tropate directly. That this occurs was clearly demonstrated by 
feeding 3-phenyl[l ,3~ 13C2]lactic acid to whole plants 13 or root 
cultures 14 of D. stramonium and showing the contiguity of the 
13C nuclei in the derived ·hyoscyamine and scopolamine. 
Furthermore, Ansarin and Woolley ha~e demonstrated 11 with 
D. stramonium plants that 3H from (RS)-3-phenyl[l-14C,2-
3H]Iactate is incorporated into the hydroxymethyl group at C-
3' of the tropoyl moiety of hyoscyamine, albeit with a low 
specific incorporation (0.1%). Over a series of experiments, the 
3H: 14C ratio of the ·recovered tropic acid remained similar to 
that of the 3-phenyl[l-14C,2-3H]Iactate administered to the 
plants. This result suggests that 3-phenyllactic acid 9 is an 
obligatory precursor to this group and that it is not first 
oxidised to phenylpyruvic acid 8. Additional evidence from 
competitive feeding, experiments in which phenyl[l- 14C]-
alanine, phenyi[2- 14C]pyruvate or 3-phenyi[I-14C]Iactate 
were fed with added unlabelled precursors, 12 indicates thai 
phenyllactate ·is the closest precursor to the tropoyl moiety 
of hyoscyamine and scfJpolomine. 
We are prompted now to report our results on the in-
corporation of (RS)-3-phenyi[2- 13C,2-2H]lactate 9a into the 
tropic acid ester p10iety of hyoscyamine 2. A dual isotope [ 13C-
2H] labelling strategy was employe9 to allow an unambiguous 
assessment of the fate of the C-2-H bond of phenyllactate 
during tropic acid biosynthesis. Oxidation to phenylpyruvic 
acid 8, with or without subsequent transaminatioq to (S)-
phenylalanine, would result in the loss of the deuterium atom 
(Scheme 2). On the other hand direct rearrangement would 
result in retention of the 13C-2H bond at C-3' in the tropoyl 
moiety of hyosc~amine. The extent of incorporation of 13C 
1160 
I 
? 
-o--------· 
Scheme2 
98 
Scheme 3 Reagents and conditions: i, CH2 N2; ii, LiAlD4 ; iii, 
pyridinium chlorochromate (PCC), 3 A mol sieves; iv, NaHS03 ; v, 
NaCN; vi, 50% HCl; vii, dil. NaOH 
alone will indicate the degree to which phenylpyruvate has 
acted as an intermediary in the incorporation. To this end, 
sodium (RS)-3-pheny1[2- 13C,2-2H]Iactate 9a was prepared 
by the synthetic route outlined in Scheme 3. This double-
labelled precursor was fed to transformed root cultures of D. 
stramonium. These cultures produce hyoscyamine as the pre-
dominant alkaloid 15 with lesser amounts of other alkaloids, 
including littorine. Examination of the crude alkaloidal extract 
by GC-MS showed both labels to have been incorporated into 
littorine, hyoscyamine and apoatropine as indicated by 
enhancementsoftheM + 2ionsby 18, 17and 12%respectively, 
indicating 13C-2H incorporations. Preparative TLC gave 
hyoscyamine 2 containing a small amount ( 4.6%) of littorine lO. 
These two alkaloids have similar chromatographic character-
istics but distinct 13C NMR resonances for the C-1', C-2' and 
C-3' nuclei. Thus, the presence of a small amount oflittorine did 
not interfere when the mixture was examined by 13C{ 1 H} and 
13C{ 1H/H} NMR spectroscopy. In the 13C{ 1H} spectrum 
[spectrum (a) in Fig. I] the incorporation of 13C from 9a into 
the C-3' of the tropate moiety ofl was evident by an enrichment 
at o 63.9.4 Of greater significance however, was a triplet (J"c,'H 
22Hz) shifted further upfield by 0.35 ppm (ex-shift) diagnostic 16 
of the intact incorporation of 13C-2H at C-3' retained from the 
3-phenyi[2-13C,2-2H]Iactate precursor. As expected, this triplet 
collapsed to a singlet in the 13C{ 1 H,2 H} NMR experiment 
[spectrum (b), Fig. 1]. · 
A similar pattern was also evident for the minor peaks at o 
71.5 (singlet) and 71.1 (triplet) in spectrum (a) in Fig. 1, arising 
from 13C- and 13C-2H-enrichments, respectively, at C-2' of the 
3-phenyllactoyl moiety of littorine 1~. The triplet at o 71.1 again 
collapsed to a singlet in the 13C{ 1H,2H} NMR experiment 
[spectrum (b), Fig. I]. These isotopic enrichments clearly arise 
as a result of direct esterification of the labelled 3-phenyllactate 
during littorine biosynthesis. 
It is clear from this study that the C-2-H bond of 3-
phenyllactic acid 9 can remain intact during the rearrange-
ment process to become one of the C-3'-H bonds of the tropoyl 
moiety of hyoscyamine (Scheme 4). This experiment demon-
C-3 
75 70 
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C-3' ~ 
65 
Scheme'il 
C-1 
& 
C-5 
60 
C-3' 
(a) ! 
__luw_ 
(b) 
64.0 63.5 
Fig. l (a) 13C{ 1H} and (b) 13C{ 1H, 2H} NMR spectra of hyoscyamine 
after incorporation of sodium DL-3-phenyl[2-13C,2-2H]lactate. The 
13C-2H incorporation is evident by a triplet in spectrum (a) at li 63.6, 
upfield from the 13C-signal assigned to C-3' of tropate at<> 63.9. The 
triplet collapses to a singlet in spectrum (b) (see inset for clarification). 
The triplet at <> 71.5 in spectrum (a) also collapses to a singlet in 
spectrum (b), 0.35 ppm upfield from the enriched uncoupled signal 
corresponding to C-2' of littorine. The signals from C- I, C-3 and C-5 of 
hyoscyamine are also shown. 
strates unambiguously that 3-phenyllactic acid is a more 
direct precursor than phenylpyruvic acid 3 on the pathway to 
the tropate ester, confirming evidence obtained previously by 
inference. 12 It is noteworthy that there was significant washout 
of deuterium in both the resultant hyoscyamine 2 and littorine 3. 
The mass enhancements, determined by GC-MS, of theM + 1 
ions of littorine and hyoscyamine were 5.1 and 5.7% 
respectively, approximately one-third that of theM + 2 ions. 
This finding indicates that significant loss of the 2H has 
occurred in vivo during the experiment. The most likely cause of 
this is the interconversion of 3-phenyllactate with phenyl-
pyruvate. This contrasts with the previous report that negligible 
loss of 3H relative to 14C occurred. 11 However the operation of 
a kinetic isotope effect and the different biological systems used 
(plants versus root cultures) may invalidate too critical a 
comparison between these two experiments. Littorine has 
recently been demonstrated to be converted directly into 
hyoscyamine. 17 This evidence, coupled with the physiological 
evidence that free topic acid is not incorporated into 
hyoscyamine, 3•14 indicates that the putative mutase enzyme 
involved in hyoscyamine biosynthesis probably acts on littorine 
as a substrate. The similarity of this rearrangement to coenzyme 
8 12-mediated vicinal interchange processes, such as methyl-
malonyi-CoA mutase, has been discussed previously, 2 •6 and is 
becoming increasingly striking. The occurrence ofvitamin-812 
in higher plants is, however, not well documented and the 
J. CHEM. SOC. PERKIN TRANS. I 1994 
involvement of this co-factor must remain speculative. Indeed a 
study 6 by Leete failed to detect any vitamin-B12 from tropane-
alkaloid-producing Datura plants. 
~~~ 
0 
10 
Studies to determine the absolute stereochemistry of the 
3-phenyllactate employed in the rearrangement process, and the 
stereochemical location of the hydrogen mjgrating to C-3' in 
tropate, are ongoing. 
Experimental 
General Details. -IR spectra were recorded on a Perkin-Elmer 
F. T. 1720X or 1600 spectrometer. Mass spectra were recorded on 
a VG Analytical 7070E Organic mass spectrometer. NMR 
spectra were recorded on Varian Gemini 200 MHz e Hat 199.975 
MHz, 13C at 50.289 MHz), Varian XL-200 e Hat 200.057 MHz), 
Varian VXR 400(SW Hat 399.952 13C at 100.577 MHz) and 600 
MHz Edinburgh spectrometers. Chemical shifts are quoted 
relative to TMS (Me4 Si) in CDC13 and H20 in D20, all 
coupling constants are in Hz. GC-MS were recorded on a 
VG TRIO-IS mass spectrometer (VG Masslab Ltd., 
Manchester) fitted with a Hewlett Packard 5890 series II gas 
chromatograph (Hewlett Packard Inc., Fort Collins, USA) 
and a DB-17 column (J&W Scientific, Folsom, USA) was 
used for separation. 18 Flash chromatography was carried out 
using silica gel-60 (35-70 Jlm) (Fiuka) or Sorbsil-C60-H (40-
60 Jlffi). All solvents were dried and distilled prior to use and 
ether refers to diethyl ether. 
2-Phenyl[l- 13C, l-2H2]ethanol.-Phenyl[l-13C]acetic acid 
(1.0 g, 7.34 mmol, 99 atom% 13C, Aldrich Chern. Co. Ltd.) was 
converted directly into its methyl ester by the addition of an 
excess of an ethereal solution of diazomethane. The excess of 
CH2N 2 was destroyed after 5 min by addition of a few drops of 
glacial acetic acid. After the solution had been dried (MgS04 ) 
the solvent was removed under reduced pressure to give methyl 
phenyl[l- 13C]acetate, which was then dissolved in ether (10 
cm3) and added to a stirred suspension of lithium aluminium-
deuteride (1.3 g, 35 mmol) in ether (40 cm3) and the reaction 
mixture was heated under reflux for 2 h under N2. The reaction 
was then quenched by the addition of wet ether (30 cm3) and 
then 5% H2S04 (30 cm3). The aqueous layer was extracted into 
ether (2 x 30 cm3) and the combined organic extracts dried 
(MgS04 ), and evaporated under reduced pressure to give a 
yellow oil. Purification by chromatography over silica gel 
(CH2CI2-ether, 9: 1), afforded 2-phenyl[l-13C,l-2H2]ethanol 
as a clear oil (0.65 g, 5.2 mmol, 71 %); vm • .(neat)/cm-1 3346br, 
3027, 2931, 2190, 2090, 1603, 1496 and 1453; m/z (EI+) 125 
(M+ 38.60%),91 (100);~H(CDCI3)2.15(1 H,s,OH),2.81 (2H, 
d, J"c.'H 5.3, CH2) and 7.25 (5 H, m, ArH); iic(CDCI3 ) 39.5 (d, 
J"c."c 35, C-2), 63.4 (quintet, J"c.'H 21.9, C-1), 126.9 (C-4'), 
129.1 (C-2',-6'), 129.5(C-3',-5')and 139.1 (C-1'). 
Phenyl[1- 13C,l-2H]acetaldehyde.-To a stirred suspension 
of pyridinium chlorochromate (2.9 g, 13.4 mmol) and dry 
powdered 3 A molecular sieves (35 g) in dichloromethane (60 
cm 3) was added 2-phenyl[l- 13C,l-2H2]ethanol (0.65 g, 5.2 
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mmol) and the reaction mixture was stirred vigorously for 2 h. 
The reaction mixture was filtered through a silica gel pad, 
washing with dichloromethane (400 cm3). The solvent was 
removed under reduced pressure to give phenyl[l- 13C,l-2H]-
acetaldehyde (0.533 g, 4.53 mmol, 87%) which was used 
directly, without further purification. 
Selected spectroscopic data from an unlabelled synthesis: 
Vmax(neat)/cm-1 3020, 1725, 1500, 1455, 750 and 700; ~H(CDC1 3) 
3.66 (2 H, d, Jvic 2.3, CH2), 7.30 (5 H, m, Ar-H) and 9.72 (1 H, d, 
2.3, CHO); ~c(CDC13) 50.54 (C-2), 127.4 (C-4'), 129.9 (C-2', 
-6'), 129.6(C-3',-5'), 131.9(C-l')and 199.4(C-l). 
Sodium (RS)-3-phenyl[2- 13C,2-2H]lactate9a.-A solution of 
sodium metabisulfite (1.04 g, 5.47 mmol) in water (5 cm3) was 
added to phenyl[l-13C, l-2H]acetaldehyde (0.533 g, 4.53 mmol) 
and the mixture was shaken vigorously for 10 min. Sodium 
cyanide (0.54 g, 11.02 mmol) was then added in several portions 
to the reaction mixture, and the cyanohydrin could be seen 
formipg as a clear oil after a few minutes. This was then 
extracted into benzene (3 x 15 em 3) and the organic extracts 
were combined, dried (MgS04) and evaporated to afford a clear 
oil. 50% HCI (20 cm3) was added to the oil and the reactiun 
heated under reflux for 2 h. The solution was allowed to 
cool and the product was extracted into ether (3 x 30 cm3). 
The organic extracts were combined, dried (MgS04 ) and 
evaporated to afford (RS)-3-phenyl[2- 13C,2-2H]lactic acid, 
which was recrystallised from chloroform, m.p. 96---98 °C 
(racemate). 
Selected analytical and spectroscopic data from an unlabelled 
synthesis (Found: C, 64.7; H, 5.9. C9H 100 2 requires C, 65.0; H, 
6.02%);~H(CDCI3)2.98 (1 H, dd, JI4, 6.9, CHH), 3.19 (1 H, dd, 
J 14, 4.2, CHH), 4.50 (l H, dd, J 6.9, 4.2, CH) and 7.30 (5 H, m, 
Ar-H); ~c(CDCI3) 40.1 (C-3), 71.0 (C-2), 127.1 (C-4'), 129.6 
(C-2', -6'), 129.5 (C-3', -5'), 135.8 (C-1') and 178.6 (C-1). 
The 3-phenyllactic acid was then dissolved in chloroform (10 
cm3) and covered with water (10 cm3) and the aqueous layer 
was adjusted to pH 8 with aqueous NaOH (0.1 mol dm-3). 
Separation of the aqueous layer and evaporation of the water 
under reduced pressure afforded sodium (RS)-3-phenyl[2-
13C,2-2H]Iactate (128 mg, 0.673 mmol, 15%) as a white 
amorphous solid; ~H(D20) 2.74 (l H, dd, J 8em 14.0, J"c.'H 5.1, 
CH2), 2.97 (l H, dd, J 8em 14.1, J"c.'H 3.8, CH2) and 7.22(5 H, m, 
Ar-H); ~c(D20), 43.1 (d, J"c."c 35.4, C-3). 75.9 (t, J"c.'H 22.4, 
C-2), 129.5 (C-4'), 131.4 (C-2', -6'), 132.3 (C-3', -5') and 14l.l 
(C-1'). An additional signal in the 13C NMR spectrum at ~ 
183.9 was apparent, only in the isotopically enriched 
synthesis, and was estimated to constitute 3.6% of the label. 
This was assigned to the carbonyl resonance of sodium 
phenyl[l- 13C]acetic acid after analysis of the 1H NMR 
spectrum which showed a small doublet (J"c.'H 6.8) in 
the base line at ~ 3.41. Reanalysis of 1H NMR spec-
tra from an unlabelled synthesis showed a minor signal 
(singlet) at~ 3.41, consistent with this interpretation. 
Feeding Experiment and Alkaloid Extraction.-Transformed 
root cultures of D. stramonium D15f5 were maintained and 
grown in B50 medium as previously described. 15 Nine 
subcultured flasks each containing an initial inoculum of 0.5 g 
fresh mass of roots in 50 cm3 of medium were pulse-fed with a 
sterile neutral solution of sodium (RS)-3-phenyl[2-13C,2-
2H]Iactate (21 mmol dm-3) on days 5, 7 and 9 to a final 
concentration of0.4 mmol dm-3 in the medium. The roots were 
harvested after 17 days. The freeze-dried roots (2. 72 g) were 
ground with acid-washed sand and extracted into H2S04 
(0.05 mol dm-3; 60 cm3) by stirring for 15 min. The aqueous 
extract was made basic with 35% NH3 solution (10 cm3) and 
the solution filtered through Kieselguhr (Varian Bondelut *) 
and eluted with CHCI3-Me0H (20: 1). The eluent was 
1162 
evaporated to give a :l)rown oil (40.5 mg), which was purified 
by preparative TLC (CHCIFEt2NH, 9: 1) to afford hyo-
scyamine. (18.1 mg) contaminated with a trace amount of 
littorine (0.83 mg). 
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(a) 
(b) 
-
64.2 63.8 
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Fig. 1 The C-3' resonance at 6 64.05 of the tropate moiety of 1 after 
incorporation of (R)-D-phenyl[2-13C,2H]lactic acid Sa. The intact 13C-
2H incorporation is evident by the triplet at 6 63.7 in (a) corresponding 
to the deuterium-induced ex-shift, and 13C_2H coupling. This triplet 
collapses to a singlet in (b), the 13C{ 1H,2H) spectrum. 
Table 1 Isotope enrichments of alkaloids determined by GCMS 
analysis after feeding experiments with Sa and Sb. Values represent the 
total isotope excess, corrected for natural abundance_? 
1 (hyoscyamine) 
6 (littorine) 
7 
8 
Phenyl[2-'3C,2H]lactate 
(R)-D 
M+ I 
0.8 
1.5 
1.4 
-1.5" 
Sa (S)-L 
M + 2 (%) M +I 
21.7 
28.9 
18.4 
-0.4 
5.1 
10.3 
9.8 
-0.6 
Sb 
M + 2 (%) 
2.4 
3.3 
l.O 
-0.4 
" Negative values represent an error in determination of "'2%. 
tropane 8, from either enantiomer, consistent with our previous 
evaluation 14 that the phenylacetyl ester moiety originates from 
hyoscyamine after rearrangement of littorine. Adventitious 
'oxidative removal of the C-3' carbon of the tropate moiety 
during hyoscyamine formation emerges as the most likely 
pathway to 8. 
These experiments demonstrate unambigiously that (R)-o-
phenyllactate Sa is processed more directly that (S)-L-phenyl-
lactate Sbt and are consistent with (R)-o-littorine 6 as the true 
substrate for the mutase as shown in Scheme 2. (R)-o-Littorine 
is shown to be a precursor of hydroxyacetyl tropane and 
hyoscyamine and by implication 14 of phenylacetoxy tropane. It 
is already established16 that littorine 6 has the (R)-o-configura-
tion and clearly this stereochemical result is consistent with the 
direct interconversion of littorine and hyoscyamine in Datura 
stramonium. Implicit in this conclusion is the role of a (R)-o-
phenyllactate dehydrogenase operating at a pivotal point 
J, CHEM. SOC., CHEM. COMMUN., 1995 
~OR 0-::::yOR ' V Ho'~o D. stramonium ~D 
(R=H5a 
R = tropinyl (l~torine) 6 
l 
0 D00R 
OH 
R = tropinyl 7 
1'-':: 
h 
R = tropinyl 8 
Scheme 2 The metabolic relationship between co-produced alkaloids in 
Datura stramonium. The (R)-o-phenyllactate moiety of littorine 6 is 
converted directly to hyoscyamine 1 and also labels the hydroxyacetyl 
moiety of 7. No isotope is incorporated into the phenylacetyl moiety of 
8. 
between phenylalanine metabolism and alkaloid biosynthesis. 
We thank Dr John Parkinson of the Edinburgh University 
ultra high field NMR Service for recording 13C NMR spectra 
and Mrs Louise Tatton for recording GCMS spectra. The 
EPSRC is gratefully acknowledged for a studentship (N.C. J. E. 
C.) and the University of Durham is thanked for additional 
financial support. 
Received, 25th October 1994; Com. 410654/G 
Footnotes 
t (R)-D-Pheny1[2-13C,2H]Iactate Sa: mp 119-121 °C (lit. 14 124-
125 °C), [cx] 0 23 = +17.28 (c4.6, EtOH); (S)-L-pheny1[2-UC,2H]Jactate 
Sb: mp 120--121 °C, [cx] 0 23 = -16.0 (c 10, EtOH). In both cases 
unlabelled preparations of Sa and Sb gave the higher optical rotation 
values of +22.5 (c 4.4, EtOH) [1it. 14 +19 (c 3.1, EtOH)] for Sa and 
-21.27 (c 23.5, EtOH) for Sb. We attribute this anomaly to the 
presence of the deuterium atom at the chiral centre. The optical purity 
of our samples was found to be at least > 95% ee in each case after 
conversion of Sa and Sb to their methyl ester acetates, by 1H NMR 
using the chiral shift reagent tris[3-heptafluoropropy1hydroxymethy-
lene)-(+ )-camphoratol, europium( III) derivative [Eu(hfch]. 
:j: During the preparation of this manuscript we became aware that Dr 
1. G. Woolley, De Montfort University, Leicester, has drawn a 
complementary conclusion after incorporation studies of (R)-D- and 
(S)-L-phenyl[ I ,3-13C2 ; J-14C]lactate into scopolamine and hyoscyam-
ine from Datura stramonium plants.'5 
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Incubations of (R)-o-phenyi[2-13C,2H]Iactic acid 5s and (S)-L-phenyi[2-13C,2H]Iactic acid 5b with transformed root 
cultures of Datura stramonium have revealed that the 13C-2H bond is retained, intact at C-3 of the tropate moiety of 
hyoscyamine, only in the case of the (R)-o enantiomer 5a (the deuterium is lost from the (S)-L-enantiomer 5b); 0 
therefore, it is the (R)-o-phenyllactate moiety of littorine which is the enantiomer processed by the mutase in 
hyoscyamine biosynthesis. 
The (S)-tropate ester moiety is found in the alkaloids hyoscya-
mine 1 and scopolamine 2 and its biosynthetic origin has been 
the focus of much interest for many years. 1 In 1975 Leete et al. 
showed2 that the tropate moiety of hyoscyamine 1 originates 
from an intramolecular rearrangement of the L-phenylalanine 3 
skeleton. Feeding of L-phenyl[l ,3-13C2]alanine 3 to Datura 
plants resulted in hyoscyamine ll with a [I ,2- 13C2]-labelled 
tropate moiety. The resultant contiguous arrangement of 
isotopes established the intramolecular nature of the rearrange-
ment. Leete also demonstrated3·4 that the carboxylate group of 
phenylalanine 3 migrates to C-3 with retention of configuration 
and that the 3-pro-S hydrogen of L-phenylalanine is abstracted 
during the rearrangement and is delivered to the hydroxymethyl 
carbon, C-3' of 1 (Scheme 1). 
Recently, phenyllactate has been identified5•6 as an obliga-
tory intermediate in tropate biosynthesis in Datura stramonium. 
A radiolabelled study5 showed that the 3H : 14C ratio from fed 
(R,S)-DL-phenyl[l-14C,2-3H]lactate remained essentially the 
same in the recovered hyoscyamine 1 and scopolamine 2. In a 
stable isotope study6 we have demonstrated that the 13C_2H 
bond of (R,S)-DL-phenyl[2- 13C,2H]Iactate 5 is incorporated 
intact into C-3' of ll. Further, in an exciting development, 
Robins et . al. have demonstrated7 that hyoscyamine 1 is 
generated by an intramolecular rearrangement of littorine 6, the 
phenyllactate ester of tropine. The study involved the incorpora-
tion of racemic phenyl[l ,3- 13C2]lactyl-[N-methyPH3]tropine 
o-
Oo/OR 
#f : W mutase 
H0 (vicinal int0rchange) 
H 
Me 
0~ 
Oo/0 
' 
' ObH 
2 
CR=H5n A= tropinyl (lillorine) G 
ScDieme 1 Biosynthetic intermediates and stereochemical summary 
between L-phenylalanine and hyoscyamine in Datura stramonium 
(littorine) and it was shown that the quintuply-labelled pre-
cursor was predominantly incorporated intact, suggesting no 
requirement for tropate ester hydrolysis. These studies lay to 
rest speculationB-11 on the nature of intermediates after L-
phenylalanine and establish littorine 6 as the true substrate for 
the mutase enzyme. The pathway between L-phenylalanine and 
hyoscyamine is summarised in Scheme I . In this and the 
following Communication we report the resolution of the 
remaining stereochemical questions concerning the rearrange-
ment of the phenyllactate moiety of littorine 6 to the tropate 
moiety of hyoscyamine 1. 
It became relevant to establish whether (R)-n- or (S)-L-
phenyllactate is the true substrate for the mutase enzyme. To 
this end we have prepared both sodium (R)-n-phenyl[2-
13C,2H]lactic acid Sa and (S)-L-phenyl[2-13C,2H]lactic acid Sb. 
To achieve this, t11e dual-labelled racemate was synthesised as 
previously described6 and was then resolved into its component 
enantiomers Sa and Sbt by the method of Saigo et a/,12 Due to 
the in vivo interconversion of these enantiomers, via phenyl-
pyruvate 4,13 it was necessary to incorporate deuterium at C-2. 
Clearly any equilibrium with, or processing via phenylpyruvate 
4l, will result in loss of the deuterium atom. Also, the double-
labelling strategy provides a sensitive probe for deuterium 
incorporation as demonstrated previously with the dual-labelled 
racemate of phenyi[2-!3C,2H]lactic acid,6 
The hyoscyamine 1, which was isolated after separate 
feeding experiments of 3 and 4 to transformed root cultures of 
Datura stramonium, was analysed by 13C( 1H} and 13C( IH,2H} 
NMR experiments. From the relevant sections of the 13C NMR 
spectra shown iri Fig. 1 it is apparent that the greater part of (R)-
n-phenyl[2-13C,2H]lactic acid §a is incorporated into hyoscya-
mine with its 13C_2H bond intact. There is a clear ex-shift 
associated with the enriched resonance at 6 64.05 correspond-
ing to C-3', the hydroxymethyl carbon of the tropate moiety of 
:n.. Conversely for (S)-L-phenyl[2-13C,2H]lactic acid 5b, there 
was no ex-shift component associated with the enriched C-3' 
signal at 6 64, indicating that all of the deuterium had been 
washed out. 
GCMS analysis of the crude alkaloidal extracts, conducted 
after each experiment, confirmed this isotopic distribution and 
allowed quantification of the enrichments. The percentage 
enrichments of the M + 1 and M + 2 ions are shown in Table 1. 
Such an analysis also allowed isotopic enrichments into the co-
produced tropane alkaloids 3ex-(2' -hydroxyacetoxy )tropane 7 
and 3ex-phenylacetoxytropane 3 to be evaluated. These alka-
loids are produced at much lower levels and were not 
observable by DC NMR. Of some significance was the M + 2 
ion (18.4%) evaluated for 7 after the (R)-n-phenyl[2-
13C,2H]Jactic acid Sa feeding experiment. This demonstrates 
that one of the C-H bonds of the hydroxymethyl group of 7 
derives intact from C-2 of (R)-phenyllactate, presumably after 
C-2/C-3 sission of littorine, and lends further support to a recent 
proposal 14 from our laboratories defining the metabolic rela-
tionship between these alkaloids. Also, in these experiments 
there was no significant incorporation into 3ex-phenylacetoxy-
130 
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Incubation of (R,S)-DL-phenyi[2-3H]Iactic acid with Datura stramonium generates hyoscyamine 2 with the tritium 
isotope located at C-3' of the tropic acid ester moiety; the C-3' hydroxymethyl group of 2 is converted into a chiral <ll 
methyl group and is oxidised to generate chiral sodium acetate, with the (R) configuration (96% ee); the tritium is 
therefore located at the 3'-pro-S site of 2; it follows that the 3'-pro-R hydrogen is introduced with inversion of 
configuration by the mutase operating during hyoscyamine biosynthesis. 
In the preceding communication1 we report that (R)-D-
phenyllactate is the stereoisomer processed by the mutase 
involved in the interconversion of littorine 1 and hyoscyamine 
2. During the rearrangement, the 3' -pro-S hydrogen of the 
phenyllactate moiety of littorine migrates in a vicinal inter-
change process, with the carbonyl group, to generate tropate.2 
The carbon hydrogen bond at C-3' of the phenyllactate is broken 
and the new carbon-carbon bond is formed with retention of 
configuration. 3 The stereochemical course of the delivery and 
the location of the 3'-pro-S hydrogen after its delivery, to C-3' 
of the tropate moiety have not previously been evaluated and are 
now rep011ed. 
To solve this problem we deployed chiral methyl group 
methodology and our approach is summarised in Scheme 1. 
(R,S)-DL-Phenyl[2-3H]lactic acid 3 [specific activity 204 f.lCi 
mmol- 1) was incubated with transformed root cultures of 
Datura stramonium. The isolated hyoscyamine (50 mg) was 
diluted tenfold with cold hyoscyamine (500 mg) and then 
subjected to barium hydroxide hydrolysis to release the tropate 
moiety. Treatment of an acidic ether extract with diazomethane 
allowed recovery of the tropic acid 4 as its methyl ester 5. 
Conversion of the alcohol moiety of 5 to a mesylate generated 
6, which was then reduced with LiAlD4 (98 atom%). The 
resultant 2-phenyl[1-2H2, 3-3H, 2H]propan-1-ol 7 now posessed 
a chiral methyl group at C-3 of 7, which was chiral by virtue of 
the presence of three isotopes of hydrogen. Oxidation of 7 with 
Kl04-KMn04 , and then steam distillation, allowed chiral acetic 
0 
~OH V Hd 'r D. stramonium 
3 
O.:::::yOR 
' ~.T 
v OH 
iii 
~OR v HO·~T 
R = tropinyl (mtorine) 1 
O~OMe 
' ~-T 
V OMs 
; ( R = tropinyl (hyoscyamine) 2 G 
.. (R=OH4 / 11 R=M05 iv 
D 
o-YOH 
~T 
v HD -~~ H v Na* 
(A)-acetate II 
Scheme 1 Reagents and conditions: i, Ba(OI-Ih; ii, CH2N2 , Et 20, 67% 
from 2: iii. methanesulfonyl chloride, DMAP. pyridine, 0.5 h. 78'7.-: iv, 
LiAID4 , Et20, 2 h, 82'k; v, KI04-KMn04 , 2 h, steam distillation then 
lyophilisation, 16~6 
acid to be isolated.4 After neutralisation with dilute NaOH 
followed by lyophilisation, sodium acetate 8 and sodium 
formate (ratio, acetate: formate 2: l, as determined by 1H 
NMR) were recovered as a mixture. 1H NMR analysis of this 
mixture [specific activity 6.0 ~tCi mmol- 1] distinguished two 
populations of acetate, singly deuteriated and unlabelled, in a 
3:4 ratio. We have deduced that the unlabelled acetate arose 
from another source during the oxidation reaction. Reanalysis 
of the 1H NMR spectrum recorded of 7 prior to its oxidation, 
revealed a trace of diethyl ether, the solvent used in the LiAlD4 
reduction. We therefore attribute the resultant unlabelled acetate 
to oxidation of this material. In the event, it was determined that 
the acetate molecules containing three different isotopes of 
hydrogen had predominantly a single configuration. The chiral 
purity ofthe acetate sample was assayed in the usual mrumer5 by 
the coupled malate synthase/fumarase assay, and indicated the 
(R)-configuration for the acetic acid, with an enantiomeric 
excess of 96% (F value = 77.9). 
Taking into account the stereochemical inversion at carbon 
during the LiAlD4 reduction, it is deduced that the tritium 
isotope occupied the 3'-pro-S site in the tropate moiety of 
hyoscyamine 2. Consequently the migrating hydrogen from the 
3'-pro-S site of phenyllactate must rest in the 3'-pro-R site of 
tropate after the vicinal interchange process. It can be further 
deduced, from a knowledge that (R)-o-phenyllactate is pro-
cessed,1 that the new C-H bond at C-3' of the tropate moiety, 
replaces the old CLC2 bond of phenyllactate with inversion of 
configuration. 
All of the stereochemical features of the reanangement of 
littorine to hyoscyamine are now evaluated and are summarised 
in Scheme 2. The vicinal interchange process has obvious 
similarities to the coenzyme-8 12-mediated rearrangements of 
methylmalonyl-CoA mutase6 and isobutyryi-CoA mutase.7·8 
In both of these cases, however, the migrating hydrogen atom 
replaces the COSCoA group with retention of configuration. 
Therefore the steric course in this respect is opposite. 
We thank Dr Peter Bachmann for assistance with the feeding 
experiments and are grateful to the EPSRC for a studentship 
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Scheme?. Summary of the stereochemical course of the rearrangement 
of littorine ! and hyoscyamine 2 in Datura srramonium 
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of hyoscyamine is indicative of la as a component (42%) of 
the alkaloids where deuterium occurs only on-the adjacent C-2' 
carbon. Thus, from this experiment it is deduced that the 
3-pro-S hydrogen to carbon bond remains intact during the 
rearrangement In the case of 5b the isolated alkaloids contained 
lb (20.8%). The enriched 13C-NMR signal has a single a.-shift 
(Appm = 0.35 ppm) associated with it, consistent with the 
retention of the 13C-2H bond from Sb. Significantly there was 
no evidence of an additional P-shift, and thus there was no 
indication of deuterium retention at C-2' of lb. Thus, the 
3-pro-R hydrogen is lost during the rearrangement process; it 
does not migrate to the adjacent carbon. 
The results of the feeding experiments with Sa and 5b are 
unambiguous and demonstrate that the 3-pro-R hydrogen is 
removed and the 3-pro-S hydrogen retained during the rear-
rangement of (R)-phenyllactate to (S)-tropate. The rearrange-
ment proceeds with stereochemical inversion at this migration 
terminus. Additionally there is no evidence of a vicinal 
interchange process. The 3-pro-R deuterium of 5b was not 
returned at a detectable level to C-3' of the tropate skeleton. In 
order to further reinforce this conclusion we challenged the 
system with (R.S)-[2-13C,3-2H2]phenyllactate (Sc), in which both 
of the C-3 hydrogen atoms are replaced by deuterium. This 
compound was prepared by a modification of our previous 
method3, and the result of the feeding experiment is summarized 
in Scheme 2. The 13C-NMR spectrum of the resultant hyos-
cyamine showed a P-shift (Appm = 0.063 ppm) associated with 
the enriched C-3' carbon atom (64 ppm) indicative of the 
presence of lc (45%). In the light of the above results this 
observation is consistent with the loss of the 3-pro-R, and 
Communications to the Editor 
Scheme 3 
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5 
retention of the 3-pro-S, deuterium atom. There was again no 
evidence of an intact 13C-2H bond (a.-shift) at C-3' of the 
tropate ester; thus we can exclude the operation of a vicinal 
interchange process. 
We can only speculate ,why Leete reached a different 
conclusion in his work.8 Both previous studies7·8 were carried 
out with appropriately labeled (S)-phenylalanines rather than 
the more immediate precursor, (R)-phenyllactate. Some ste-
reospecific loss of tritium during the transamination of (2S,3R( or 
3S))-[2-14C,3-3HJ]phenylalanines cannot be excluded and could 
complicate the interpretation of the previous results. Further-
more, the enantiomeric purity of the labeled (2S,3R(or 3S))-[2-
14C,3-3HJ]phenylalanines at the C-3 stereogenic center in both 
of the previous studies was only about 90% ee and the 
incorporation of the precursors into the alkaloids was very low 
(<1%). Perhaps more importantly, the previous analyses7•8 
relied on 3HJ14C ratios and the definitive conclusion was 
dependent on the complete postbiosynthetic washout of tritium 
at C-2 of the tropate ester moiety of hyoscyamine. If a kinetic 
isotope effect resulted in only partial washout during the 
relatively short (30 min) hydrolysis treatments, then this would 
validate Haslam's original conclusions_? 
In summary, all of the stereochemical aspects of the o-
phenyllactate to tropate rearrangement have been evaluated and 
are summarized in Scheme 3. During carboxylate migration 
an inversion of configuration occurs at both migration termini, 
and we can exclude the back migration of a hydrogen atom in 
a vicinal interchange process, as previously suggested. 8• 
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The biosynthetic ongm of the tropate ester moiety of 
hyoscy!qtline (1) and scopolamine (2) has attracted a lot of 
interest over many years,1 yet many details of the process remain 
obscure. In 1975 Leete et al. showed2 that the tropate moiety 
of ll originates by an intramolecular rearrangement of the (S)-
phenylalanine (~)skeleton. Incorporation studies with (S)-[1,3-
13C2]phenylalanine (.:&) in Datura plants resulted in Jl with a 
l',2'-13C2·labeled tropate moiety as shown in Scheme 1. The 
resultant contiguous arrangement of isotopes established the 
intramolecular nature of the rearrangement. 
~ ~ It' ~ 0~ ~ 0~0 0~0 0 ,,. 
i veo (Y13' O)H OH H 
1 2 3 
We have recently demonstrated3 that (R)-phenyllactate §is 
a closer precursor than (S)-phenylalanine (<&)or (S)-phenyllactate 
to the tropate ester moiety, and in. an illuminating study Robins 
et al.4 ha..;e presented eviden~e which implicates the alkaloid 
littorine J3), the (R)-pherwllac~te ·· est~r of tropine, as the 
su\)strate ·for the rearrangement. This coun~rs the long-held 
contention that tlie rearrangement occurs at ihe coenzyme A 
ester level, whi~h e)(tended the analogy from methylmalonyl-
CoA, mutase which catalyzes a coenzyme B12 mediaied rear-
rangemerit~5 · 
Using.chiral methyl group methodology we have showri6 that 
the carboxylate group at C-2 of (R)-phenyllactate, whicH 
migrates in· the process, is replaced by a hydrogen. atom at· C:3 
ofth\). (S)-tropate ester moiety of ]., with inversion of confiti· 
uratiori.. The stereocheuiistcy atthe other migration terminus 
has been;probed in two _previous hue contradictory studies7•8 
utilizing approptiately labeled· (2S,3R(or 3S))-[2-14C,3-3Hil-
phenylalanines. Haslam ~t az.7 concluded that the 3-pio-R 
hydTogen w~ lost during the rearrange111ent and thus, the new 
t University of Durham. 
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c-c bond was formed with inversion of configuration. 
However, in a reevaluation of this issue, Leete8 concluded that 
the 3-pro~S hydrogen was replaced with retention of configu-
ration. Leete argued that tritium at C-2' in the resultant tropate 
ester was susceptible to washout, during the base hydrolysis 
required to release free tropic acid, prior to scintillation counting. 
The hyoscyamine was stirred in either NaOH or Ba(OH)2 
solution for 30 min prior to workup. Thus, if this is taken into 
account in the Haslam study, 7 then the absence of tritium at 
this site was not a consequence of the stereochemical course of 
the reaction, but of chemical manipulation. A fwther conclusion 
of Leete's study8 was that the 3-pro-S hydrogen underwent an 
intra- or intermolecular vicinal interchange with the migrating 
carboxylate group and was returned to C-3' of the tropate ester 
moiety. This further strengthened the analogy between this 
rearrangement and methyln:ialonyl-CoA mutase, where such a 
vicinal interchange is well established.5 
Since our recent stereochemical study has established an 
inversion of configuration at the other migration terminus, the 
enzyme appeared to mediate a reten!,ionlinversion process, which 
is difficult to reconcile with a viciiial interchange process. Such 
a process would require the putative mutase to remove and 
deliver the migrating hydrogen to opposite faces of the substrate. 
We therefore decided to reinvestigate this issue. The knowledge 
that (R)-phenyllactate is a more proximate precursor of ll than 
is <$, and the availability of transformed root cultures which give 
much higher levels of precursor iricoiporatiQn (20...:..45% for § 
into 1),3 ·allowed a more defmitive-examination ofthe reaction 
stereochemistry than was possible at the time. of the earlier 
sfudies. Using dual labeled (2H ahd 13C) sampl~s O.f §, the 
regiospecific location of the deuteritim atoms in the resultant 
samples of ll could,. be determined :directly' by 13C-NMR 
spectr()scopy by employing a t3C lal:>ef at C-2 ofS a§ a reporter 
atoin, without recourse to hydrolysis and isolatiol) of tropic acid. 
Deuterium dit:ectly·attached to or one bond rerriove(j ·from a 
carbon~l3 atom induces a detectable a- or ·p~upfield-shifted 
sign3J., respectively, in the 13C{1H,2H}-NMR spectrirm:9 
(2R,3S)-[2-13C,3-2H1,phenyJ-2H5]-Phenyllactate (§a)Cmying 
deuterium at the J.:pro-S site and (2R,3RH2-13C,2,3-2H2}· 
phenyllaciaie (§b) cap}ting deuterluiiHt the 3~pro-R site' were 
prepare<f.,by-appropriate modifications to the route described 
by Ffryzuk and Bosnich.10 In each case [2-I3C]glycine was wed 
as . a starting material; For. §a [2~]benzaldehyde tl replaced 
benzaldehyde, and for §b) ·deuterium· gas was used in place of 
hydroge•i.gas. The. stereochemical:integritj of this synthetic 
protocol is already demonstrated, and as expected,'. the ee's. of 
compounds §a and §b were judged io be '96% by GG analysis 
of the~Mosher: s :ester derivatives o( tlje methyl ~sters of the 
phenyllactates. ·compounds §a· aD.c:J'SII) were then' introduced 
i.rito .submerged· cultures, of D~ stramonium,: arid the"resultant 
erode hyoscyamine samples were purified by chromatogrnphy3b 
and analyzed bynC{ 1H,2H}-NMR .. The (esultS are suinm.arized 
in Scheme 2, _ In the case of§~ a·p~shift (.!1ppm := 0.064 ppm) 
associated with:the:;caroon-13. signal ( oc :=::. 64 ,ppm)::f6r C-'3' 
. .-. - . - . . ""-
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_ :(II) The first sample synthesized; the (2R,3S} isomer Sa, also carried 
five atoms of deuterium· in the aromatic ring tofacilitate aiia,Iysis of the 
product by mass spectroscopy, should this become nec~ssary. 
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